Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
32 "Oxidative stress"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Basic and Translational Research
Article image
PUM2 Lowers HDAC9 mRNA Stability to Improve Contrast-Induced Acute Kidney Injury through Attenuating Oxidative Stress and Promoting Autophagy
Wei Chen, Hengcheng Lu, Wenni Dai, Hao Li, Yinyin Chen, Guoyong Liu, Liyu He
Received July 18, 2024  Accepted May 21, 2025  Published online September 10, 2025  
DOI: https://doi.org/10.4093/dmj.2024.0396    [Epub ahead of print]
  • 4,375 View
  • 49 Download
  • 2 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Contrast-induced acute kidney injury (CIAKI) is the third cause of hospital-acquired acute kidney injury and diabetes mellitus (DM) was identified as a risk factor for CIAKI. However, the molecular mechanism underlying DM-CIAKI remains unclear, which needs further investigation.
Methods
DM-CIAKI models of mice and cells were established. The functions of kidneys were evaluated by detecting indicators and using hematoxylin and eosin staining. The abundance of genes and proteins was evaluated by real-time quantitative reverse transcription polymerase chain reaction, immunohistochemistry, immunofluorescence, and Western blot. Glutathione peroxidase, superoxide dismutase, and malondialdehyde were measured using commercial kits and reactive oxygen species was detected using dihydroethidium (DHE) probe and 2ʹ,7ʹ-dichloroflfluorescein diacetate (DCFH-DA) method. Apoptosis of tissues and cells was evaluated by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL). Cell viability and proliferation were measured using Cell Counting Kit-8 and 5-ethynyl-2ʹ-deoxyuridine (EdU) assay. The interaction between pumilio RNA binding family member 2 (PUM2) and histone deacetylase 9 (HDAC9) was validated using RNA immunoprecipitation (RIP) and RNA pull-down.
Results
PUM2 expression was observably reduced in DM-CIAKI models while HDAC9 expression was notably boosted. Subsequently, PUM2 silencing resulted in aggravation of kidney injury in DM-CIAKI mice through enhancing oxidative stress and suppressing autophagy, while HDAC9 inhibitor or HDAC9 silencing achieved the opposite results. In terms of mechanism, PUM2 could suppress stability of HDAC9 mRNA to attenuate HDAC9 expression. Furthermore, HDAC9 overexpression abolished PUM2 overexpression-mediated oxidative stress inhibition and autophagy promotion in high glucose and contrast media treatments-induced human kidney-2 (HK-2) cells.
Conclusion
PUM2 overexpression suppressed oxidative stress and promoted autophagy to alleviate renal injury in DM-CIAKI through interacting with HDAC9 mRNA, which mediated degradation of HDAC9 mRNA and inhibition of HDAC9 expression.

Citations

Citations to this article as recorded by  
  • Purpurin Rescues Contrast-Induced Acute Rat Kidney Injury via Inducing Autophagy and Inhibiting Apoptosis
    Kangxu He, Xiaoying Sun, Xinhui Pan, Xiaoda Yang, Qi Wang, Kai Liao
    Pharmaceuticals.2026; 19(1): 116.     CrossRef
  • Rubia cordifolia L. Dichloromethane Extract Ameliorates Contrast-Induced Acute Kidney Injury by Activating Autophagy via the LC3B/p62 Axis
    Xiaoying Sun, Kangxu He, Guanzhong Chen, Xiaoda Yang, Xinhui Pan, Kai Liao
    Molecules.2026; 31(2): 316.     CrossRef
Sulwon Lecture 2024
Basic and Translational Research
Article image
Overcoming β-Cell Dysfunction in Type 2 Diabetes Mellitus: CD36 Inhibition and Antioxidant System
Il Rae Park, Yong Geun Chung, Kyu Chang Won
Diabetes Metab J. 2025;49(1):1-12.   Published online January 1, 2025
DOI: https://doi.org/10.4093/dmj.2024.0796
  • 11,678 View
  • 464 Download
  • 9 Web of Science
  • 9 Crossref
AbstractAbstract PDFPubReader   ePub   
Type 2 diabetes mellitus (T2DM) is marked by chronic hyperglycemia, gradually worsening β-cell failure, and insulin resistance. Glucotoxicity and oxidative stress cause β-cell failure by increasing reactive oxygen species (ROS) production, impairing insulin secretion, and disrupting transcription factors such as pancreatic and duodenal homeobox 1 (PDX-1) and musculoaponeurotic fibrosarcoma oncogene family A (MafA). Cluster determinant 36 (CD36), an essential glycoprotein responsible for fatty acid uptake, exacerbates oxidative stress and induces the apoptosis of β-cells under hyperglycemic conditions through pathways involving ceramide, thioredoxin-interacting protein (TXNIP), and Rac1-nicotinamide adenine dinucleotide phosphate oxidase (NOX)-mediated redoxosome formation. Targeting CD36 pathways has emerged as a promising therapeutic strategy. Oral hypoglycemic agents, such as metformin, teneligliptin, and pioglitazone, have shown protective effects on β-cells by enhancing antioxidant defenses. These agents reduce glucotoxicity via mechanisms such as suppressing CD36 expression and stabilizing mitochondrial function. Additionally, novel insights into the glutathione antioxidant system and its role in β-cell survival underscore its therapeutic potential. This review focuses on the key contribution of oxidative stress and CD36 to β-cell impairment, the therapeutic promise of antioxidants, and the need for further research to apply these findings in clinical practice. Promising strategies targeting these mechanisms may help preserve β-cell function and slow T2DM progression.

Citations

Citations to this article as recorded by  
  • Small‐Molecule Sarco/Endoplasmic Reticulum Ca2+‐ATPase Activators Reverse Methylglyoxal‐Induced Inhibition through Nonantioxidant Mechanisms
    Carlos Cruz‐Cortés, Silvia Micháliková, Petronela Rezbáriková, L. Michel Espinoza‐Fonseca, Jana Viskupičová
    ChemMedChem.2026;[Epub]     CrossRef
  • Bone Marrow Mesenchymal Stromal Cells and Their Derived Extracellular Vesicles Protect Pancreatic Beta‐TC‐6 Cells From Hypoxia‐Induced Injury via miR‐539‐3p‐Mediated Downregulation of CD36 Expression
    Na Lin, Yaoyao Liang, Minying Tang, Fei Liu, Liuyan Chen, Lvying Wu, Yunfeng Fu, Zhuoyu Li, Lingfeng Zhu, Jin Chen, Yuelin Zhang
    Stem Cells International.2026;[Epub]     CrossRef
  • Polygonatum sibiricum polysaccharides enhance pancreatic β-cell function in diabetic zebrafish by mitigating mitochondrial oxidative damage via the AMPK-SIRT1 pathway
    Fan Lin, Wenjing Yu, Ping Li, Shuyao Tang, Yitong Ouyang, Liya Huang, Di Wu, Shaowu Cheng, Zhenyan Song
    Frontiers in Nutrition.2025;[Epub]     CrossRef
  • Melatonin Improves Lipid Homeostasis, Mitochondrial Biogenesis, and Antioxidant Defenses in the Liver of Prediabetic Rats
    Milena Cremer de Souza, Maria Luisa Gonçalves Agneis, Karoliny Alves das Neves, Matheus Ribas de Almeida, Geórgia da Silva Feltran, Ellen Mayara Souza Cruz, João Paulo Ferreira Schoffen, Luiz Gustavo de Almeida Chuffa, Fábio Rodrigues Ferreira Seiva
    International Journal of Molecular Sciences.2025; 26(10): 4652.     CrossRef
  • From Glucotoxicity to Lung Injury: Emerging Perspectives on Diabetes-Associated Respiratory Complications
    Hongmei Yu, Jie Liu, Xiaojuan He
    Lung.2025;[Epub]     CrossRef
  • Quercetin as an Anti-Diabetic Agent in Rodents—Is It Worth Testing in Humans?
    Tomasz Szkudelski, Katarzyna Szkudelska, Aleksandra Łangowska
    International Journal of Molecular Sciences.2025; 26(15): 7391.     CrossRef
  • Preclinical Evaluation of 2-Aminobenzothiazole Derivatives: In Silico, In Vitro, and Preliminary In Vivo Studies as Diabetic Treatments and Their Complications
    Natalia Reyes-Vallejo, Miguel Valdes, Adelfo Reyes-Ramírez, Juan Andres Alvarado-Salazar, Alejandro Cruz, Erik Andrade-Jorge, Jessica Elena Mendieta-Wejebe
    Molecules.2025; 30(16): 3427.     CrossRef
  • Metal organic frameworks (MOFs) synthesis and their use as a loading agent in oxidative stress-based diseases
    Muhammad Saqib Saif, Sana Batool, Yusra Majeed, Asadullah, Tuba Tariq, Li Haitao, Yanjun Duan, Ghazala Mustafa, Murtaza Hasan
    Journal of Environmental Chemical Engineering.2025; 13(5): 118725.     CrossRef
  • Synergism of Synthetic Sulfonamides and Natural Antioxidants for the Management of Diabetes Mellitus Associated with Oxidative Stress
    Ancuța Dinu (Iacob), Luminita-Georgeta Confederat, Ionut Dragostin, Ionela Daniela Morariu, Dana Tutunaru, Oana-Maria Dragostin
    Current Issues in Molecular Biology.2025; 47(9): 709.     CrossRef
Original Article
Basic Research
Article image
N6-Methyladenosine Methyltransferase METTL3 Alleviates Diabetes-Induced Testicular Damage through Modulating TUG1/Clusterin Axis
Yuan Tian, Yue-Hai Xiao, Chao Sun, Bei Liu, Fa Sun
Diabetes Metab J. 2023;47(2):287-300.   Published online January 19, 2023
DOI: https://doi.org/10.4093/dmj.2021.0306
  • 6,534 View
  • 185 Download
  • 13 Web of Science
  • 15 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
The present study investigated the regulatory effects of N6-methyladenosine (m6A) methyltransferase like-3 (METTL3) in diabetes-induced testicular damage.
Methods
In vivo diabetic mice and high glucose (HG) treated GC-1 spg cells were established. The mRNA and protein expressions were determined by real-time quantitative polymerase chain reaction, Western blot, immunofluorescence and immunohistochemistry staining. Levels of testosterone, blood glucose, cell viability, and apoptosis were detected by enzyme-linked immunosorbent assay, MTT, and flow cytometry, respectively. Molecular interactions were verified by RNA immunoprecipitation and RNA pull-down assay. Histopathological staining was performed to evaluate testicular injury.
Results
METTL3 and long non-coding RNA taurine up-regulated 1 (lncRNA TUG1) were downregulated in testicular tissues of diabetic mice and HG-treated GC-1 spg cells. METTL3 overexpression could reduce the blood glucose level, oxidative stress and testicular damage but enhance testosterone secretion in diabetic mouse model and HG-stimulated GC-1 spg cells. Mechanically, METTL3-mediated m6A methylation enhanced the stability of TUG1, then stabilizing the clusterin mRNA via recruiting serine and arginine rich splicing factor 1. Moreover, inhibition of TUG1/clusterin signaling markedly reversed the protective impacts of METTL3 overexpression on HG-stimulated GC-1 spg cells.
Conclusion
This study demonstrated that METTL3 ameliorated diabetes-induced testicular damage by upregulating the TUG1/clusterin signaling. These data further elucidate the potential regulatory mechanisms of m6A modification on diabetes-induced testicular injury.

Citations

Citations to this article as recorded by  
  • GALNT3-mediated AKT1 glycosylation activates the AKT1/CREB signaling pathway to inhibit high glucose-induced spermatogenic cell apoptosis and mitochondrial dysfunction
    Yong Zhao, Jia Luo, Lu Wu
    Biochemical and Biophysical Research Communications.2026; 802: 153329.     CrossRef
  • Targeting lncRNA-mediated networks to overcome doxorubicin resistance in cancer
    Mengru Qiu, Zhaoting Wang, Yuanyin Teng, Mengxi Li, Fan Wu, Yu Tian
    Critical Reviews in Oncology/Hematology.2026; 221: 105214.     CrossRef
  • Rbbp6-Mediated Bmal1 Ubiquitination Inhibits YAP1 Signaling Pathway to Promote Ferroptosis in Diabetes-Induced Testicular Damage
    Yuan Tian, Zhiqiang Zhu, Jun Qiao, Bei Liu, Yuehai Xiao
    Diabetes & Metabolism Journal.2025; 49(2): 210.     CrossRef
  • METTL3 promotes podocyte pyroptosis in diabetic nephropathy through N 6 -methyladenosine modification of TRIM29 mRNA
    Xiaohong Xu, Xiaolin Huang, Ce Zhang, Xia Mi, Chi Zhang, Fei Hua, Liexiang Zhang
    Renal Failure.2025;[Epub]     CrossRef
  • The m6A transferase METTL3 regulates high glucose-induced proliferation and apoptosis of human lens epithelial cells through the lncRNA TUG1/KHSRP/p38MAPK signaling axis
    Yuxuan Li, Ziyi Yao, Xiaoqin Gao, Yaxin Niu, Ziqing Gao, Shengqun Jiang
    Experimental Eye Research.2025; 258: 110492.     CrossRef
  • METTL3 alleviates renal tubular mitochondrial dysfunction by regulating the TUG1/PGC-1a axis in an IGF2BP2-dependent manner in diabetic nephropathy
    Tong Chen, Juan Wang, Yanyan Xu, Yonghong Zhu, Ying Jin, Qiuling Fan
    Renal Failure.2025;[Epub]     CrossRef
  • m6A modification of non‑coding RNA: Mechanisms, functions and potential values in human diseases (Review)
    Qian Yi, Yi Liao, Wei Sun, Jiachen Li, Dahang Yang, Hongxi Shang, Weichao Sun
    International Journal of Molecular Medicine.2025; 56(4): 1.     CrossRef
  • The role of m6A methyltransferase METTL3 in metabolism-related diseases: Mechanism and clinical implications
    Libao Cui, Wang Jun, Yan Ying, Hengrong Fang
    Pharmacological Research.2025; 221: 107962.     CrossRef
  • Regulation of m6A methylation in the immune microenvironment in the development of diabetes mellitus
    Haoyue Deng, Qiang Liu, Yanning Gong, Yue Qiu
    Journal of Translational Medicine.2025;[Epub]     CrossRef
  • Mechanism of the traditional Chinese medicine SMBJ alleviates diabetes mellitus-induced Leydig cell dysfunction in rats testes
    Wenxiu Zhang, Yuanyuan Liu, Li Tong, Yihan Jin, Chao Gao, Yugui Cui, Baofang Jin, Dalin Sun
    Scientific Reports.2025;[Epub]     CrossRef
  • Negative Regulation of LINC01013 by METTL3 and YTHDF2 Enhances the Osteogenic Differentiation of Senescent Pre‐Osteoblast Cells Induced by Hydrogen Peroxide
    Jiaxin Song, Yuejun Wang, Zhao Zhu, Wanqing Wang, Haoqing Yang, Zhaochen Shan
    Advanced Biology.2024;[Epub]     CrossRef
  • Diabetes and diabetic associative diseases: An overview of epigenetic regulations of TUG1
    Mohammed Ageeli Hakami
    Saudi Journal of Biological Sciences.2024; 31(5): 103976.     CrossRef
  • BRD7 facilitates ferroptosis via modulating clusterin promoter hypermethylation and suppressing AMPK signaling in diabetes-induced testicular damage
    Yuehai Xiao, Zongjian Liang, Jun Qiao, Zhiqiang Zhu, Bei Liu, Yuan Tian
    Molecular Medicine.2024;[Epub]     CrossRef
  • Roles of m6A modification in regulating PPER pathway in cadmium-induced pancreatic β cell death
    Yifei Sun, Rongxian Li, Wenhong Li, Nan Zhang, Guofen Liu, Bo Zhao, Zongqin Mei, Shiyan Gu, Zuoshun He
    Ecotoxicology and Environmental Safety.2024; 282: 116672.     CrossRef
  • METTL14-Mediated m6A Modification of TUG1 Represses Ferroptosis in Alzheimer's Disease via Inhibiting GDF15 Ubiquitination
    Xunhu Gu, Yuanqing Song, Xu Liu, Zhijuan Cheng, Jun Min, Yangbo Zhang
    Frontiers in Bioscience-Landmark.2024;[Epub]     CrossRef
Review
Complications
Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
Chan-Young Jung, Tae-Hyun Yoo
Diabetes Metab J. 2022;46(2):181-197.   Published online March 24, 2022
DOI: https://doi.org/10.4093/dmj.2021.0329
  • 35,749 View
  • 1,498 Download
  • 162 Web of Science
  • 176 Crossref
AbstractAbstract PDFPubReader   ePub   
Although diabetic kidney disease (DKD) remains the leading cause of end-stage kidney disease eventually requiring chronic kidney replacement therapy, the prevalence of DKD has failed to decline over the past 30 years. In order to reduce disease prevalence, extensive research has been ongoing to improve prediction of DKD onset and progression. Although the most commonly used markers of DKD are albuminuria and estimated glomerular filtration rate, their limitations have encouraged researchers to search for novel biomarkers that could improve risk stratification. Considering that DKD is a complex disease process that involves several pathophysiologic mechanisms such as hyperglycemia induced inflammation, oxidative stress, tubular damage, eventually leading to kidney damage and fibrosis, many novel biomarkers that capture one specific mechanism of the disease have been developed. Moreover, the increasing use of high-throughput omic approaches to analyze biological samples that include proteomics, metabolomics, and transcriptomics has emerged as a strong tool in biomarker discovery. This review will first describe recent advances in the understanding of the pathophysiology of DKD, and second, describe the current clinical biomarkers for DKD, as well as the current status of multiple potential novel biomarkers with respect to protein biomarkers, proteomics, metabolomics, and transcriptomics.

Citations

Citations to this article as recorded by  
  • Diabetic kidney disease: exploring mechanistic depths and the future of pharmacological intervention
    Pratik Shankar Rakshe, Anil Bhanudas Gaikwad
    Naunyn-Schmiedeberg's Archives of Pharmacology.2026; 399(2): 1625.     CrossRef
  • β-sitosterol potential against chronic hyperglycemia induced diabetic nephropathy: A dual approach using computational and in-vivo studies
    Sachin Sharma, Manjusha Choudhary, Jeevan K, Onkar Sharma, Hari Kishan, Ashwani Mittal
    Journal of Ethnopharmacology.2026; 357: 120934.     CrossRef
  • Diabetic peripheral neuropathy as measured using a point‐of‐care sural nerve conduction device is associated with a faster decline in renal function in patients with type 2 diabetes
    Tatsuya Fukuda, Akiko Fujii, Taro Akihisa, Naoya Otsubo, Tetsuya Yamada, Chisato Maki
    Journal of Diabetes Investigation.2026; 17(2): 291.     CrossRef
  • Duration-dependent alterations of lipid profiles and microvascular complications in GCK-MODY
    Yadi Huang, Yuxin Fan, Yang Liu, Xuan Liu, Wei Li, Ying Yang, Ziyue Zhang, Shifeng Ma, Shuhui Ji, Shanshan Chen, Hua Shu, Wenli Feng, Kunling Wang, Qing He, Wenjun Qi, Ming Liu, Xin Li, Yu Fan
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2026; 1872(3): 168137.     CrossRef
  • Extracellular vesicles in diabetic kidney disease: Emerging mechanisms, therapeutic implications, and biomarker prospects
    Yang Yu, Yunjie Shan, Anjie Ding, Hui Qian
    Biochemical Pharmacology.2026; 244: 117605.     CrossRef
  • S-methylmethionine ameliorates renal injury in diabetic mice by modulating macrophage inflammaging via ERK/NF-κb signaling pathway
    Hao Dong, Linjie Shen, Pawuziya Abulizi, Yuezhang Sun, Lulingxiao Nie, Aimin Cui, Qian Fu, Ning Ji, Yuwen Luo, Chienshan Chen, Aimin Xu, Wai Keung Leung, Qi Wang
    International Immunopharmacology.2026; 170: 116038.     CrossRef
  • A non-invasive urinary diagnostic signature for diabetic kidney disease revealed by machine learning and single-cell analysis
    Yonggang Chen, Jintai Luo, Yingying Zheng, Xiaomei Jiang, Zixiang Yang, Xiaobing Liu, Yusuf Oloruntoyin Ayipo
    PLOS One.2026; 21(1): e0340096.     CrossRef
  • Emerging technologies for early risk stratification and precision management of diabetic kidney disease: a multimodal framework integrating digital phenotypes and clinical biomarkers
    Lingdong Meng, Zhen Li, Ling Xu, Fang Wei, Hongyan Ji, Lankun Zhang, Anning Zhu, Zhijia Zhou
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Glycerol-selective biosensor and microbial biofuel cell based on recombinant yeast and glycerol dehydrogenase nanocomposite
    Nataliya Stasyuk, Andriy Zakalskiy, Daria Larowska-Zarych, Oksana Zakalska, Susanna Kushnir, Iryna Slyvka, Olha Demkiv, Sylwester Gawinkowski, Marcin Holdynski, Wojciech Nogala, Mykhailo Gonchar
    Microchemical Journal.2026; 221: 116853.     CrossRef
  • C‐X‐C Motif Chemokine Ligand 3 as a Potential Biomarker for Diagnosis and Prognosis of Diabetic Kidney Disease
    Sensen Su, Xin Chen, Li Zhang, Hui Yu, Han Qin, Lin Li, Zhanchuan Ma, Yinyu Yu, Zhonggao Xu, Huanfa Yi
    The FASEB Journal.2026;[Epub]     CrossRef
  • The triglyceride-high-density lipoprotein-glucose-body index: a superior novel biomarker for diabetic kidney disease in type 2 diabetes
    Jian Yang, Bingsong Xie, Zhiling Deng, Zhifu Zhang, Hairong Zhou
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Diabetic kidney disease, biomarkers, and finerenone
    Ashish Verma, Ashish Upadhyay
    Diabetes, Obesity and Metabolism.2026;[Epub]     CrossRef
  • Functional Molecular Plasma Biomarkers of Inflammation and Repair in Kidney Disease Progression in Gum Arabica Modality of CKD
    Sameeha AlShelleh, Maysa Suyagh, Hussein Alhawari, Nailya Bulatova, Violet Kasabri, Ayman Wahbeh, Izzat Alawwa, Ashraf Oweis, Haneen Mustafa
    International Journal of Molecular Sciences.2026; 27(2): 973.     CrossRef
  • Integrated Transcriptomic Analysis Identifies TAP1 as a Key Regulator of PANoptosis in Diabetic Kidney Disease Tubular Injury
    Qingsong Chen, Hongxuan He, Gang Wang, Lili Huang, Jiakun Yang, Yan Sun, Zheng Zhang, Xiaohui Liao
    Inflammation.2026;[Epub]     CrossRef
  • Network Pharmacology Prediction and Molecular Docking Validation of Active Components of Atractylodes macrocephala in Intervening Diabetic Nephropathy
    新宇 刘
    Journal of Clinical Personalized Medicine.2026; 05(01): 414.     CrossRef
  • Integrated network pharmacology and bioinformatics analysis reveals MME as key target of Notoginsenoside R1 in diabetic nephropathy
    Xinyu Gan, Mingzhu Liang, Halinuer Shadekejiang, Huan Hong, Jinyu Lu, Xu Li, Xueqin Zhang, Chen Lu
    BMC Complementary Medicine and Therapies.2026;[Epub]     CrossRef
  • Characterization of gut microbiota in patients with diabetic kidney disease
    Shoujuan Yu, Huimin Niu, Yan Zhang, Ling Yu, Qi Zhang, Xingchen Liu, Yue Sang, Ran Wang, Min Zhang
    Frontiers in Cellular and Infection Microbiology.2026;[Epub]     CrossRef
  • N6-methyladenosine in inflammatory diseases: Important actors and regulatory targets
    Zewen Li, Yongfeng Lao, Rui Yan, Fuhan Li, Xin Guan, Zhilong Dong
    Gene.2025; 936: 149125.     CrossRef
  • Proteomics exploration of metformin hydrochloride for diabetic kidney disease treatment via the butanoate metabolism pathway
    Jinxuan Chai, Yan Wang, Sifan Guo, Zhibo Wang, Hongwei Chen, Xian Wang, Dandan Xie, Ying Cai, Shiwei Wang, Zhencai Hu, Aihua Zhang, Shi Qiu
    Journal of Pharmaceutical and Biomedical Analysis.2025; 254: 116584.     CrossRef
  • Global research hotspots and trends in oxidative stress-related diabetic nephropathy: a bibliometric study
    Xiao-rong Wang, Zeng Wu, Tong-tong He, Xiao-han Chen, Xiao-fei Jin, Chun-yue Zuo, Shao-ze Yang, Yu Gao, Xiao-hong Zhou, Wei-juan Gao
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Implementing novel complete blood count-derived inflammatory indices in the diabetic kidney diseases diagnostic models
    Ali Hassanzadeh, Mehdi Allahdadi, Sepehr Nayebirad, Nazli Namazi, Ensieh Nasli-Esfahani
    Journal of Diabetes & Metabolic Disorders.2025;[Epub]     CrossRef
  • NR4A1 silencing alleviates high-glucose-stimulated HK-2 cells pyroptosis and fibrosis via hindering NLRP3 activation and PI3K/AKT pathway
    Jin-Meng Li, Zi-Hua Song, Yuan Li, Han-Wen Chen, Han Li, Lu Yuan, Jing Li, Wen-Yue Lv, Lei Liu, Na Wang
    World Journal of Diabetes.2025;[Epub]     CrossRef
  • Association between drinking patterns and diabetic kidney disease in United States adults: a cross-sectional study based on data from NHANES 1999–2016
    Xusheng Yang
    Renal Failure.2025;[Epub]     CrossRef
  • Mechanisms, Biomarkers, and Treatment Approaches for Diabetic Kidney Disease: Current Insights and Future Perspectives
    Jean Paule Joumaa, Angela Raffoul, Charbel Sarkis, Elizabeth Chatrieh, Sally Zaidan, Philippe Attieh, Frederic Harb, Sami Azar, Hilda E. Ghadieh
    Journal of Clinical Medicine.2025; 14(3): 727.     CrossRef
  • Investigation of the role and mechanism of dapagliflozin in mitigating renal injury in rats afflicted with diabetic kidney disease
    Hao Wang, Xiuli Zhao, Xiao Wang, Yi Gong, Songping Li, Yanting Gu, Bosai He, Jiahong Wang
    Biochemical Pharmacology.2025; 233: 116795.     CrossRef
  • Progress in the application of novel inflammatory indicators in chronic kidney disease
    Wenrui Gao, Xiangyu Wang, Yulin Zou, Sheng Wang, Jun Dou, Senlin Qian
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Serum advanced glycation end products as a putative biomarker in Type2 DKD patients’ prognosis
    Ze-Hou Wang, Zong-Jin Zhang, Yue-Fen Wang, Jin Xie, Yi-Min Li, Cun Shen, Yuan Meng, Wen-Jing Zhao, Lu-Ying Sun, Wei Jing Liu
    Frontiers in Physiology.2025;[Epub]     CrossRef
  • The Potential of Blood KIM‐1 as a Biomarker in Early Diagnosis of Diabetic Kidney Disease
    Ningjie Gong, Qian Wang, Zhaoqing Cong, Lezhi Xu, Wenqian Yang, Yang Du
    iLABMED.2025; 3(1): 29.     CrossRef
  • Detection of Fast Decliner of Diabetic Kidney Disease Using Chiral Amino Acid Profiling: A Pilot Study
    Yosuke Hirakawa, Tomonori Kimura, Shinsuke Sakai, Masayuki Mizui, Masashi Mita, Yoshitaka Isaka, Masaomi Nangaku, Reiko Inagi
    Chemistry & Biodiversity.2025;[Epub]     CrossRef
  • Biomarkers: New Advances in Diabetic Nephropathy
    Yujia Chen, Xinan Liu, Meniga Shengbu, Qian Shi, Suolang Jiaqiu, Xianrong Lai
    Natural Product Communications.2025;[Epub]     CrossRef
  • Uncovering the mechanism of Huangkui capsule in the treatment of diabetic kidney disease based on network pharmacology and experimental validation
    Junhong Liu, Ziwei Li, ZongYao Zhang, Zhongyuan Shen
    Scientific Reports.2025;[Epub]     CrossRef
  • Melatonin attenuates kidney injury by alleviating lysosomal damage in diabetic kidney disease
    Jiaqi Chen, Shuting Zhang, Xiaoquan Xue, Xiaoqin Ma, Aomiao Chen, Yichuan Wu, Geningyue Wang, Qian Zhang, Yaoming Xue, Yijie Jia, Zongji Zheng
    Acta Biochimica et Biophysica Sinica.2025; 57(10): 1589.     CrossRef
  • Association of normal range of urinary albumin‐to‐creatinine ratio with all‐cause mortality among diabetic adults with preserved kidney function: National Health and Nutrition Examination Survey (NHANES) 2003–2018
    Xiaoxia Pang, Wenchao Dan, Lan Lin, Huimei Li, Xiangrong Rao, Shen Li
    Diabetes, Obesity and Metabolism.2025; 27(5): 2670.     CrossRef
  • Oxidative protein destruction products as markers of chronic kidney disease progression in diabetes mellitus
    MV Osikov, LA Efros, LYu Zhuravleva, AA Fedosov
    Bulletin of Russian State Medical University.2025;[Epub]     CrossRef
  • Research Progress of Factors Influencing Bleeding of Percutaneous Nephrolithotomy
    丽梅 王
    Advances in Clinical Medicine.2025; 15(03): 1580.     CrossRef
  • Serum metabolic profiling of patients with diabetic kidney disease based on gas chromatography-mass spectrometry
    Xueyan Bian, Chenwen Wang, Majie Wang, Ailing Yin, Jiayan Xu, Mijia Liu, Hui Wang, Yating Cao, Xin Huang, Chenxue Qin, Ye Zhang, Heming Yu
    Frontiers in Molecular Biosciences.2025;[Epub]     CrossRef
  • A Machine Learning-Based Prediction Model for Diabetic Kidney Disease in Korean Patients with Type 2 Diabetes Mellitus
    Kyung Ae Lee, Jong Seung Kim, Yu Ji Kim, In Sun Goak, Heung Yong Jin, Seungyong Park, Hyejin Kang, Tae Sun Park
    Journal of Clinical Medicine.2025; 14(6): 2065.     CrossRef
  • Association of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in population with cardiovascular-kidney-metabolic syndrome stages 0–4: evidence from a large cohort study
    Fan-Shun Guo, Jia-Hao Dou, Jun-Xiang Wang, Chen Guo, Rui-Yun Wu, Xue-Lu Sun, Yi-Wei Hu, Jin Wei
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • Progress and perspectives of metabolic biomarkers in blood sample for diabetic microvascular complications
    Li Yan, Xu Wang, Yujie Xiang, Shuyi Ru, Cheng Fang, Xiuhong Wu
    Metabolomics.2025;[Epub]     CrossRef
  • Predicting diabetic kidney disease with serum metabolomics and gut microbiota
    Yuyun Hu, Xue Ni, Qinghuo Chen, Yihui Qu, Kanan Chen, Gaohui Zhu, Minqiao Zhang, Ningjie Xu, Xu Bai, Jing Wang, Yanhong Ma, Qun Luo, Kedan Cai
    Scientific Reports.2025;[Epub]     CrossRef
  • Loureirin B analogs mitigate oxidative stress and confer renal protection
    Haowen Fang, Xiaodong Sun, Yanting Ding, Bing Niu, Qin Chen
    Cellular Signalling.2025; 132: 111787.     CrossRef
  • Circulating Neutrophil and Monocyte Ratios to High Density Lipoprotein-Cholesterol Are Elevated with Increased Triglyceride-Glucose Index
    Ishwarlal Jialal, Beverley Adams-Huet
    International Journal of Clinical and Translational Medicine.2025; : 5.     CrossRef
  • Cardiovascular Risk Reduction in Patients with Type 2 Diabetes: What Does the Cardiologist Need to Know?
    Martin Berger, Nikolaus Marx, Katharina Marx-Schütt
    European Cardiology Review.2025;[Epub]     CrossRef
  • Contemporary Perspectives on Chronic Renal Disorders
    Deenadhayalan Ashok, Poornima Ajay Manjrekar, Bhushan C. Shetty, Sujina S. S, Rukmini Mysore Srikantiah, Sowndarya Kollampare
    Chronic Diseases and Translational Medicine.2025; 11(2): 89.     CrossRef
  • Baseline comorbidity of cardiovascular-kidney-metabolic syndrome increases the risk of adverse clinical outcomes in patients with chronic kidney disease
    Jiali Meng, Wen Li, Wenjing Fu, Aihua Zhang
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Yangonin Attenuates Streptozotocin-induced Diabetic Nephropathy in Rats via Downregulating Oxidative Stress and Inflammatory Responses
    Zhenzhen Hao, Lin Li, Youlan Gong, Yang Xu
    Pharmacognosy Magazine.2025; 21(4): 1562.     CrossRef
  • The association between the cardiac metabolic index and rapid kidney function decline and CKD in individuals with different glucose metabolism statuses: results from the China health and retirement longitudinal study
    Wei-Zhen Tang, Qin-Yu Cai, Tai-Hang Liu, Tao-Ting Li, Gao-hui Zhu, Jia-cheng Li, Kang-Jin Huang, Hong-Yu Xu, He-Zhe Hua, Rong Li
    Lipids in Health and Disease.2025;[Epub]     CrossRef
  • Systemic immune indicators for predicting renal damage in newly diagnosed type 1 diabetic children
    Lan-Fang Cao, Qing-Bo Xu, Li Yang
    World Journal of Diabetes.2025;[Epub]     CrossRef
  • Shenzhuo formulation ameliorates diabetic nephropathy by regulating cytochrome P450-mediated arachidonic acid metabolism
    Zhong-Yong Zhang, Yu-Ming Wang, Ning Wang, Yuan-Song Wang, Hui Zhang, Duo Wang, Li-Xin Wang, Huan-Tian Cui, Wei-Bo Wen, Shu-Quan Lv, Yong-Jun Cao
    World Journal of Diabetes.2025;[Epub]     CrossRef
  • An update on renal tubular injury as related to glycolipid metabolism in diabetic kidney disease
    Anqi Feng, Ruili Yin, Rong Xu, Baoyu Zhang, Longyan Yang
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Revealing VCAN as a Potential Common Diagnostic Biomarker of Renal Tubules and Glomerulus in Diabetic Kidney Disease Based on Machine Learning, Single-Cell Transcriptome Analysis and Mendelian Randomization
    Li Jiang, Jie Jian, Xulin Sai, Xiai Wu
    Diabetes & Metabolism Journal.2025; 49(3): 407.     CrossRef
  • Dynamic DNA methylation of EPHX2 in diabetic kidney disease progression: A potential biomarker
    Guoxiong Deng, Ziyi Feng, Xiaomu Kong, Peng Gao, Yongwei Jiang, Yi Liu, Meimei Zhao, LiangMa
    Gene Reports.2025; 40: 102245.     CrossRef
  • Histone deacetylases and their inhibitors in kidney diseases
    Yue Zheng, Tie-Ning Zhang, Peng-Hui Hao, Ni Yang, Yue Du
    Molecular Therapy.2025; 33(8): 3485.     CrossRef
  • Spinach Extract Reduces Kidney Damage in Diabetic Rats by Impairing the AGEs/RAGE Axis
    Javier Flores-Estrada, Agustina Cano-Martínez, Luz Ibarra-Lara, Adriana Jiménez, Carmen Palacios-Reyes, Luis J. Pinto García, María G. Ortiz-López, Olga Nelly Rodríguez-Peña, Luis Barbo Hernández-Portilla
    International Journal of Molecular Sciences.2025; 26(10): 4730.     CrossRef
  • KIM-1 como biomarcador de lesão tubular renal em pacientes com diabetes mellitus tipo 2 normoalbuminúricos e com resistência à insulina
    Laura Eduarda de Oliveira, Clóvis Paniz, Rafael Noal Moresco, José Antonio Mainardi de Carvalho
    Brazilian Journal of Nephrology.2025;[Epub]     CrossRef
  • KIM-1 as a biomarker of kidney tubular damage in normoalbuminuric patients with type 2 diabetes mellitus and insulin resistance
    Laura Eduarda de Oliveira, Clóvis Paniz, Rafael Noal Moresco, José Antonio Mainardi de Carvalho
    Brazilian Journal of Nephrology.2025;[Epub]     CrossRef
  • Role of Physical Activity in Reducing Diabetic Kidney Disease Risk in Adults: Data From the National Health and Nutrition Examination Survey, 2017–2018
    Wirampa Tanglai, Apichai Wattanapisit, Osamu Watanabe, Thanakrit Jeamjitvibool, Mark Lockwood, Mia Cajita
    Diabetes/Metabolism Research and Reviews.2025;[Epub]     CrossRef
  • Genetics of diabetes and its complications: a comprehensive review
    Abdul Sami, Ahsan Javed, Dilber Uzun Ozsahin, Ilker Ozsahin, Khalid Muhammad, Yasir Waheed
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • Serum metabolic profiling in diabetic kidney disease patients using ultra-high performance liquid chromatography-tandem mass spectrometry
    Bin Zhang, Chunmei Dai, Jiuyi Jiang, Jun Wang, Yuwei Yang, Jiafu Feng
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • Urine Biomarkers for Diabetic Kidney Disease Progression in Participants of the Chronic Renal Insufficiency Cohort Study
    Sarah J. Schrauben, Xiaoming Zhang, Dawei Xie, Steven Coca, Jason H. Greenberg, Joachim H. Ix, Michael G. Shlipak, Chi-yuan Hsu, Jonathan J. Taliercio, Chirag R. Parikh, Orlando Gutierrez, Mark J. Sarnak, Mirela A. Dobre, Debbie Cohen, Jeffrey R. Schellin
    Clinical Journal of the American Society of Nephrology.2025; 20(7): 958.     CrossRef
  • Melatonin Protects Against Diabetic Kidney Disease via the SIRT1/NLRP3 Signalling Pathway
    Yaping Zhang, Yinghui Wang, Jingyan Yang, Gang Liu
    Nephrology.2025;[Epub]     CrossRef
  • Apelin Alleviated Endothelial‐To‐Mesenchymal Transition via Increasing BKCa in Diabetic Nephropathy
    Chunmeng Fan, Yu Liu, Jing Chang, Mingcong Huang, Zihao Gao, Huade Wang, Xiang Zheng, Menghe Li, Jialiang Xu, Jiming Yin, Xiangjun Zeng
    The FASEB Journal.2025;[Epub]     CrossRef
  • Association Between DNA Methylation of MTHFR and Diabetic Kidney Disease
    Guoxiong Deng, Ziyi Feng, Xiaomu Kong, Peng Gao, Yongwei Jiang, Yi Liu, Meimei Zhao, Liang Ma, Kalyani Sen
    Journal of Diabetes Research.2025;[Epub]     CrossRef
  • PHGDH alleviates DKD by regulating YB1/SLC7A11-mediated ferroptosis in podocytes
    Yinghui Wang, Qingqing Zhang, Shasha Lv, Xueling Wang, Qingzhen Liu, Xiangchun Liu, Yaping Zhang, Gang Liu
    Translational Research.2025; 282: 1.     CrossRef
  • Comparative effectiveness of traditional Chinese medicine injections combined with ACEI/ARB for diabetic nephropathy: A systematic review and network meta-analysis
    Aijing Li, Maoying Wei, Chan Wu, Dan Yin, Yiting Tang, Yijia Jiang, Churan Wang, Jingyi Guo, Anning Sun, Xin Gu, Yanbing Gong
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Fecal microbiota transplantation is a promising therapy for kidney diseases
    Jiawei Zhang, Xiangge Ren, Bing Li, Zhifen Zhao, Shoudao Li, Wensheng Zhai
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Kaempferol improves mitochondrial homeostasis via mitochondrial dynamics and mitophagy in diabetic kidney disease
    Chenhui Xia, Jiale Zhang, Huixi Chen, Weimin Jiang, Shaofeng Zhou, Huijuan Zheng, Weiwei Sun
    International Immunopharmacology.2025; 162: 115121.     CrossRef
  • Polygonati Rhizoma Polysaccharides Ameliorated Diabetic Kidney Disease in db/db Mice via Inhibiting TGFβ/Smad2 Signaling Pathway
    Xiyu Mei, Zeming Ren, Ziyun Gao, Sisi Chen, Xuan Chen, Qingyun Zhou, Yeling Tong, Guanhai Dai
    Food Science & Nutrition.2025;[Epub]     CrossRef
  • Therapeutic Potential of Cinnamic Acid as an SGLT2 Inhibitor in Mitigating Diabetic Nephropathy in a Rat Model of Type 2 Diabetes
    Setah Naif Alotaibi, Ghedeir M. Alshammari, Nawal A. Albadr, Mohammed Abdo Yahya
    Molecular Nutrition & Food Research.2025;[Epub]     CrossRef
  • Asprosin Levels in Adults with Type 2 Diabetes Mellitus and Diabetic Kidney Disease: A Systematic Review and Meta-Analysis
    Jovana Ristic, Sena Kodalak, Gonzalo Peralta-Jiménez, Maria Moura de Lima, Marijana Kovacevic, Srdjan Masic, Tatjana Nikolic
    Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 2493.     CrossRef
  • Notch signaling in diabetic kidney disease: recent progress
    Zhi-Hui Wang, Wei Tu, Ya-Ni Long, Peng-Fei Li, Kai-Ying He, Jing Wu
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Sirtuin 3 in diabetic kidney disease: mechanisms and pharmacotherapy
    Yinfeng Chen, Ying Wang, Dongrong Yu, Hailing Zhao, Ping Li
    Renal Failure.2025;[Epub]     CrossRef
  • Mechanism of Rhizoma Chuanxiong for the treatment of diabetic kidney disease based on network pharmacology
    Yuhe Yan, Honghong Shi, Yue Li, Xing Wan, Jinxin Li, Lihua Wang
    Renal Failure.2025;[Epub]     CrossRef
  • The potential adding therapeutic effect of pentoxifylline and/or folic acid for chronic kidney disease patients: randomized controlled trial
    Amira Reda Muhammad Galal, Nahla Mohamed Teama, Karema Abu–Elfotuha, Ahmed D. Alatawi, Hanan Alshareef, Ahmed M. E. Hamdan, Ahmed Aljabri, Mohannad Alshibani, Zeinab AlKasaby Mahmoud Zalat
    BMC Nephrology.2025;[Epub]     CrossRef
  • Association between a diabetes-predictive index and diabetes-related kidney disease in U.S. adults: A cross-sectional study
    Haonan Wu, Zheng Nan
    Preventive Medicine Reports.2025; 58: 103225.     CrossRef
  • Asprosin Aggravates Tubular Epithelial Cell Injury and Phenotypic Transformation via Mitochondrial Dynamics Disorder Mediated by Excessive Drp1 SUMOylation in Diabetic Nephropathy Mice
    Qianqian Huang, Xiaowei Xiong, Sheng Chen, Yuan Wang, Li Wang, Wentao Liu, Chen Liu, Guohua Zeng, Qiren Huang
    Advanced Science.2025;[Epub]     CrossRef
  • C3AR1 may aggravate diabetic nephropathy by mediating oxidative stress via ITGB2 regulation in renal tubular epithelial cells
    Alex Abura, Shan Gao, Shinsuke Yuasa
    PLOS One.2025; 20(9): e0331900.     CrossRef
  • Exploration of the renoprotective effect of Yi-Shen-Hua-Shi granules on db/db mice and the mechanism of podocyte apoptosis based on the GRP78/CHOP signaling pathway
    Yanmo Cai, Yunhua Liu, Sitong Wang, Ge Jin, Kaidong Zhou, Xin Zhou, Xinxue Zhang, Min Zhang, Zongjiang Zhao
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Protective effects of Shenkang injection against diabetic kidney disease via p38 MAPK/NFκB/MCP-1/CCR2 pathway inhibition
    Xin Zhou, Sitong Wang, Ge Jin, Kaidong Zhou, Yanmo Cai, Zongjiang Zhao
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Prevalence of diabetes and prediabetes among working-age adults and influencing factors of new-onset diabetes: a five-year cohort study (2018–2023)
    Jing Tan, Mingzhu Chen, Yang Lei, Xiaofen Shi, Cuiping Cao, Naili Du, Yuyou Yao, Xiaojuan Yao
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Celastrol, a bioactive compound from Tripterygium wilfordii, exerts renoprotective effects by modulating the gut-kidney axis and PPAR signaling in a mouse model of diabetic kidney disease
    Yue-Wen Tang, Jia-Wei Cao, Meng-Dan Lu, Ru-Chun Yang, Feng Wan
    Asian Pacific Journal of Tropical Biomedicine.2025; 15(9): 353.     CrossRef
  • Expression Profile of Urinary Exosomal miRNAs in Patients With Diabetic Kidney Disease and Their Association With Kidney Damage
    Juan Li, Lulu Han, Ting Wang, Lin Yang, Hong Zhou, Pawel Grzmil
    International Journal of Endocrinology.2025;[Epub]     CrossRef
  • Commentary on: Inhibition of LINC00707/miR‐223‐3p/FKBP5 axis has a protective effect on diabetic kidney disease
    Yirui Zhao, Fengyue Zhang
    Journal of Diabetes Investigation.2025; 16(12): 2251.     CrossRef
  • Research on Glycemic Variability Characteristics in Diabetic Patients Undergoing Hemodialysis
    俊杰 苏
    Journal of Clinical Personalized Medicine.2025; 04(05): 100.     CrossRef
  • Short-Term: Cellular Metabolism and Gene Expression During the Onset of Diabetic Kidney Disease: A Diabetes Mellitus Experimental Model
    Jéssica Encinas, Glaucia Veiga, Joyce Raimundo, Matheus Perez, Giuliana Petri, Renan Cavalheiro, Pedro Reis, Laura Maifrino, Beatriz Alves, Fernando Fonseca
    International Journal of Molecular Sciences.2025; 26(19): 9676.     CrossRef
  • Construction of a diagnostic model and identification of effect genes for diabetic kidney disease with concurrent vascular calcification based on bioinformatics and multiple machine learning approaches
    Lili Huang, Wenjing Wu, Shenhui Lv, Danfang Deng, Xiaoqin Wang
    Frontiers in Molecular Biosciences.2025;[Epub]     CrossRef
  • Selected miRNAs in Urinary Extracellular Vesicles Show Promise for Early and Specific Diagnostics of Diabetic Kidney Disease
    Karina Barreiro, Jenni Karttunen, Erkka Valo, Essi Viippola, Ileana Quintero, Annemari Käräjämäki, Antti Rannikko, Harry Holthöfer, Andrea Ganna, Niina Sandholm, Lena M. Thorn, Per‐Henrik Groop, Tiinamaija Tuomi, Om Prakash Dwivedi, Maija Puhka
    Journal of Extracellular Biology.2025;[Epub]     CrossRef
  • Metabolic reprogramming in diabetes and other endocrine and metabolic disorders: exploring the Warburg effect, ketones, and SGLT2 inhibitors
    Pedro Carrera-Bastos, Marcel H. A. Muskiet, Fernando Mata-Ordoñez, Leo Pruimboom, Alejandro Lucia, Raul M. Luque, Frits A. J. Muskiet
    Reviews in Endocrine and Metabolic Disorders.2025;[Epub]     CrossRef
  • Multi-omics and machine learning identify FN1 and ALDH2 as diagnostic biomarkers and therapeutic targets in early and late diabetic kidney disease
    Jingwei Lin, Yingying Zheng, Diman Mai, Fuxiang Fang, Zhuokun Wei, Mengyu Liu, Trung Hieu Pham, Ming Li, Jiawen Zhao
    Renal Failure.2025;[Epub]     CrossRef
  • Yiqi Wenyang Formula ameliorates diabetic kidney disease via inhibiting inflammation and regulating the gut microbiota-bile acid axis in mice by FXR signaling pathway
    Tongyi Yuan, Xiang Gao, Xinxin Wang, Xiaolei Tang, Zuguo Liang, Yifei Yin, Songyan Liu, Jianze Ou, Wenjie Su, Zepeng Zhang, Xiangyan Li, Qingxia Huang, Daqing Zhao, He Zhang
    Chinese Medicine.2025;[Epub]     CrossRef
  • Qing-Re-Xiao-Zheng-yi-qi formula protects renal function by stabilizing lysosomal membranes and inhibiting NLRP3-inflammasome-mediated pyroptosis in diabetic kidney disease
    Lei Tian, Lin Wang, Yutong Wang, Weijing Liu, Wenjing Zhao, Yaoxian Wang
    Annals of Medicine.2025;[Epub]     CrossRef
  • Andrographolide alleviates type 2 diabetic nephropathy through suppressing PI3K/AKT1/RRM2-triggered oxeiptosis
    Mingzheng Han, Jingchun Wang, Shuaihao Guo, Heyun Zhu, Lijiao Zhao, Ziqi Wu, Yijin Wu, Jianying Guo, Jianzhao Liao, Zhaoxin Tang
    Journal of Advanced Research.2025;[Epub]     CrossRef
  • The Inflammatory Cell Death in Diabetic Kidney Disease: Integrating Multifactorial Mechanisms into Novel Therapeutics
    Bin Fang, Wei Huang, Sijia Du, Yu Hao, Fangfang He, Chun Zhang
    International Journal of Molecular Sciences.2025; 26(22): 11033.     CrossRef
  • Rhein Inhibits Podocyte Ferroptosis and Epithelial-Mesenchymal Transition in Diabetic Nephropathy by Activating the SIRT1/p53/SLC7A11 Pathway
    Wei Hu, Dan Xiong
    BIOCELL.2025; 49(9): 1711.     CrossRef
  • Diagnostic Roles of circXPNPEP3 as Biomarker for Diabetic Nephropathy
    Miao Liu, Qiunan Zhan, Junjun Zhu, Junli Zhao, Danyan Min
    Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 4287.     CrossRef
  • Protective Effects of Hydrogen Treatment Against High Glucose-Induced Oxidative Stress and Apoptosis via Inhibition of the AGEs/RAGE/NF-κB Signaling Pathway in Skin Cells
    Pan Yu, Nan Hong, Qiong Wu, Zhipeng Zhao
    Endocrine, Metabolic & Immune Disorders - Drug Targets.2025;[Epub]     CrossRef
  • The Clinical Significance of Serum Sirtuin 2 in Diabetic Nephropathy: Evidence for a Potential Biomarker of Renal Injury
    Ozgur Yilmaz, Osman Erinc, Murvet Algemi, Recep Demirci, Sengul Aydin Yoldemir, Murat Akarsu
    Journal of Clinical Medicine.2025; 14(22): 8095.     CrossRef
  • The “Picasso faces” of diabetic kidney disease – how the art of phenotyping and molecular biomarkers is transforming clinical nephrology: an observational study in patients with type 2 diabetes
    Małgorzata Rodzoń-Norwicz, Natalia Potocka, Marzena Skrzypa, Izabela Zawlik, Katarzyna Milian–Ciesielska, Patryk Kogut, Krzysztof Gargasz, Michael Maes, Magdalena Sowa-Kućma, Agnieszka Gala-Błądzińska
    BMC Nephrology.2025;[Epub]     CrossRef
  • The Association of Lipoic Acid Synthase (LIAS) Gene Methylation With Diabetic Kidney Disease
    Ziyi Feng, Ting Liu, Peng Gao, Yongwei Jiang, Meimei Zhao, Yi Liu, Haoyan Zhu, Mo Li, Nan Li, Xiaomu Kong, Liang Ma, Zhipeng Tao
    Journal of Diabetes Research.2025;[Epub]     CrossRef
  • Association between triglyceride–glucose index and its derivatives and lung adenocarcinoma risk: a case–control study in Chinese adults
    Pengcheng Qiu, Jinshi Xie, Yayuan He, Rizheng Cong, Keyue Huang, Bo Huang
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Klotho in diabetes mellitus: research progress and clinical implications
    Tingyuan Zhu, Songfeng Zhao, Ning Lu
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • The mediating role of inflammation in the association between coagulation parameters and diabetic kidney diseases in patients with type 2 diabetes mellitus: a muti-center cross-sectional retrospective study in Southwest China from 2013 to 2022
    Bei-Hui Ren, Ling-Zhi Xing, Bai-Yu-Lu Chen, Guo-Jia Liao, Li-Yuan Chen, Ying-Dan Zhang, Jie Fan, Ling Chen
    BMC Nephrology.2025;[Epub]     CrossRef
  • Syndecan-1 as a Prognostic Biomarker for Early Diabetic Kidney Disease Progression: A Cohort Study
    Yiqun Peng, Dongguang Wang, Kaifa Guo, Liang Peng
    Journal of Medicine and Physical Education.2025; 2(5): 40.     CrossRef
  • Role of polyphenols in the management of diabetic complications
    Jeevika Raina, Atika Firdous, Gurvinder Singh, Rajesh Kumar, Charanjit Kaur
    Phytomedicine.2024; 122: 155155.     CrossRef
  • Single-Cell RNA Sequencing Reveals RAC1 Involvement in Macrophages Efferocytosis in Diabetic Kidney Disease
    Yi Song, Yifan Liu, Feng Guo, Lin Zhao, Guijun Qin
    Inflammation.2024; 47(2): 753.     CrossRef
  • Role of MCP-1 as an inflammatory biomarker in nephropathy
    Yanlong Liu, Ke Xu, Yuhua Xiang, Boyan Ma, Hailong Li, Yuan Li, Yue Shi, Shuju Li, Yan Bai
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Urinary podocyte stress marker as a prognostic indicator for diabetic kidney disease
    Lingfeng Zeng, Jack Kit-Chung Ng, Winston Wing-Shing Fung, Gordon Chun-Kau Chan, Kai-Ming Chow, Cheuk-Chun Szeto
    BMC Nephrology.2024;[Epub]     CrossRef
  • Identification and validation of immune and cuproptosis - related genes for diabetic nephropathy by WGCNA and machine learning
    Yubing Chen, Lijuan Liao, Baoju Wang, Zhan Wu
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Specific Alternation of Gut Microbiota and the Role of Ruminococcus gnavus in the Development of Diabetic Nephropathy
    Jinni Hong, Tingting Fu, Weizhen Liu, Yu Du, Junmin Bu, Guojian Wei, Miao Yu, Yanshan Lin, Cunyun Min, Datao Lin
    Journal of Microbiology and Biotechnology.2024; 34(3): 547.     CrossRef
  • The triglyceride-glucose index is superior to homeostasis model assessment of insulin resistance in predicting metabolic syndrome in an adult population in the United States
    Beverley Adams-Huet, Rafael Zubirán, Alan T. Remaley, Ishwarlal Jialal
    Journal of Clinical Lipidology.2024; 18(4): e518.     CrossRef
  • Association of the dietary inflammatory index with complicated diabetic kidney disease in people with diabetes mellitus: evidence from NHANES 2009–2018
    Yixin Rui, Xiumeng Zhang, Hongxiao Xie, Hu Qi, Rong Liu, Nan Zeng
    Acta Diabetologica.2024; 61(11): 1375.     CrossRef
  • Multiomics Analyses Identify AKR1A1 as a Biomarker for Diabetic Kidney Disease
    DengFeng Li, Fang-Chi Hsu, Nicholette D. Palmer, Liang Liu, Young A. Choi, Mariana Murea, John S. Parks, Donald W. Bowden, Barry I. Freedman, Lijun Ma
    Diabetes.2024; 73(7): 1188.     CrossRef
  • Serum L C3-II levels in type 2 diabetic patients with impaired renal functions
    Shahab Ahmed Salıh Gezh, Koksal Deveci, Hakan Sivgin, Figen Guzelgul
    Cytokine.2024; 181: 156683.     CrossRef
  • Diabetic Nephropathy as a Result of Uncontrolled Hyperglycemia
    Camila Silva de Aquino, Estênio Gabriel Miranda, Francisco José Pascoal Ribeiro Júnior, Hérika Juliana de Araújo Lucena, Jéssica Pará Amaral de Oliveira, João Ferreira Lima Neto, Lênio Airam de Pinho, Miguel Valentim Rodrigues, Pedro Henrique Borges Silve
    Revista de Gestão Social e Ambiental.2024; 18(1): e07716.     CrossRef
  • Pharmacological effects of bioactive agents in earthworm extract: A comprehensive review
    Zihan Zhu, Xinyi Deng, Wenqing Xie, Hengzhen Li, Yusheng Li, Zhenhan Deng
    Animal Models and Experimental Medicine.2024; 7(5): 653.     CrossRef
  • Efficacy and safety of polyethylene glycol loxenatide in treating mild-to-moderate diabetic kidney disease in type 2 diabetes patients: a randomized, open-label, clinical trial
    YongSheng Cao, Shujie Cao, Jiangang Zhao, Jianqin Zhao, Yanan Zhao, Ying Liu
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Fish oil supplementation in relation to the risk of chronic kidney disease among patients with diabetes
    Yang Ao, Hao Ye, Xiaohui Liu, Yin Li, Haoyin Liu, Shu Ye, Yepeng Hu, Pan Zhuang, Yu Zhang, Chao Zheng, Jingjing Jiao
    Diabetes, Obesity and Metabolism.2024; 26(11): 5283.     CrossRef
  • CYSTATIN C—A Monitoring Perspective of Chronic Kidney Disease in Patients with Diabetes
    Alexandra-Mihaela Visinescu, Emilia Rusu, Andrada Cosoreanu, Gabriela Radulian
    International Journal of Molecular Sciences.2024; 25(15): 8135.     CrossRef
  • Role of proadrenomedullin in the progression of diabetic kidney disease in patients with type 2 diabetes mellitus
    A.M. Urbanovych, A.P. Vereshchynska
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2024; 20(4): 266.     CrossRef
  • Sirt6 overexpression relieves ferroptosis and delays the progression of diabetic nephropathy via Nrf2/GPX4 pathway
    Lingyu Du, Canghui Guo, Shengnan Zeng, Ke Yu, Maodong Liu, Ying Li
    Renal Failure.2024;[Epub]     CrossRef
  • Single-cell RNA sequencing in diabetic kidney disease: a literature review
    Wei Tan, Jiaoyan Chen, Yunyan Wang, Kui Xiang, Xianqiong Lu, Qiuyu Han, Mingyue Hou, Jurong Yang
    Renal Failure.2024;[Epub]     CrossRef
  • Podocyte Death in Diabetic Kidney Disease: Potential Molecular Mechanisms and Therapeutic Targets
    Suye Zhong, Na Wang, Chun Zhang
    International Journal of Molecular Sciences.2024; 25(16): 9035.     CrossRef
  • Serum biomarkers for predicting microvascular complications of diabetes mellitus
    Jiajia Wang, Xiaoyi Song, Ziqiao Xia, Shu Feng, Hangfeng Zhang, Chengjie Xu, Hui Zhang
    Expert Review of Molecular Diagnostics.2024; 24(8): 703.     CrossRef
  • Association of Serum Tsukushi Levels with Urinary Albumin-Creatinine Ratio in Type 2 Diabetes Patients
    Yanyan Li, Xia Deng, Xunan Wu, Ligang Zhou, Guoyue Yuan
    Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 3295.     CrossRef
  • Liraglutide ameliorates inflammation and fibrosis by downregulating the TLR4/MyD88/NF-κB pathway in diabetic kidney disease
    Linjing Huang, Tingting Lin, Meizhen Shi, Peiwen Wu
    American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.2024; 327(4): R410.     CrossRef
  • Molecular Therapeutics for Diabetic Kidney Disease: An Update
    Man Guo, Fangfang He, Chun Zhang
    International Journal of Molecular Sciences.2024; 25(18): 10051.     CrossRef
  • Angiopoietin‐like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients
    Yan Wang, Kun Li, Shasha Yuan, Caiguo Yu, Ruili Yin, Di Wang, Yongsong Xu, Lijie Zhang, Lingling Wei, Yanan Cheng, Lin Mao, Dong Zhao, Longyan Yang
    Journal of Diabetes Investigation.2024; 15(12): 1763.     CrossRef
  • Integrating network pharmacology and experimental validation to decipher the pharmacological mechanism of DXXK in treating diabetic kidney injury
    Chenxu Zhang, Zhangxin Ji, Na Xu, Jingjing Yuan, Wen Zeng, Yadong Wang, Qing He, Jiaxing Dong, Xinyu Zhang, Dongmei Yang, Wei Jiang, Yibo Yan, Wencui Shang, Jun Chu, Quangen Chu
    Scientific Reports.2024;[Epub]     CrossRef
  • Proteome-wide mendelian randomization identifies novel therapeutic targets for chronic kidney disease
    Pin Zhao, Zhenhao Li, Shilong Xue, Jinshan Cui, Yonghao Zhan, Zhaowei Zhu, Xuepei Zhang
    Scientific Reports.2024;[Epub]     CrossRef
  • Update on the Pathogenesis, Diagnosis, and Treatment of Diabetic Tubulopathy
    Danfeng Liu, Xiaojie Chen, Weiting He, Min Lu, Qiuling Li, Shaogui Zhang, Jianteng Xie, Yifan Zhang, Wenjian Wang
    Integrative Medicine in Nephrology and Andrology.2024;[Epub]     CrossRef
  • Identification of circulating microbial DNA and its association with kidney function in patients with diabetic kidney disease
    Hoang Thuy Linh, Megumi Oshima, Keisuke Sako, Masahiro Konishi, Daiki Hayashi, Hajime Sanada, Takahiro Yuasa, Akihiko Koshino, Keisuke Horikoshi, Taichiro Minami, Shunsuke Tsuge, Akira Tamai, Shiori Nakagawa, Ryo Nishioka, Takeshi Zoshima, Kiyoaki Ito, Ic
    Nephrology.2024; 29(12): 909.     CrossRef
  • Association of Succinate and Adenosine Nucleotide Metabolic Pathways with Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
    Inha Jung, Seungyoon Nam, Da Young Lee, So Young Park, Ji Hee Yu, Ji A Seo, Dae Ho Lee, Nan Hee Kim
    Diabetes & Metabolism Journal.2024; 48(6): 1126.     CrossRef
  • Role of Epigenetic Changes in the Pathophysiology of Diabetic Kidney Disease
    Marita Liebisch, Gunter Wolf
    Glomerular Diseases.2024; 4(1): 211.     CrossRef
  • Characteristics and Risk of Incident Diabetic Nephropathy between Early-onset versus Late-onset Type 2 Diabetics of Nigerian Origin
    Collins Amadi, Johnbosco Chidozie Okafor, Ochuko Otokunefor, Ezra Agbo
    European Journal of Medical and Health Sciences.2024; 6(6): 60.     CrossRef
  • Research progress of gut microbiome and diabetic nephropathy
    Chenling Chu, Tapas Ranjan Behera, Ying Huang, Wenhui Qiu, Jiayi Chen, Quanquan Shen
    Frontiers in Medicine.2024;[Epub]     CrossRef
  • Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy
    Fengzhao Liu, Zhenyu Yang, Jixin Li, Tao Wu, Xiangyu Li, Lijuan Zhao, Wenru Wang, Wenfei Yu, Guangheng Zhang, Yunsheng Xu
    Molecular Medicine.2024;[Epub]     CrossRef
  • Dynamic changes of inflammatory markers in the early stages of chronic kidney disease in patients with type 1 diabetes mellitus
    MV Osikov, LA Efros, LYu Zhuravleva, AA Fedosov
    Bulletin of Russian State Medical University.2024;[Epub]     CrossRef
  • A Narrative Review of New Treatment Options for Diabetic Nephropathy
    Aadhira Pillai, Darshna Fulmali
    Cureus.2023;[Epub]     CrossRef
  • Bamboo leaf: A review of traditional medicinal property, phytochemistry, pharmacology, and purification technology
    Yaqian Cheng, Siqi Wan, Linna Yao, Ding Lin, Tong Wu, Yongjian Chen, Ailian Zhang, Chenfei Lu
    Journal of Ethnopharmacology.2023; 306: 116166.     CrossRef
  • Molecular Pathways of Diabetic Kidney Disease Inferred from Proteomics
    Lan Wei, Yuanyuan Han, Chao Tu
    Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 117.     CrossRef
  • Omics and Artificial Intelligence in Kidney Diseases
    Nadja Grobe, Josef Scheiber, Hanjie Zhang, Christian Garbe, Xiaoling Wang
    Advances in Kidney Disease and Health.2023; 30(1): 47.     CrossRef
  • Intestinal microbiome diversity of diabetic and non-diabetic kidney disease: Current status and future perspective
    Soumik Das, Ramanathan Gnanasambandan
    Life Sciences.2023; 316: 121414.     CrossRef
  • Pediatric Diabetic Nephropathy: Novel Insights from microRNAs
    Francesca Lanzaro, Annalisa Barlabà, Angelica De Nigris, Federica Di Domenico, Valentina Verde, Emanuele Miraglia del Giudice, Anna Di Sessa
    Journal of Clinical Medicine.2023; 12(4): 1447.     CrossRef
  • Novel Biomarkers of Diabetic Kidney Disease
    Jorge Rico-Fontalvo, Gustavo Aroca-Martínez, Rodrigo Daza-Arnedo, José Cabrales, Tomás Rodríguez-Yanez, María Cardona-Blanco, Juan Montejo-Hernández, Dairo Rodelo Barrios, Jhonny Patiño-Patiño, Elber Osorio Rodríguez
    Biomolecules.2023; 13(4): 633.     CrossRef
  • Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
    Yiwen Li, Yanfei Liu, Shiwei Liu, Mengqi Gao, Wenting Wang, Keji Chen, Luqi Huang, Yue Liu
    Signal Transduction and Targeted Therapy.2023;[Epub]     CrossRef
  • Metabolic phenotypes and risk of end-stage kidney disease in patients with type 2 diabetes
    Lijun Zhao, Yutong Zou, Yucheng Wu, Linli Cai, Yuancheng Zhao, Yiting Wang, Xiang Xiao, Qing Yang, Jia Yang, Honghong Ren, Nanwei Tong, Fang Liu
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Identification of a New RNA and Protein Integrated Biomarker Panel Associated with Kidney Function Impairment in DKD: Translational Implications
    Alessandra Scamporrino, Stefania Di Mauro, Agnese Filippello, Grazia Di Marco, Antonino Di Pino, Roberto Scicali, Maurizio Di Marco, Emanuele Martorana, Roberta Malaguarnera, Francesco Purrello, Salvatore Piro
    International Journal of Molecular Sciences.2023; 24(11): 9412.     CrossRef
  • Increased serum PCSK9 levels are associated with renal function impairment in patients with type 2 diabetes mellitus
    Zhicai Feng, Xiangyu Liao, Hao Zhang, Juan Peng, Zhijun Huang, Bin Yi
    Renal Failure.2023;[Epub]     CrossRef
  • Analysis of Serum Pyrodeath Re-lated Proteins and Renal Injury in Patients with Type 2 DKD
    茹洁 马
    Asian Case Reports in Emergency Medicine.2023; 11(02): 53.     CrossRef
  • Loganin reduces diabetic kidney injury by inhibiting the activation of NLRP3 inflammasome-mediated pyroptosis
    Xiangri Kong, Yunyun Zhao, Xingye Wang, Yongjiang Yu, Ying Meng, Guanchi Yan, Miao Yu, Lihong Jiang, Wu Song, Bingmei Wang, Xiuge Wang
    Chemico-Biological Interactions.2023; 382: 110640.     CrossRef
  • Machine-learning algorithm-based prediction of a diagnostic model based on oxidative stress-related genes involved in immune infiltration in diabetic nephropathy patients
    Heng-Mei Zhu, Na Liu, Dong-Xuan Sun, Liang Luo
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • The roles of gut microbiota and its metabolites in diabetic nephropathy
    Hui Zhao, Cheng-E Yang, Tian Liu, Ming-Xia Zhang, Yan Niu, Ming Wang, Jun Yu
    Frontiers in Microbiology.2023;[Epub]     CrossRef
  • High triglyceride levels increase the risk of diabetic microvascular complications: a cross-sectional study
    Jiahang Li, Lei Shi, Guohong Zhao, Fei Sun, Zhenxing Nie, Zhongli Ge, Bin Gao, Yan Yang
    Lipids in Health and Disease.2023;[Epub]     CrossRef
  • Correlation of Kidney Injury Molecule-1 and Nephrin Levels in Iraqi Patients with Diabetic Nephropathy
    Raghda Hisham Aljorani, Eman Saadi Saleh , Khalaf Gata Hussein Al Mohammadawi
    Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ).2023; 5: 99.     CrossRef
  • Diabetic Nephropathy: Significance of Determining Oxidative Stress and Opportunities for Antioxidant Therapies
    Marina Darenskaya, Sergey Kolesnikov, Natalya Semenova, Lyubov Kolesnikova
    International Journal of Molecular Sciences.2023; 24(15): 12378.     CrossRef
  • Evaluation of Neutrophil/Lymphocyte Ratio, Low-Density Lipoprotein/Albumin Ratio, and Red Cell Distribution Width/Albumin Ratio in the Estimation of Proteinuria in Uncontrolled Diabetic Patients
    Duygu Tutan, Murat Doğan
    Cureus.2023;[Epub]     CrossRef
  • Hedysarum polybotrys polysaccharide attenuates renal inflammatory infiltration and fibrosis in diabetic mice by inhibiting the HMGB1/RAGE/TLR4 pathway
    Changqing Xu, Yanxu Cheng, Zongmei Liu, Xiaoyan Fu
    Experimental and Therapeutic Medicine.2023;[Epub]     CrossRef
  • Abdominal adipose tissue and type 2 diabetic kidney disease: adipose radiology assessment, impact, and mechanisms
    Fei Lu, Jinlei Fan, Fangxuan Li, Lijing Liu, Zhiyu Chen, Ziyu Tian, Liping Zuo, Dexin Yu
    Abdominal Radiology.2023; 49(2): 560.     CrossRef
  • Inhibition of MD2 by natural product-drived JM-9 attenuates renal inflammation and diabetic nephropathy in mice
    Minxiu Wang, Qianhui Zhang, Shuaijie Lou, Leiming Jin, Gaojun Wu, Wenqi Wu, Qidong Tang, Yi Wang, Xiaohong Long, Ping Huang, Wu Luo, Guang Liang
    Biomedicine & Pharmacotherapy.2023; 168: 115660.     CrossRef
  • Multifaceted relationship between diabetes and kidney diseases: Beyond diabetes
    Pasquale Esposito, Daniela Picciotto, Francesca Cappadona, Francesca Costigliolo, Elisa Russo, Lucia Macciò, Francesca Viazzi
    World Journal of Diabetes.2023; 14(10): 1450.     CrossRef
  • Mitochondrial antiviral signaling protein: a potential therapeutic target in renal disease
    Meng Wu, Zhiyin Pei, Guangfeng Long, Hongbing Chen, Zhanjun Jia, Weiwei Xia
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Research progress on multiple cell death pathways of podocytes in diabetic kidney disease
    Can Yang, Zhen Zhang, Jieting Liu, Peijian Chen, Jialing Li, Haiying Shu, Yanhui Chu, Luxin Li
    Molecular Medicine.2023;[Epub]     CrossRef
  • Quantitative profiling of carboxylic compounds by gas chromatography-mass spectrometry for revealing biomarkers of diabetic kidney disease
    Rongrong Zhu, Yan Yuan, Rourou Qi, Jianying Liang, Yan Shi, Hongbo Weng
    Journal of Chromatography B.2023; 1231: 123930.     CrossRef
  • Jiangtang Decoction Ameliorates Diabetic Kidney Disease Through the Modulation of the Gut Microbiota
    Jinni Hong, Tingting Fu, Weizhen Liu, Yu Du, Junmin Bu, Guojian Wei, Miao Yu, Yanshan Lin, Cunyun Min, Datao Lin
    Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 3707.     CrossRef
  • GLP-1RA Combined with SGLT2 Inhibitors for the Treatment of Diabetic Kidney Disease: A Meta Analysis
    莹 郭
    Advances in Clinical Medicine.2023; 13(11): 18117.     CrossRef
  • Potential application of Klotho as a prognostic biomarker for patients with diabetic kidney disease: a meta-analysis of clinical studies
    Li Xia Yu, Min Yue Sha, Yue Chen, Fang Tan, Xi Liu, Shasha Li, Qi-Feng Liu
    Therapeutic Advances in Chronic Disease.2023;[Epub]     CrossRef
  • Research progress of natural active compounds on improving podocyte function to reduce proteinuria in diabetic kidney disease
    Le Gong, Rui Wang, Xinyu Wang, Jing Liu, Zhaodi Han, Qian Li, Yi Jin, Hui Liao
    Renal Failure.2023;[Epub]     CrossRef
  • Identification of potential crosstalk genes and mechanisms between periodontitis and diabetic nephropathy through bioinformatic analysis
    Huijuan Lu, Jia Sun, Jieqiong Sun
    Medicine.2023; 102(52): e36802.     CrossRef
  • Mitochondrial RNAs as Potential Biomarkers of Functional Impairment in Diabetic Kidney Disease
    Stefania Di Mauro, Alessandra Scamporrino, Agnese Filippello, Maurizio Di Marco, Maria Teresa Di Martino, Francesca Scionti, Antonino Di Pino, Roberto Scicali, Roberta Malaguarnera, Francesco Purrello, Salvatore Piro
    International Journal of Molecular Sciences.2022; 23(15): 8198.     CrossRef
  • Renoprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors: Focusing on Renal Hemodynamics
    Nam Hoon Kim, Nan Hee Kim
    Diabetes & Metabolism Journal.2022; 46(4): 543.     CrossRef
  • Partial Synthetic PPARƳ Derivative Ameliorates Aorta Injury in Experimental Diabetic Rats Mediated by Activation of miR-126-5p Pi3k/AKT/PDK 1/mTOR Expression
    Yasmin M. Ahmed, Raha Orfali, Nada S. Abdelwahab, Hossam M. Hassan, Mostafa E. Rateb, Asmaa M. AboulMagd
    Pharmaceuticals.2022; 15(10): 1175.     CrossRef
  • Polydatin attenuates tubulointerstitial fibrosis in diabetic kidney disease by inhibiting YAP expression and nuclear translocation
    Manlin He, Lan Feng, Yang Chen, Bin Gao, Yiwei Du, Lu Zhou, Fei Li, Hongbao Liu
    Frontiers in Physiology.2022;[Epub]     CrossRef
  • Prevalence of diabetic nephropathy in the diabetes mellitus population: A protocol for systematic review and meta-analysis
    Sicheng Li, Huidi Xie, Yang Shi, Hongfang Liu
    Medicine.2022; 101(42): e31232.     CrossRef
  • Stratification of diabetic kidney diseases via data-independent acquisition proteomics–based analysis of human kidney tissue specimens
    Qinghua Huang, Xianming Fei, Zhaoxian Zhong, Jieru Zhou, Jianguang Gong, Yuan Chen, Yiwen Li, Xiaohong Wu
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives
    Ziyan Xie, Xinhua Xiao
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Diabetic Kidney Disease
    Susanne B. Nicholas, Amy K. Mottl
    Nephrology Self-Assessment Program.2022; 21(5): 394.     CrossRef
Original Article
Basic Research
Article image
Hypoxia Increases β-Cell Death by Activating Pancreatic Stellate Cells within the Islet
Jong Jin Kim, Esder Lee, Gyeong Ryul Ryu, Seung-Hyun Ko, Yu-Bae Ahn, Ki-Ho Song
Diabetes Metab J. 2020;44(6):919-927.   Published online May 11, 2020
DOI: https://doi.org/10.4093/dmj.2019.0181
  • 10,221 View
  • 194 Download
  • 20 Web of Science
  • 22 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Hypoxia can occur in pancreatic islets in type 2 diabetes mellitus. Pancreatic stellate cells (PSCs) are activated during hypoxia. Here we aimed to investigate whether PSCs within the islet are also activated in hypoxia, causing β-cell injury.

Methods

Islet and primary PSCs were isolated from Sprague Dawley rats, and cultured in normoxia (21% O2) or hypoxia (1% O2). The expression of α-smooth muscle actin (α-SMA), as measured by immunostaining and Western blotting, was used as a marker of PSC activation. Conditioned media (hypoxia-CM) were obtained from PSCs cultured in hypoxia.

Results

Islets and PSCs cultured in hypoxia exhibited higher expressions of α-SMA than did those cultured in normoxia. Hypoxia increased the production of reactive oxygen species. The addition of N-acetyl-L-cysteine, an antioxidant, attenuated the hypoxia-induced PSC activation in islets and PSCs. Islets cultured in hypoxia-CM showed a decrease in cell viability and an increase in apoptosis.

Conclusion

PSCs within the islet are activated in hypoxia through oxidative stress and promote islet cell death, suggesting that hypoxia-induced PSC activation may contribute to β-cell loss in type 2 diabetes mellitus.

Citations

Citations to this article as recorded by  
  • Engineering the pancreatic niche: Mechanobiological insights into stem cell-derived β-cell therapy for diabetes mellitus
    Swaminadhan Dandapani, Yongsung Hwang
    Mechanobiology.2026;[Epub]     CrossRef
  • Practical application of melatonin for pancreas disorders: protective roles against inflammation, malignancy, and dysfunctions
    Mohammad Sheibani, Azam Hosseinzadeh, Iman Fatemi, Ali Jamshidi Naeini, Saeed Mehrzadi
    Pharmacological Reports.2025; 77(2): 315.     CrossRef
  • Genome-Scale Metabolic Modeling of Human Pancreas with Focus on Type 2 Diabetes
    Mustafa Sertbas, Kutlu O. Ulgen
    OMICS: A Journal of Integrative Biology.2025; 29(4): 125.     CrossRef
  • Integration of Immune Cell Signatures and Diagnostic Gene Markers in Pancreatitis: A Comprehensive Study on Therapeutic Targets and Predictive Diagnosis
    Qianyu Xie, Birong Liu, Xiao Yu, Xiang Wei, Qiangsheng Xiao, Minghua Ren
    Human Mutation.2025;[Epub]     CrossRef
  • Effects of hypoxia in the diabetic corneal stroma microenvironment
    Purnima Sharma, Jian-Xing Ma, Dimitrios Karamichos
    Experimental Eye Research.2024; 240: 109790.     CrossRef
  • High‐resolution magic angle spinning nuclear magnetic resonance of donor pancreatic tissue may predict islet viability prior to isolation
    Carolyn M. Slupsky, Brian D. Sykes, Jonathan R. T. Lakey
    NMR in Biomedicine.2024;[Epub]     CrossRef
  • Nanomedicine regulating PSC-mediated intercellular crosstalk: Mechanisms and therapeutic strategies
    Hui Wang, Liang Qi, Han Han, Xuena Li, Mengmeng Han, Lei Xing, Ling Li, Hulin Jiang
    Acta Pharmaceutica Sinica B.2024; 14(11): 4756.     CrossRef
  • Visualizing hypoxic modulation of beta cell secretions via a sensor augmented oxygen gradient
    Kai Duan, Mengyang Zhou, Yong Wang, Jose Oberholzer, Joe F. Lo
    Microsystems & Nanoengineering.2023;[Epub]     CrossRef
  • Pancreatic stellate cells promote pancreatic β-cell death through exosomal microRNA transfer in hypoxia
    Esder Lee, Gyeong Ryul Ryu, Seung-Hyun Ko, Yu-Bae Ahn, Ki-Ho Song
    Molecular and Cellular Endocrinology.2023; 572: 111947.     CrossRef
  • Pancreatic stellate cells in pancreatic cancer: as potential targets for future therapy
    Zhengfeng Wang, Ru He, Shi Dong, Wence Zhou
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Recent advances in the development of bioartificial pancreas using 3D bioprinting for the treatment of type 1 diabetes: a review
    Anushikha Ghosh, Arka Sanyal, Abhik Mallick
    Exploration of Medicine.2023; : 886.     CrossRef
  • Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes
    Sarah S. Malik, Diksha Padmanabhan, Rebecca L. Hull-Meichle
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Diabetic mellitus, vascular calcification and hypoxia: A complex and neglected tripartite relationship
    Xue-Jiao Sun, Nai-Feng Liu
    Cellular Signalling.2022; 91: 110219.     CrossRef
  • HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer
    Shin Hamada, Ryotaro Matsumoto, Atsushi Masamune
    Cancers.2022; 14(2): 411.     CrossRef
  • Pancreatic Stellate Cells and Metabolic Alteration: Physiology and Pathophysiology
    Shin Hamada, Ryotaro Matsumoto, Atsushi Masamune
    Frontiers in Physiology.2022;[Epub]     CrossRef
  • Exosomal miR-140–3p and miR-143–3p from TGF-β1-treated pancreatic stellate cells target BCL2 mRNA to increase β-cell apoptosis
    Xiangyun Zhu, Dechen Liu, Guoqing Li, Mengmeng Zhi, Ji Sun, Liang Qi, Jingbo Li, Stephen J. Pandol, Ling Li
    Molecular and Cellular Endocrinology.2022; 551: 111653.     CrossRef
  • Mitochondria oxidative stress mediated nicotine-promoted activation of pancreatic stellate cells by regulating mitochondrial dynamics
    Yue Yuan, Zhiren Li, Miaomiao Li, Tong Jin, Xiaoyun Zhang, Xinjuan Liu, Jianyu Hao
    Toxicology in Vitro.2022; 84: 105436.     CrossRef
  • Antioxidant Mitoquinone Alleviates Chronic Pancreatitis via Anti-Fibrotic and Antioxidant Effects
    Miaomiao Li, Yue Yuan, Xue Han, Xinjuan Liu, Weizhen Zhang, Jianyu Hao
    Journal of Inflammation Research.2022; Volume 15: 4409.     CrossRef
  • Diabetic Ferroptosis and Pancreatic Cancer: Foe or Friend?
    Le Li, Xing-jia Yu, Lei Gao, Long Cheng, Bei Sun, Gang Wang
    Antioxidants & Redox Signaling.2022; 37(16-18): 1206.     CrossRef
  • Melatonin Induces Apoptosis and Modulates Cyclin Expression and MAPK Phosphorylation in Pancreatic Stellate Cells Subjected to Hypoxia
    Matias Estaras, Manuel R. Gonzalez-Portillo, Miguel Fernandez-Bermejo, Jose M. Mateos, Daniel Vara, Gerardo Blanco-Fernandez, Diego Lopez-Guerra, Vicente Roncero, Gines M. Salido, Antonio González
    International Journal of Molecular Sciences.2021; 22(11): 5555.     CrossRef
  • Integrated pancreatic microcirculatory profiles of streptozotocin‐induced and insulin‐administrated type 1 diabetes mellitus
    Yuan Li, Bingwei Li, Bing Wang, Mingming Liu, Xiaoyan Zhang, Ailing Li, Jian Zhang, Honggang Zhang, Ruijuan Xiu
    Microcirculation.2021;[Epub]     CrossRef
  • Pancreatic stellate cells - rising stars in pancreatic pathologies
    P Hrabák, M Kalousová, T Krechler, T Zima
    Physiological Research.2021; (S4): S597.     CrossRef
Review
Basic Research
The Role of CD36 in Type 2 Diabetes Mellitus: β-Cell Dysfunction and Beyond
Jun Sung Moon, Udayakumar Karunakaran, Elumalai Suma, Seung Min Chung, Kyu Chang Won
Diabetes Metab J. 2020;44(2):222-233.   Published online April 23, 2020
DOI: https://doi.org/10.4093/dmj.2020.0053
  • 14,301 View
  • 223 Download
  • 31 Web of Science
  • 30 Crossref
AbstractAbstract PDFPubReader   ePub   

Impaired β-cell function is the key pathophysiology of type 2 diabetes mellitus, and chronic exposure of nutrient excess could lead to this tragedy. For preserving β-cell function, it is essential to understand the cause and mechanisms about the progression of β-cells failure. Glucotoxicity, lipotoxicity, and glucolipotoxicity have been suggested to be a major cause of β-cell dysfunction for decades, but not yet fully understood. Fatty acid translocase cluster determinant 36 (CD36), which is part of the free fatty acid (FFA) transporter system, has been identified in several tissues such as muscle, liver, and insulin-producing cells. Several studies have reported that induction of CD36 increases uptake of FFA in several cells, suggesting the functional interplay between glucose and FFA in terms of insulin secretion and oxidative metabolism. However, we do not currently know the regulating mechanism and physiological role of CD36 on glucolipotoxicity in pancreatic β-cells. Also, the downstream and upstream targets of CD36 related signaling have not been defined. In the present review, we will focus on the expression and function of CD36 related signaling in the pancreatic β-cells in response to hyperglycemia and hyperlipidemia (ceramide) along with the clinical studies on the association between CD36 and metabolic disorders.

Citations

Citations to this article as recorded by  
  • Integrative gene target mapping, RNA sequencing, in silico molecular docking, ADMET profiling and molecular dynamics simulation study of marine derived molecules for type 1 diabetes mellitus
    Basavaraj Vastrad, Shivaling Pattanashetti, Veeresh Sadashivanavar, K. S. R. Pai, Chanabasayya Vastrad
    Molecular Diversity.2026;[Epub]     CrossRef
  • Bone Marrow Mesenchymal Stromal Cells and Their Derived Extracellular Vesicles Protect Pancreatic Beta‐TC‐6 Cells From Hypoxia‐Induced Injury via miR‐539‐3p‐Mediated Downregulation of CD36 Expression
    Na Lin, Yaoyao Liang, Minying Tang, Fei Liu, Liuyan Chen, Lvying Wu, Yunfeng Fu, Zhuoyu Li, Lingfeng Zhu, Jin Chen, Yuelin Zhang
    Stem Cells International.2026;[Epub]     CrossRef
  • CD36 inhibition corrects lipid-FetuinA mediated insulin secretory defects by preventing intracellular lipid accumulation and inflammation in the pancreatic beta cells
    Samanwita Mandal, Snehasish Nag, Oindrila Mukherjee, Nandita Das, Priyajit Banerjee, Tanmay Majumdar, Satinath Mukhopadhyay, Kathrin Maedler, Rakesh Kundu
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2025; 1871(2): 167580.     CrossRef
  • CD36 in liver diseases
    Yi Liu, Wenwei Yin
    Hepatology Communications.2025;[Epub]     CrossRef
  • Overcoming β-Cell Dysfunction in Type 2 Diabetes Mellitus: CD36 Inhibition and Antioxidant System
    Il Rae Park, Yong Geun Chung, Kyu Chang Won
    Diabetes & Metabolism Journal.2025; 49(1): 1.     CrossRef
  • Sulfo‐N‐Succinimidyl Oleate Sodium as CD36 Inhibitor: Dose Optimization and Its Effects on FFA Uptake, Inflammation, and ER Stress in HepG2 Cells
    Widya Wasityastuti, Shabrina Farras Tsany, Hanif Shidqi Pasaribu, Rahmalia Diani Saffana, Daniel Saputra Wahyudi, Dwi Aris Agung Nugrahaningsih
    Journal of Biochemical and Molecular Toxicology.2025;[Epub]     CrossRef
  • Structural insights and therapeutic potential of plant-based pectin as novel therapeutic for type 2 diabetes mellitus: A review
    Ting Ren, Xinrong Fan, Qifang Wu, Yu Wu, Xin Sun, Haibin Tong
    International Journal of Biological Macromolecules.2025; 307: 141876.     CrossRef
  • The potential biomarker value of soluble CD36 in the treatment of diabetic kidney disease: evidence from GLP-1 and insulin interventions
    Wenxuan Li, Yangang Wang
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • “Medicine food homology” plants in the treatment of diabetic nephropathy: pathogenic pathways and therapeutic approaches
    Zhong-Hong Yan, Dan-Mai Zhao, Xiao-Tian Wang, Rui Zhong, Bei-Chen Ding
    Food & Medicine Homology.2025;[Epub]     CrossRef
  • Palmitoylation-dependent modulation of CD36 trafficking and signaling integrates lipid uptake with metabolic disease pathogenesis
    Mingxun Li, Haoran Jia, Lei Zhang, Peng Chen, Shimeng Wang, Yongjiang Mao, Zhangping Yang
    Pharmacological Research.2025; 220: 107935.     CrossRef
  • Hyperglycemia Induced in Sprague–Dawley Rats Modulates the Expression of CD36 and CD69 During Wound Healing
    Vy Ho, Tommy Tran, Jaylan Patel, Betelhem Teshome, Vikrant Rai
    International Journal of Molecular Sciences.2025; 26(24): 12032.     CrossRef
  • Nrf2 inhibition regulates intracellular lipid accumulation in mouse insulinoma cells and improves insulin secretory function
    Alpana Mukhuty, Samanwita Mandal, Chandrani Fouzder, Snehasis Das, Dipanjan Chattopadhyay, Tanmay Majumdar, Rakesh Kundu
    Molecular and Cellular Endocrinology.2024; 581: 112112.     CrossRef
  • CD36 gene variant rs1761667(G/A) as a biomarker in obese type 2 diabetes mellitus cases
    Ashwin Kumar Shukla, Amreen Shamsad, Atar Singh Kushwah, Shalini Singh, Kauser Usman, Monisha Banerjee
    Egyptian Journal of Medical Human Genetics.2024;[Epub]     CrossRef
  • CD36 regulates macrophage and endothelial cell activation and multinucleate giant cell formation in anti neutrophil cytoplasm antibody vasculitis
    Xiang Zhang, Catherine King, Alexander Dowell, Paul Moss, Lorraine Harper, Dimitrios Chanouzas, Xiong-zhong Ruan, Alan David Salama
    Clinical Immunology.2024; 260: 109914.     CrossRef
  • Identification and validation of oxidative stress-related genes in sepsis-induced myopathy
    Ning Zhang, Dan Huang, Xiang Li, JinXia Yan, Qi Yan, WeiXing Ge, Jun Zhou
    Medicine.2024; 103(18): e37933.     CrossRef
  • Monocyte CD36 Expression Predicts Disease Activity in Patients With Crohn’s Disease
    Jiejie Zhu, Nannan Zhu, Jiren Wang, Qiuyuan Liu, Qiao Mei, Andrew S. Day
    Gastroenterology Research and Practice.2024;[Epub]     CrossRef
  • The identification of key genes and pathways in polycystic ovary syndrome by bioinformatics analysis of next-generation sequencing data
    Varun Alur, Basavaraj Vastrad, Varshita Raju, Chanabasayya Vastrad, Shivakumar Kotturshetti
    Middle East Fertility Society Journal.2024;[Epub]     CrossRef
  • The association of soluble cluster of differentiation 36 with metabolic diseases: A potential biomarker and therapeutic target
    Yun Li, Yaxi Chen, Xiong Z. Ruan
    Pediatric Discovery.2023;[Epub]     CrossRef
  • The role of candidate transport proteins in β‐cell long‐chain fatty acid uptake: Where are we now?
    Christina Clavelo‐Farrow, Patricia Thomas
    Diabetic Medicine.2023;[Epub]     CrossRef
  • SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients
    Ningfei Ji, Mingshun Zhang, Liang Ren, Yunyun Wang, Bicheng Hu, Jie Xiang, Yingyun Gong, Chaojie Wu, Guoqiang Qu, Wenqiu Ding, Zhiqiang Yin, Shan Li, Zhengxia Wang, Lianzheng Zhou, Xueqin Chen, Yuan Ma, Jinhai Tang, Yun Liu, Liang Liu, Mao Huang
    Emerging Microbes & Infections.2022; 11(1): 1115.     CrossRef
  • Is imaging-based muscle quantity associated with risk of diabetes? A meta-analysis of cohort studies
    Shanhu Qiu, Xue Cai, Yang Yuan, Bo Xie, Zilin Sun, Tongzhi Wu
    Diabetes Research and Clinical Practice.2022; 189: 109939.     CrossRef
  • Lipotoxicity in a Vicious Cycle of Pancreatic Beta Cell Exhaustion
    Vladimir Grubelnik, Jan Zmazek, Matej Završnik, Marko Marhl
    Biomedicines.2022; 10(7): 1627.     CrossRef
  • Association of cluster determinant 36, scavenger receptor class B type 1, and major facilitator superfamily domain containing the 2a genetic polymorphism with serum lipid profile in aging population with type 2 diabetes mellitus
    Xixiang Wang, Xiaojun Ma, Jingjing Xu, Yujie Guo, Shaobo Zhou, Huiyan Yu, Linhong Yuan
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • CD36-Fatty Acid-Mediated Metastasis via the Bidirectional Interactions of Cancer Cells and Macrophages
    Noorzaileen Eileena Zaidi, Nur Aima Hafiza Shazali, Thean-Chor Leow, Mohd Azuraidi Osman, Kamariah Ibrahim, Wan-Hee Cheng, Kok-Song Lai, Nik Mohd Afizan Nik Abd Rahman
    Cells.2022; 11(22): 3556.     CrossRef
  • The Past and Present Lives of the Intraocular Transmembrane Protein CD36
    Rucui Yang, Qingping Liu, Mingzhi Zhang
    Cells.2022; 12(1): 171.     CrossRef
  • Implicating the effect of ketogenic diet as a preventive measure to obesity and diabetes mellitus
    Sachin Kumar, Tapan Behl, Monika Sachdeva, Aayush Sehgal, Shilpa Kumari, Arun Kumar, Gagandeep Kaur, Harlokesh Narayan Yadav, Simona Bungau
    Life Sciences.2021; 264: 118661.     CrossRef
  • Contribution of rs3211938 polymorphism at CD36 to glucose levels, oxidized low-density lipoproteins, insulin resistance, and body mass index in Mexican mestizos with type-2 diabetes from western Mexico
    Beatriz Teresita Martín-Márquez, Flavio Sandoval-Garcia, Mónica Vazquez-Del Mercado, Erika-Aurora Martínez-García, Fernanda-Isadora Corona-Meraz, Ana-Lilia Fletes-Rayas, Soraya-Amalí Zavaleta-Muñiz
    Nutrición Hospitalaria.2021;[Epub]     CrossRef
  • Investigating the association of CD36 gene polymorphisms (rs1761667 and rs1527483) with T2DM and dyslipidemia: Statistical analysis, machine learning based prediction, and meta-analysis
    Ma’mon M. Hatmal, Walhan Alshaer, Ismail S. Mahmoud, Mohammad A. I. Al-Hatamleh, Hamzeh J. Al-Ameer, Omar Abuyaman, Malek Zihlif, Rohimah Mohamud, Mais Darras, Mohammad Al Shhab, Rand Abu-Raideh, Hilweh Ismail, Ali Al-Hamadi, Ali Abdelhay, Kanhaiya Singh
    PLOS ONE.2021; 16(10): e0257857.     CrossRef
  • Misregulation of Wnt Signaling Pathways at the Plasma Membrane in Brain and Metabolic Diseases
    Mustafa Karabicici, Yagmur Azbazdar, Evin Iscan, Gunes Ozhan
    Membranes.2021; 11(11): 844.     CrossRef
  • CD36 Signal Transduction in Metabolic Diseases: Novel Insights and Therapeutic Targeting
    Udayakumar Karunakaran, Suma Elumalai, Jun-Sung Moon, Kyu-Chang Won
    Cells.2021; 10(7): 1833.     CrossRef
Short Communication
Clinical Diabetes & Therapeutics
Three Months Monitored Metabolic Fitness Modulates Cardiovascular Risk Factors in Diabetic Patients
Ilenia Cirilli, Sonia Silvestri, Fabio Marcheggiani, Fabiola Olivieri, Roberta Galeazzi, Roberto Antonicelli, Rina Recchioni, Fiorella Marcheselli, Tiziana Bacchetti, Luca Tiano, Patrick Orlando
Diabetes Metab J. 2019;43(6):893-897.   Published online June 27, 2019
DOI: https://doi.org/10.4093/dmj.2018.0254
  • 7,138 View
  • 59 Download
  • 14 Web of Science
  • 14 Crossref
AbstractAbstract PDFPubReader   ePub   

Cardiovascular diseases represent the leading cause of death and moderate physical exercise is associated with a reduction in cardiovascular risk. The aim of the study was to evaluate the correlation between the amount of exercise recorded daily by a wearable gravitometer for 3 months and selected biochemical and clinical parameters. Nineteen sedentary type 2 diabetics were recruited and distributed into three homogenous groups, low, medium, and high exercise, according to the level of physical exercise monitored and expressed as MOVEs. Data showed an inverse correlation between MOVEs and oxidative stress indexes and a significant improvement in paraoxonase-1 activities and endothelial functionality. Decrease of visceral/total adipose tissue ratio, systolic blood pressure and a down-regulation of the inflammatory microRNA-146a in high exercise group were observed. Finally, a decrease of glycosylated hemoglobin and an up-regulation of the angiogenic microRNA-130a in medium exercise one was obtained. In this study, precise daily monitoring permitted to underline the importance of the amount of physical activity to counteract some cardiovascular risk factors persisting in diabetes. Finally, it identifies new microRNA biomarkers for future investigation on the same topic.

Citations

Citations to this article as recorded by  
  • The comparison of miRNA expression levels in Type 2 diabetes and diabetic peripheral neuropathy patients
    Aleyna Ayaz, Sibel Kuras, Bekir Erdogan, Hanife Serife Aktas, Mahmud Esad Pence, Halime Hanim Pence
    Clinical Biochemistry.2025; 138: 110946.     CrossRef
  • Effectiveness of Wearable Technologies in Supporting Physical Activity and Metabolic Health in Adults with Type 2 Diabetes: A Systematic–Narrative Hybrid Review
    Alessandra Laffi, Michela Persiani, Alessandro Piras, Andrea Meoni, Milena Raffi
    Healthcare.2025; 13(19): 2422.     CrossRef
  • Redox-sensitive miRNAs and Humanin could mediate effects of exercise and astaxanthin on oxidative stress and inflammation in type 2 diabetes
    Aref Basereh, Karen Khoramipour, Najmeh Hosseini, Mahdieh HajHosseini, Adeleh Khodabakhshi, Ladan Amirkhosravi, Kayvan Khoramipour
    Scientific Reports.2025;[Epub]     CrossRef
  • Emerging roles of microRNAs as diagnostics and potential therapeutic interest in type 2 diabetes mellitus
    Dharmsheel Shrivastav, Desh Deepak Singh
    World Journal of Clinical Cases.2024; 12(3): 525.     CrossRef
  • Is It Possible to Train the Endothelium?—A Narrative Literature Review
    Karolina Biernat, Natalia Kuciel, Justyna Mazurek, Katarzyna Hap
    Life.2024; 14(5): 616.     CrossRef
  • The Effect of Physical Activity/Exercise on miRNA Expression and Function in Non-Communicable Diseases—A Systematic Review
    Moomna Afzal, Francesca Greco, Federico Quinzi, Francesca Scionti, Samantha Maurotti, Tiziana Montalcini, Annamaria Mancini, Pasqualina Buono, Gian Pietro Emerenziani
    International Journal of Molecular Sciences.2024; 25(13): 6813.     CrossRef
  • Dose-Response Relationship Between Physical Activity and the Morbidity and Mortality of Cardiovascular Disease Among Individuals With Diabetes: Meta-Analysis of Prospective Cohort Studies
    Yang Chen, Xingsheng Jin, Guochong Chen, Ru Wang, Haili Tian
    JMIR Public Health and Surveillance.2024; 10: e54318.     CrossRef
  • Modulation of the antioxidant enzyme paraoxonase-1 for protection against cardiovascular diseases
    Waleska Dornas, Maisa Silva
    Nutrition, Metabolism and Cardiovascular Diseases.2024; 34(12): 2611.     CrossRef
  • Research Landscape of Diabetes mHealth Technologies
    Pedro F. Castillo-Valdez, Marisela Rodriguez-Salvador, Yuh-Shan Ho
    Foresight and STI Governance.2024; 18(1): 19.     CrossRef
  • Effects of Seven Weeks of Combined Physical Training on High-Density Lipoprotein Functionality in Overweight/Obese Subjects
    Tiziana Bacchetti, Camilla Morresi, Gianna Ferretti, Anders Larsson, Torbjörn Åkerfeldt, Michael Svensson
    Metabolites.2023; 13(10): 1068.     CrossRef
  • Physical Exercise Protects Against Endothelial Dysfunction in Cardiovascular and Metabolic Diseases
    Juan Gao, Xue Pan, Guoping Li, Emeli Chatterjee, Junjie Xiao
    Journal of Cardiovascular Translational Research.2022; 15(3): 604.     CrossRef
  • Effects of Exercise Training on the Paracrine Function of Circulating Angiogenic Cells
    William S. Evans, Ryan M. Sapp, Katherine I. Kim, James M. Heilman, James Hagberg, Steven J. Prior
    International Journal of Sports Medicine.2021; 42(12): 1047.     CrossRef
  • Chronic and Transient Hyperglycemia Induces Changes in the Expression Patterns of IL6 and ADIPOQ Genes and Their Associated Epigenetic Modifications in Differentiating Human Visceral Adipocytes
    Adam Wróblewski, Justyna Strycharz, Ewa Świderska, Aneta Balcerczyk, Janusz Szemraj, Józef Drzewoski, Agnieszka Śliwińska
    International Journal of Molecular Sciences.2021; 22(13): 6964.     CrossRef
  • The Potential Role of MicroRNA in Diabetic Cardiomyopathy
    Jin Hwa Kim
    Diabetes & Metabolism Journal.2020; 44(1): 54.     CrossRef
Original Articles
Pathophysiology
Metformin Ameliorates Lipotoxic β-Cell Dysfunction through a Concentration-Dependent Dual Mechanism of Action
Hong Il Kim, Ji Seon Lee, Byung Kook Kwak, Won Min Hwang, Min Joo Kim, Young-Bum Kim, Sung Soo Chung, Kyong Soo Park
Diabetes Metab J. 2019;43(6):854-866.   Published online June 27, 2019
DOI: https://doi.org/10.4093/dmj.2018.0179
  • 11,406 View
  • 139 Download
  • 18 Web of Science
  • 18 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Chronic exposure to elevated levels of free fatty acids contributes to pancreatic β-cell dysfunction. Although it is well known that metformin induces cellular energy depletion and a concomitant activation of AMP-activated protein kinase (AMPK) through inhibition of the respiratory chain, previous studies have shown inconsistent results with regard to the action of metformin on pancreatic β-cells. We therefore examined the effects of metformin on pancreatic β-cells under lipotoxic stress.

Methods

NIT-1 cells and mouse islets were exposed to palmitate and treated with 0.05 and 0.5 mM metformin. Cell viability, glucose-stimulated insulin secretion, cellular adenosine triphosphate, reactive oxygen species (ROS) levels and Rho kinase (ROCK) activities were measured. The phosphorylation of AMPK was evaluated by Western blot analysis and mRNA levels of endoplasmic reticulum (ER) stress markers and NADPH oxidase (NOX) were measured by real-time quantitative polymerase chain reaction analysis.

Results

We found that metformin has protective effects on palmitate-induced β-cell dysfunction. Metformin at a concentration of 0.05 mM inhibits NOX and suppresses the palmitate-induced elevation of ER stress markers and ROS levels in a AMPK-independent manner, whereas 0.5 mM metformin inhibits ROCK activity and activates AMPK.

Conclusion

This study suggests that the action of metformin on β-cell lipotoxicity was implemented by different molecular pathways depending on its concentration. Metformin at a usual therapeutic dose is supposed to alleviate lipotoxic β-cell dysfunction through inhibition of oxidative stress and ER stress.

Citations

Citations to this article as recorded by  
  • Metformin promotes lipid droplet-mitochondria coupling and improves insulin secretion in pancreatic β-cells exposed to lipotoxicity
    Aneta M. Dobosz, Ewelina Krogulec, Nataniel Stefanowski, Maria Kendziorek, Magdalena Lebiedzinska-Arciszewska, Mariusz R. Wieckowski, Justyna Janikiewicz, Agnieszka Dobrzyn
    Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.2025; 1870(7): 159664.     CrossRef
  • 5‐Aminoimidazole‐4‐carboxamide‐1‐β${bf {beta}}$‐d‐ribofuranoside ameliorates lipotoxicity through enhanced reticulophagy in HepG2 cells
    Ajay Krishnan U, Anuradha Carani Venkataraman, Vidhya Ramachandran
    Biotechnology and Applied Biochemistry.2025;[Epub]     CrossRef
  • Metformin enhances METTL14-Mediated m6A methylation to alleviate NIT-1 cells apoptosis induced by hydrogen peroxide
    Si-min Zhou, Xin-ming Yao, Yi Cheng, Yu-jie Xing, Yue Sun, Qiang Hua, Shu-jun Wan, Xiang-jian Meng
    Heliyon.2024; 10(2): e24432.     CrossRef
  • Roles of m6A modification in regulating PPER pathway in cadmium-induced pancreatic β cell death
    Yifei Sun, Rongxian Li, Wenhong Li, Nan Zhang, Guofen Liu, Bo Zhao, Zongqin Mei, Shiyan Gu, Zuoshun He
    Ecotoxicology and Environmental Safety.2024; 282: 116672.     CrossRef
  • Metformin’s effect on metabolic dysfunction-associated steatotic liver disease through the miR-200a-5p and AMPK/SERCA2b pathway
    Hang Chen, Minshan Huang, Dan Zhang, Hui Wang, Da Wang, Mengwei Li, Xianmei Wang, Rui Zhu, Jianjun Liu, Lanqing Ma
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Reduced Expression Level of Protein PhosphatasePPM1EServes to Maintain Insulin Secretion in Type 2 Diabetes
    Sevda Gheibi, Luis Rodrigo Cataldo, Alexander Hamilton, Mi Huang, Sebastian Kalamajski, Malin Fex, Hindrik Mulder
    Diabetes.2023; 72(4): 455.     CrossRef
  • Metformin restores prohormone processing enzymes and normalizes aberrations in secretion of proinsulin and insulin in palmitate‐exposed human islets
    Quan Wen, Azazul Islam Chowdhury, Banu Aydin, Mudhir Shekha, Rasmus Stenlid, Anders Forslund, Peter Bergsten
    Diabetes, Obesity and Metabolism.2023; 25(12): 3757.     CrossRef
  • Treatment of type 2 diabetes mellitus with stem cells and antidiabetic drugs: a dualistic and future-focused approach
    Priyamvada Amol Arte, Kanchanlata Tungare, Mustansir Bhori, Renitta Jobby, Jyotirmoi Aich
    Human Cell.2023; 37(1): 54.     CrossRef
  • Overexpression of miR-297b-5p in Mouse Insulin-Secreting Cells Promotes Metformin-Mediated Protection Against Stearic Acid-Induced Senescence by Targeting Igf1r
    Qingrui Zhao, Shenghan Su, Yuqing Lin, Xuebei Li, Lingfeng Dan, Chunxiao Yang, Chenchen Geng, Romano Regazzi, Xiaohan Li, Yimeng Dong, Changhao Sun, Xia Chu, Huimin Lu
    Frontiers in Bioscience-Landmark.2023;[Epub]     CrossRef
  • Metformin disrupts insulin secretion, causes proapoptotic and oxidative effects in rat pancreatic beta‐cells in vitro
    Maíra M.R. Valle, Eloisa Aparecida Vilas‐Boas, Camila F. Lucena, Simone A. Teixeira, Marcelo N. Muscara, Angelo R. Carpinelli
    Journal of Biochemical and Molecular Toxicology.2022;[Epub]     CrossRef
  • Protection by metformin against severe Covid-19: An in-depth mechanistic analysis
    Nicolas Wiernsperger, Abdallah Al-Salameh, Bertrand Cariou, Jean-Daniel Lalau
    Diabetes & Metabolism.2022; 48(4): 101359.     CrossRef
  • Insight Into Rho Kinase Isoforms in Obesity and Energy Homeostasis
    Lei Wei, Jianjian Shi
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Overexpression of miR-297b-5p Promotes Metformin-Mediated Protection Against Stearic Acid-Induced Senescence by Targeting Igf1r
    Qingrui Zhao, Shenghan Su, Yuqing Lin, Xuebei Li, Lingfeng Dan, Yunjin Zhang, Chunxiao Yang, Xiaohan Li, Yimeng Dong, Chenchen Geng, Changhao Sun, Xia Chu, Huimin Lu
    SSRN Electronic Journal .2022;[Epub]     CrossRef
  • Metformin Dysregulates the Unfolded Protein Response and the WNT/β-Catenin Pathway in Endometrial Cancer Cells through an AMPK-Independent Mechanism
    Domenico Conza, Paola Mirra, Gaetano Calì, Luigi Insabato, Francesca Fiory, Francesco Beguinot, Luca Ulianich
    Cells.2021; 10(5): 1067.     CrossRef
  • NADPH Oxidase (NOX) Targeting in Diabetes: A Special Emphasis on Pancreatic β-Cell Dysfunction
    Suma Elumalai, Udayakumar Karunakaran, Jun-Sung Moon, Kyu-Chang Won
    Cells.2021; 10(7): 1573.     CrossRef
  • Metformin use and cardiovascular outcomes in patients with diabetes and chronic kidney disease: a nationwide cohort study
    Min Ho Kim, Hyung Jung Oh, Soon Hyo Kwon, Jin Seok Jeon, Hyunjin Noh, Dong Cheol Han, Hyoungnae Kim, Dong-Ryeol Ryu
    Kidney Research and Clinical Practice.2021; 40(4): 660.     CrossRef
  • Different Effects of Metformin and A769662 on Sodium Iodate-Induced Cytotoxicity in Retinal Pigment Epithelial Cells: Distinct Actions on Mitochondrial Fission and Respiration
    Chi-Ming Chan, Ponarulselvam Sekar, Duen-Yi Huang, Shu-Hao Hsu, Wan-Wan Lin
    Antioxidants.2020; 9(11): 1057.     CrossRef
  • Metformin Reduces Lipotoxicity-Induced Meta-Inflammation in β-Cells through the Activation of GPR40-PLC-IP3 Pathway
    Ximei Shen, Beibei Fan, Xin Hu, Liufen Luo, Yuanli Yan, Liyong Yang
    Journal of Diabetes Research.2019; 2019: 1.     CrossRef
Serum Ceruloplasmin Level as a Predictor for the Progression of Diabetic Nephropathy in Korean Men with Type 2 Diabetes Mellitus
Min Jung Lee, Chang Hee Jung, Yu Mi Kang, Jung Eun Jang, Jaechan Leem, Joong-Yeol Park, Woo Je Lee
Diabetes Metab J. 2015;39(3):230-239.   Published online April 22, 2015
DOI: https://doi.org/10.4093/dmj.2015.39.3.230
  • 8,473 View
  • 73 Download
  • 27 Web of Science
  • 28 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Oxidative stress is known to be associated with progression of diabetic kidney disease. Ceruloplasmin acts as a pro-oxidant under conditions of severe oxidative stress. Thus, we conducted a longitudinal observational study to evaluate whether the serum ceruloplasmin level is a predictive biomarker for progression of diabetic nephropathy.

Methods

A total of 643 Korean men with type 2 diabetes mellitus were enrolled. Serum ceruloplasmin was measured using a nephelometric method. Progression of diabetic nephropathy was defined as transition in albuminuria class (i.e., normoalbuminuria to microalbuminuria, microalbuminuria to macroalbuminuria, or normoalbuminuria to macroalbuminuria) and/or a greater than 2-fold increase of serum creatinine at follow-up compared with the baseline value.

Results

During the follow-up period (median, 2.7 years; range, 0.3 to 4.4 years), 49 of 643 patients (7.6%) showed the progression of diabetic nephropathy and three patients (0.5%) developed end-stage renal disease. Baseline ceruloplasmin levels were higher in the progressors than in the nonprogressors (262.6±40.9 mg/L vs. 233.3±37.8 mg/L, P<0.001). Kaplan-Meier analysis showed a significantly higher incidence of nephropathy progression according to ceruloplasmin tertile (log-rank test, P<0.001). The hazard ratio (HR) for progression of diabetic nephropathy was significantly higher in the highest ceruloplasmin tertile category compared with the lowest ceruloplasmin tertile category, even after adjusting for confounding variables (HR, 3.32; 95% confidence interval, 1.28 to 8.61; P=0.003).

Conclusion

Baseline serum ceruloplasmin is an independent predictive factor for the progression of diabetic nephropathy in patients with type 2 diabetes mellitus.

Citations

Citations to this article as recorded by  
  • Key biomarkers in type 2 diabetes patients: A systematic review
    Thien Ngoc Le, Richard Bright, Vi‐Khanh Truong, Jordan Li, Rajiv Juneja, Krasimir Vasilev
    Diabetes, Obesity and Metabolism.2025; 27(1): 7.     CrossRef
  • Augmented Intrarenal and Urinary Angiotensinogen in Diabetic Nephropathy: The Role of Isoflavones
    Masumi Kamiyama, Kotoe Iijima, Rema Okuzawa, Ruka Kawata, Airi Kimura, Yuki Shinohara, Ayana Shimada, Mika Yamanaka, Ayuka Youda, Tamami Iwamoto
    International Journal of Molecular Sciences.2025; 26(4): 1443.     CrossRef
  • Proteomic analysis of urinary exosomes reveals ferroptosis-associated proteins are involved in diabetic nephropathy
    Kaida Mu, Yanping Yang, Xiaofei An, Jie Zhu, Jing Zhang, Yanfei Jiang, Xiaorong Yang, Jinan Zhang
    Genes & Diseases.2024; 11(5): 101138.     CrossRef
  • Modulatory role of Annona squamosa extract against streptozotocin-induced diabetic nephropathy in male rats
    Ghaliah Almalki, Norah Alothman, Gamal Mohamed, Mohammed Akeel, Abd El-Fattah B.M. El-Beltagy, Eman T. Salem
    Egyptian Journal of Basic and Applied Sciences.2024; 11(1): 536.     CrossRef
  • WITHDRAWN: Research on Traditional Chinese Medicine Syndrome Animal Models and Multi-omics Biomarkers in Type II Diabetes: A Review
    Yifei Wang, Yan Gao, Bonian Zhao
    Pharmacological Research - Modern Chinese Medicine.2024; : 100471.     CrossRef
  • Dynamic changes of inflammatory markers in the early stages of chronic kidney disease in patients with type 1 diabetes mellitus
    MV Osikov, LA Efros, LYu Zhuravleva, AA Fedosov
    Bulletin of Russian State Medical University.2024;[Epub]     CrossRef
  • In-depth urinary and exosome proteome profiling analysis identifies novel biomarkers for diabetic kidney disease
    Shichun Du, Linhui Zhai, Shu Ye, Le Wang, Muyin Liu, Minjia Tan
    Science China Life Sciences.2023; 66(11): 2587.     CrossRef
  • Serum Level of Ceruloplasmin, Angiotensin-Converting Enzyme and Transferrin as Markers of Severity in SARS-CoV-2 Infection in Patients with Type 2 Diabetes
    Patricia-Andrada Reștea, Ștefan Țigan, Laura Grațiela Vicaș, Luminița Fritea, Eleonora Marian, Tunde Jurca, Annamaria Pallag, Iulius Liviu Mureșan, Corina Moisa, Otilia Micle, Mariana Eugenia Mureșan
    Microbiology Research.2023; 14(4): 1670.     CrossRef
  • The nephropathy of sickle cell trait and sickle cell disease
    Kenneth I. Ataga, Santosh L. Saraf, Vimal K. Derebail
    Nature Reviews Nephrology.2022; 18(6): 361.     CrossRef
  • Integrated Analysis of Single-Cell RNA-seq and Bulk RNA-seq in the Identification of a Novel ceRNA Network and Key Biomarkers in Diabetic Kidney Disease
    Yuejun Wang, Mingming Zhao, Yu Zhang
    International Journal of General Medicine.2022; Volume 15: 1985.     CrossRef
  • Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology
    Zhidong Liu, Miao Wang, Chunbo Zhang, Shigao Zhou, Guang Ji
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 695.     CrossRef
  • A correlative study of copper, ceruloplasmin, iron, total iron binding capacity and total antioxidant capacity in diabetic nephropathy
    Ramlingareddy, Shivashankara A Ramachandrayya, Jeena Jacob, Malathi Mala
    Biomedicine.2022; 42(3): 469.     CrossRef
  • Novel biomarkers for prognosticating diabetic kidney disease progression
    Shilna Muttickal Swaminathan, Indu Ramachandra Rao, Srinivas Vinayak Shenoy, Attur Ravindra Prabhu, Pooja Basthi Mohan, Dharshan Rangaswamy, Mohan V Bhojaraja, Shivashankara Kaniyoor Nagri, Shankar Prasad Nagaraju
    International Urology and Nephrology.2022; 55(4): 913.     CrossRef
  • Evaluation of Serum Ceruloplasmin Levels as a Biomarker for Oxidative Stress in Patients With Diabetic Retinopathy
    Gurunadh Satyanarayana, Narendra Keisham, Hitender S Batra, Subrahmanya Murti V, Mansur Khan, Sandeep Gupta, Vikram Mahindra
    Cureus.2021;[Epub]     CrossRef
  • Prospection of plasma proteins as biomarkers for diabetes mellitus monitoring
    Liliane de Paula Silva, Fabiane Gomes de Moraes Rego, Geraldo Picheth, Marcelo Müller-Santos, Dayane Alberton
    Journal of Diabetes & Metabolic Disorders.2021; 20(1): 611.     CrossRef
  • Risk assessment for foot ulcers among Tunisian subjects with diabetes: a cross sectional outpatient study
    B. Zantour, S. Bouchareb, Z. El Ati, F. Boubaker, W. Alaya, W. Kossomtini, M. H. Sfar
    BMC Endocrine Disorders.2020;[Epub]     CrossRef
  • Metalloproteins and apolipoprotein C: candidate plasma biomarkers of T2DM screened by comparative proteomics and lipidomics in ZDF rats
    Shuai Wang, Zhiyuan Lu, Yuxin Wang, Tianran Zhang, Xiaodong He
    Nutrition & Metabolism.2020;[Epub]     CrossRef
  • Emerging vistas on electrochemical detection of diabetic retinopathy biomarkers
    K.S. Shalini Devi, Madhurantakam Sasya, Uma Maheswari Krishnan
    TrAC Trends in Analytical Chemistry.2020; 125: 115838.     CrossRef
  • Oxidative stress in peritoneal dialysis patients: Association with the dialysis adequacy and technique survival
    Natalia Stepanova, Lesya Korol, Olena Burdeyna
    Indian Journal of Nephrology.2019; 29(5): 309.     CrossRef
  • Recent advancements in biopolymer and metal nanoparticle-based materials in diabetic wound healing management
    Veena Vijayakumar, Sushanta K. Samal, Smita Mohanty, Sanjay K. Nayak
    International Journal of Biological Macromolecules.2019; 122: 137.     CrossRef
  • Rat Böbrek Dokusunda Kurşunun Neden Olduğu Oksidatif Strese Karşı Kitosanın Koruyucu etkisi
    Ugur ÖZDEK, Hasan TOZ, Ahmet Ufuk KÖMÜROĞLU, Leyla MİS, Zübeyir HUYUT, Yeter DEĞER
    Van Veterinary Journal.2019; 30(3): 187.     CrossRef
  • Changes in Trace Elements During Early Stages of Chronic Kidney Disease in Type 2 Diabetic Patients
    Ching-Chiang Lin, Ching-Tang Shih, Chien-Hung Lee, Yeou-Lih Huang
    Biological Trace Element Research.2018; 186(2): 330.     CrossRef
  • The Divalent Elements Changes in Early Stages of Chronic Kidney Disease
    Wan-Ju Kung, Ching-Tang Shih, Chien-Hung Lee, Ching-Chiang Lin
    Biological Trace Element Research.2018; 185(1): 30.     CrossRef
  • Long-term expression of glomerular genes in diabetic nephropathy
    Dominik Chittka, Bernhard Banas, Laura Lennartz, Franz Josef Putz, Kathrin Eidenschink, Sebastian Beck, Thomas Stempfl, Christoph Moehle, Simone Reichelt-Wurm, Miriam C Banas
    Nephrology Dialysis Transplantation.2018; 33(9): 1533.     CrossRef
  • Incidence of chronic kidney disease among people with diabetes: a systematic review of observational studies
    D. N. Koye, J. E. Shaw, C. M. Reid, R. C. Atkins, A. T. Reutens, D. J. Magliano
    Diabetic Medicine.2017; 34(7): 887.     CrossRef
  • Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis
    Pengzi Zhang, Jing Lu, Yali Jing, Sunyinyan Tang, Dalong Zhu, Yan Bi
    Annals of Medicine.2017; 49(2): 106.     CrossRef
  • Biomarkers of diabetic nephropathy: A 2017 update
    Nektaria Papadopoulou-Marketou, Christina Kanaka-Gantenbein, Nikolaos Marketos, George P. Chrousos, Ioannis Papassotiriou
    Critical Reviews in Clinical Laboratory Sciences.2017; 54(5): 326.     CrossRef
  • Serum Vascular Adhesion Protein-1 Predicts End-Stage Renal Disease in Patients with Type 2 Diabetes
    Hung-Yuan Li, Hung-An Lin, Feng-Jung Nien, Vin-Cent Wu, Yi-Der Jiang, Tien-Jyun Chang, Hsien-Li Kao, Mao-Shin Lin, Jung-Nan Wei, Cheng-Hsin Lin, Shyang-Rong Shih, Chi-Sheng Hung, Lee-Ming Chuang, Emmanuel A Burdmann
    PLOS ONE.2016; 11(2): e0147981.     CrossRef
Reviews
Diabetic Cardiomyopathy and Its Prevention by Nrf2: Current Status
Jing Chen, Zhiguo Zhang, Lu Cai
Diabetes Metab J. 2014;38(5):337-345.   Published online October 17, 2014
DOI: https://doi.org/10.4093/dmj.2014.38.5.337
  • 10,495 View
  • 83 Download
  • 90 Web of Science
  • 91 Crossref
AbstractAbstract PDFPubReader   ePub   

Diabetic cardiomyopathy (DCM), as one of the major cardiac complications in diabetic patients, is known to related with oxidative stress that is due to a severe imbalance between reactive oxygen species (ROS) and/or reactive nitrogen species (RNS) generation and their clearance by antioxidant defense systems. Transcription factor nuclear factor NF-E2-related factor 2 (Nrf2) plays an important role in maintaining the oxidative homeostasis by regulating multiple downstream antioxidants. Diabetes may up-regulate several antioxidants in the heart as a compensative mechanism at early stage, but at late stage, diabetes not only generates extra ROS and/or RNS but also impairs antioxidant capacity in the heart, including Nrf2. In an early study, we have established that Nrf2 protect the cardiac cells and heart from high level of glucose in vitro and hyperglycemia in vivo, and in the following study demonstrated the significant down-regulation of cardiac Nrf2 expression in diabetic animals and patients. Using Nrf2-KO mice or Nrf2 inducers, blooming evidence has indicated the important protection by Nrf2 from cardiac pathogenesis in the diabetes. Therefore, this brief review summarizes the status of studies on Nrf2's role in preventing DCM and even other complications, the need for new and safe Nrf2 inducer screening and the precaution for the undesirable side of Nrf2 under certain conditions.

Citations

Citations to this article as recorded by  
  • Paraquat-induced neurotoxicity: Mechanisms and potential therapies
    Roghayeh Jahani, Hamidreza Mohammadi
    Letters in Drug Design & Discovery.2026; : 100258.     CrossRef
  • Modulation of PPAR-γ/Nrf2 and AGE/RAGE signaling contributes to the chrysin cardioprotection against myocardial damage following ischemia/reperfusion in diabetic rats
    Neha Rani, Dharamvir Singh Arya
    Journal of Pharmacy and Pharmacology.2025; 77(6): 794.     CrossRef
  • Novel insights into the central protective role of ACE2 in diabetic cardiomyopathy: from underlying signaling pathways to therapeutic perspectives
    Xinyi Li, Shunlin Qu
    Molecular and Cellular Biochemistry.2025; 480(6): 3535.     CrossRef
  • Diabetic Cardiomyopathy: An Update on Emerging Pathological Mechanisms
    Chirag Kakkar, Veerta Sharma, Ashi Mannan, Gaurav Gupta, Sachin Singh, Puneet Kumar, Kamal Dua, Amarjot Kaur, Shareen Singh, Sonia Dhiman, Thakur Gurjeet Singh
    Current Cardiology Reviews.2025;[Epub]     CrossRef
  • Mechanistic insights into temoporfin-based photodynamic therapy: Ferroptosis as a critical regulator under normoxic and hypoxic conditions in head and neck cancer
    Tong-Hong Wang, Li-Fang Chou, Yen-Wen Shen, Nan-Chin Lin, Yin-Hwa Shih, Tzong-Ming Shieh
    Journal of Photochemistry and Photobiology B: Biology.2025; 267: 113165.     CrossRef
  • Senkyunolide A mitigates lipid deposition in hyperlipidemic hepatocytes through SIRT6-mediated suppression of oxidative stress and fetuin-A
    Jun Hwi Ko, Tae Woo Jung, Min Kyung Pyo, Do Su Lim, Hyeon Ji Gwon, A.M. Abd El-Aty, Rıdvan Yağan, Jong Wook Shin, Moo Yeol Lee, Jin-Ho Song, Ji Hoon Jeong
    Biochemical and Biophysical Research Communications.2025; 771: 152046.     CrossRef
  • Erianin mitigates diabetic cardiomyopathy via adenosine monophosphate-activated protein kinase-nuclear factor erythroid 2-related factor 2-heme oxygenase-1 pathway activation
    Jia-Hui Chen, Xiao-Chun Dai, Zi-Jiao Quan, Xin-Yu Liu
    World Journal of Diabetes.2025;[Epub]     CrossRef
  • The role of Nrf2 signaling pathway in diabetic cardiomyopathy: from pathogenesis to traditional Chinese medicine interventions
    Huixian Gu, Junchang Liu, Jie Jiang, Hongyan Ma, Siyu Wu, Longfei Sun, Lan Yao
    Frontiers in Cardiovascular Medicine.2025;[Epub]     CrossRef
  • Agomelatine and empagliflozin synergistically protect against diabetic cardiomyopathy via nrf2/HO-1 signaling
    Nada A. Elbaik, Shimaa M. Elshazly, Atef El-Gharbawy, Mahmoud H. Elbatreek
    European Journal of Pharmacology.2025; 1005: 178054.     CrossRef
  • Beyond Hepatoprotection—The Cardioprotective Effects of Bicyclol in Diabetes
    Arun Samidurai, Rakesh C. Kukreja
    Cardiovascular Drugs and Therapy.2024; 38(3): 411.     CrossRef
  • Natural Products and Health
    Joanna Bartkowiak-Wieczorek, Edyta Mądry
    Nutrients.2024; 16(3): 415.     CrossRef
  • Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart
    Ge Yang, Qihe Zhang, Chao Dong, Guowen Hou, Jinjie Li, Xin Jiang, Ying Xin
    Journal of Cellular Physiology.2024;[Epub]     CrossRef
  • 3,4′,5-Trimethoxy-trans-stilbene ameliorates hepatic insulin resistance and oxidative stress in diabetic obese mice through insulin and Nrf2 signaling pathways
    Yi Tan, Chunxiu Zhou, Lingchao Miao, Xutao Zhang, Haroon Khan, Baojun Xu, Wai San Cheang
    Food & Function.2024; 15(6): 2996.     CrossRef
  • The signaling pathways of selected traditional Chinese medicine prescriptions and their metabolites in the treatment of diabetic cardiomyopathy: a review
    Wencan Li, Xiang Liu, Zheng Liu, Qichang Xing, Renzhu Liu, Qinxuan Wu, Yixiang Hu, Jiani Zhang
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Phycocyanin attenuates skeletal muscle damage and fatigue via modulation of Nrf2 and IRS-1/AKT/mTOR pathway in exercise-induced oxidative stress in rats
    Sayomphu Puengpan, Amnat Phetrungnapha, Sarawut Sattayakawee, Sakara Tunsophon, Keisuke Hitachi
    PLOS ONE.2024; 19(9): e0310138.     CrossRef
  • Cannabinoid 2 Receptor Activation Protects against Diabetic Cardiomyopathy through Inhibition of AGE/RAGE-Induced Oxidative Stress, Fibrosis, and Inflammasome Activation
    Hebaallah Mamdouh Hashiesh, Sheikh Azimullah, Mohamed Fizur Nagoor Meeran, Dhanya Saraswathiamma, Seenipandi Arunachalam, Niraj Kumar Jha, Bassem Sadek, Ernest Adeghate, Gautam Sethi, Alia Albawardi, Saeeda Al Marzooqi, Shreesh Ojha
    The Journal of Pharmacology and Experimental Therapeutics.2024; 391(2): 241.     CrossRef
  • From Microcirculation to Aging-Related Diseases: A Focus on Endothelial SIRT1
    Martin Law, Pei-Chun Wang, Zhong-Yan Zhou, Yu Wang
    Pharmaceuticals.2024; 17(11): 1495.     CrossRef
  • Concerning influences of micro/nano plastics on female reproductive health: focusing on cellular and molecular pathways from animal models to human studies
    Hasti Balali, Ali Morabbi, Mohammad Karimian
    Reproductive Biology and Endocrinology.2024;[Epub]     CrossRef
  • Natural compounds protect against the pathogenesis of osteoarthritis by mediating the NRF2/ARE signaling
    Zhenyu Wu, Zhouxin Yang, Luying Liu, Yong Xiao
    Frontiers in Pharmacology.2023;[Epub]     CrossRef
  • High fat diet exacerbates long-term metabolic, neuropathological, and behavioral derangements in an experimental mouse model of traumatic brain injury
    Stanley Ibeh, Nour-Mounira Z. Bakkar, Fatima Ahmad, Judith Nwaiwu, Chloe Barsa, Sarine Mekhjian, Mohammad Amine Reslan, Ali H. Eid, Hayat Harati, Sanaa Nabha, Yehia Mechref, Ahmed F. El-Yazbi, Firas Kobeissy
    Life Sciences.2023; 314: 121316.     CrossRef
  • The Protective Effect of 11-Keto-β-Boswellic Acid against Diabetic Cardiomyopathy in Rats Entails Activation of AMPK
    Jozaa Z. AlTamimi, Nora A. AlFaris, Ghedeir M. Alshammari, Reham I. Alagal, Dalal H. Aljabryn, Mohammed Abdo Yahya
    Nutrients.2023; 15(7): 1660.     CrossRef
  • Caffeic Acid Phenethyl Ester and Caffeamide Derivatives Suppress Oral Squamous Cell Carcinoma Cells
    Yin-Hwa Shih, Chieh-Chieh Chen, Yueh-Hsiung Kuo, Lih-Jyh Fuh, Wan-Chen Lan, Tong-Hong Wang, Kuo-Chou Chiu, Thanh-Hien Vu Nguyen, Shih-Min Hsia, Tzong-Ming Shieh
    International Journal of Molecular Sciences.2023; 24(12): 9819.     CrossRef
  • The Role of Asiatic Acid in Preventing Dental Pulp Inflammation: An in-vivo Study
    Arlina Nurhapsari, Risya Cilmiaty, Adi Prayitno, Bambang Purwanto, Soetrisno Soetrisno
    Clinical, Cosmetic and Investigational Dentistry.2023; Volume 15: 109.     CrossRef
  • Dexmedetomidine ameliorates diabetic cardiomyopathy by inhibiting ferroptosis through the Nrf2/GPX4 pathway
    Fan Li, Zhenfei Hu, Yidan Huang, Haiting Zhan
    Journal of Cardiothoracic Surgery.2023;[Epub]     CrossRef
  • Metformin-mediated epigenetic modifications in diabetes and associated conditions: Biological and clinical relevance
    Roberta Giordo, Anna Maria Posadino, Arduino Aleksander Mangoni, Gianfranco Pintus
    Biochemical Pharmacology.2023; 215: 115732.     CrossRef
  • Transient receptor potential vanilloid type 1: cardioprotective effects in diabetic models
    Jiaqi Bao, Zhicheng Gao, Yilan Hu, Lifang Ye, Lihong Wang
    Channels.2023;[Epub]     CrossRef
  • Sinapic acid ameliorates cardiac dysfunction and cardiomyopathy by modulating NF-κB and Nrf2/HO-1 signaling pathways in streptozocin induced diabetic rats
    Mohammad Raish, Ajaz Ahmad, Yousef A. Bin Jardan, Mudassar Shahid, Khalid M. Alkharfy, Abdul Ahad, Mushtaq Ahmad Ansari, Ibrahim Abdelsalam Abdelrahman, Fahad I. Al-Jenoobi
    Biomedicine & Pharmacotherapy.2022; 145: 112412.     CrossRef
  • Recent Advances in KEAP1/NRF2-Targeting Strategies by Phytochemical Antioxidants, Nanoparticles, and Biocompatible Scaffolds for the Treatment of Diabetic Cardiovascular Complications
    Andrea Rampin, Michele Carrabba, Martina Mutoli, Charlotte L. Eman, Gianluca Testa, Paolo Madeddu, Gaia Spinetti
    Antioxidants & Redox Signaling.2022; 36(10-12): 707.     CrossRef
  • Exercise and Urtica Dioica extract ameliorate mitochondrial function and the expression of cardiac muscle Nuclear Respiratory Factor 2 and Peroxisome proliferator-activated receptor Gamma Coactivator 1-alpha in STZ-induced diabetic rats
    Seyyedeh Masoumeh Seyydi, Asghar Tofighi, Masoud Rahmati, Javad Tolouei Azar
    Gene.2022; 822: 146351.     CrossRef
  • 3,3′,4,5′-Tetramethoxy-trans-stilbene Improves Insulin Resistance by Activating the IRS/PI3K/Akt Pathway and Inhibiting Oxidative Stress
    Yi Tan, Lingchao Miao, Jianbo Xiao, Wai San Cheang
    Current Issues in Molecular Biology.2022; 44(5): 2175.     CrossRef
  • The Beneficial Effects of Chinese Herbal Monomers on Ameliorating Diabetic Cardiomyopathy via Nrf2 Signaling
    Yiwei Gao, Wu Liu, Xin Su, Xinyi Li, Fangning Yu, Ning Zhang, Yuli Huang
    Oxidative Medicine and Cellular Longevity.2022;[Epub]     CrossRef
  • Cardioprotective Effects and in-silico Antioxidant Mechanism of L-Ergothioneine in Experimental Type-2 Diabetic Rats
    Ayobami Dare, Ahmed A Elrashedy, Mahendra L. Channa, Anand Nadar
    Cardiovascular & Hematological Agents in Medicinal Chemistry.2022; 20(2): 133.     CrossRef
  • Molecular Mechanisms of Ferroptosis and Relevance to Cardiovascular Disease
    Lai-Hua Xie, Nadezhda Fefelova, Sri Harika Pamarthi, Judith K. Gwathmey
    Cells.2022; 11(17): 2726.     CrossRef
  • Cardiac adaptation and cardioprotection against arrhythmias and ischemia-reperfusion injury in mammalian hibernators
    Lai-Hua Xie, Judith K. Gwathmey, Zhenghang Zhao
    Pflügers Archiv - European Journal of Physiology.2021; 473(3): 407.     CrossRef
  • Cardioprotective Effect of Glycyrrhizin on Myocardial Remodeling in Diabetic Rats
    Vikram Thakur, Narah Alcoreza, Monica Delgado, Binata Joddar, Munmun Chattopadhyay
    Biomolecules.2021; 11(4): 569.     CrossRef
  • Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy
    Nikole J. Byrne, Namakkal S. Rajasekaran, E Dale Abel, Heiko Bugger
    Free Radical Biology and Medicine.2021; 169: 317.     CrossRef
  • Punicalagin Protects Against Diabetic Cardiomyopathy by Promoting Opa1-Mediated Mitochondrial Fusion via Regulating PTP1B-Stat3 Pathway
    Feng Fu, Chaoyang Liu, Rui Shi, Man Li, Min Zhang, Yanyan Du, Qiaojuan Wang, Jun Li, Guoen Wang, Jianming Pei, Mingge Ding
    Antioxidants & Redox Signaling.2021; 35(8): 618.     CrossRef
  • Elevated type I interferon responses potentiate metabolic dysfunction, inflammation, and accelerated aging in mtDNA mutator mice
    Yuanjiu Lei, Camila Guerra Martinez, Sylvia Torres-Odio, Samantha L. Bell, Christine E. Birdwell, Joshua D. Bryant, Carl W. Tong, Robert O. Watson, Laura Ciaccia West, A. Phillip West
    Science Advances.2021;[Epub]     CrossRef
  • The potential role of Keap1-Nrf2 pathway in the pathogenesis of Alzheimer’s disease, type 2 diabetes, and type 2 diabetes-related Alzheimer’s disease
    Ling He, Yi Sun
    Metabolic Brain Disease.2021; 36(7): 1469.     CrossRef
  • The impact of mitochondria on cancer treatment resistance
    Michelle van der Merwe, Gustav van Niekerk, Carla Fourie, Manisha du Plessis, Anna-Mart Engelbrecht
    Cellular Oncology.2021; 44(5): 983.     CrossRef
  • Therapeutic Approaches Targeting Proteostasis in Kidney Disease and Fibrosis
    Jia-Huang Chen, Chia-Hsien Wu, Chih-Kang Chiang
    International Journal of Molecular Sciences.2021; 22(16): 8674.     CrossRef
  • Coronary Large Conductance Ca2+-Activated K+ Channel Dysfunction in Diabetes Mellitus
    Tong Lu, Hon-Chi Lee
    Frontiers in Physiology.2021;[Epub]     CrossRef
  • Ferroptosis: New Dawn for Overcoming the Cardio-Cerebrovascular Diseases
    Meng-Yi Luo, Jian-Hui Su, Shao-Xin Gong, Na Liang, Wen-Qian Huang, Wei Chen, Ai-Ping Wang, Ying Tian
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • Recombinant Human Growth Hormone Inhibits Lipotoxicity, Oxidative Stress, and Apoptosis in a Mouse Model of Diabetic Cardiomyopathy
    Zuowei Pei, Xiang Wang, Chenguang Yang, Min Dong, Fang Wang, Juan Gambini
    Oxidative Medicine and Cellular Longevity.2021;[Epub]     CrossRef
  • Hydrogen sulfide mitigates myocardial inflammation by inhibiting nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome activation in diabetic rats
    Qiang Jia, Shomaila Mehmood, Xiaofen Liu, Shanfeng Ma, Rui Yang
    Experimental Biology and Medicine.2020; 245(3): 221.     CrossRef
  • Heme oxygenase-1 in protozoan infections: A tale of resistance and disease tolerance
    Rafael C. M. C. Silva, Leonardo H. Travassos, Claudia N. Paiva, Marcelo T. Bozza, Marc-Jan Gubbels
    PLOS Pathogens.2020; 16(7): e1008599.     CrossRef
  • Distinct Approaches of Raloxifene: Its Far-Reaching Beneficial Effects Implicating the HO-System
    Denise Börzsei, Renáta Szabó, Alexandra Hoffmann, Médea Veszelka, Imre Pávó, Zsolt Turcsán, Csaba Viczián, Krisztina Kupai, Csaba Varga, Anikó Pósa
    Biomolecules.2020; 10(3): 375.     CrossRef
  • The Mitochondria: A Target of Polyphenols in the Treatment of Diabetic Cardiomyopathy
    Humna Bhagani, Suzanne A. Nasser, Ali Dakroub, Ahmed F. El-Yazbi, Assaad A. Eid, Firas Kobeissy, Gianfranco Pintus, Ali H. Eid
    International Journal of Molecular Sciences.2020; 21(14): 4962.     CrossRef
  • The Effects of Dietary Supplements that Overactivate the Nrf2/ARE System
    Robert E. Smith
    Current Medicinal Chemistry.2020; 27(13): 2077.     CrossRef
  • Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats
    Jierong Luo, Dan Yan, Sisi Li, Shiming Liu, Fei Zeng, Chi Wai Cheung, Hong Liu, Michael G. Irwin, Huansen Huang, Zhengyuan Xia
    Journal of Cellular and Molecular Medicine.2020; 24(2): 1760.     CrossRef
  • Rg1 protects H9C2 cells from high glucose‐/palmitate‐induced injury via activation of AKT/GSK‐3β/Nrf2 pathway
    Haitao Yu, Juan Zhen, Yang Yang, Jian Du, Jiyan Leng, Qian Tong
    Journal of Cellular and Molecular Medicine.2020; 24(14): 8194.     CrossRef
  • Ranolazine protects against diabetic cardiomyopathy by activating the NOTCH1/NRG1 pathway
    Xi Chen, Long Ren, Xing Liu, Xi Sun, Chaorun Dong, Yanan Jiang, Ying Qin, Huan Qu, Jinfeng Jiao, Shuo Wang, Yunlong Bai, Baofeng Yang
    Life Sciences.2020; 261: 118306.     CrossRef
  • Low Concentration of Withaferin a Inhibits Oxidative Stress-Mediated Migration and Invasion in Oral Cancer Cells
    Tzu-Jung Yu, Jen-Yang Tang, Fu Ou-Yang, Yen-Yun Wang, Shyng-Shiou F. Yuan, Kevin Tseng, Li-Ching Lin, Hsueh-Wei Chang
    Biomolecules.2020; 10(5): 777.     CrossRef
  • Protective Effect of Simplicillium sp. Ethyl Acetate Extract against High Glucose‐Induced Oxidative Stress in HUVECs
    Ting-Ting Tian, Qi-Rui Li, Shi-Quan Gan, Chu-Rui Chang, Xiang-Chun Shen, Shao-Hsuan Kao
    Evidence-Based Complementary and Alternative Medicine.2020;[Epub]     CrossRef
  • Deneysel Diyabet Oluşturulan Sıçanlarda Kalp ve İskelet Kası Nrf2 Yapımı ve Oksidatif Stres Üzerine Melatoninin Etkisinin İncelenmesi
    Salim ÖZENOĞLU, İnci TURAN, Hale SAYAN ÖZAÇMAK, Veysel Haktan ÖZAÇMAK
    Turkish Journal of Diabetes and Obesity.2020; 4(1): 46.     CrossRef
  • Nicorandil alleviates apoptosis in diabetic cardiomyopathy through PI3K/Akt pathway
    Xuyang Wang, Jinyu Pan, Dian Liu, Mingjun Zhang, Xiaowei Li, Jingjing Tian, Ming Liu, Tao Jin, Fengshuang An
    Journal of Cellular and Molecular Medicine.2019; 23(8): 5349.     CrossRef
  • Bailcalin Protects against Diabetic Cardiomyopathy through Keap1/Nrf2/AMPK-Mediated Antioxidative and Lipid-Lowering Effects
    Ran Li, Yuan Liu, Ying-guang Shan, Lu Gao, Fang Wang, Chun-guang Qiu
    Oxidative Medicine and Cellular Longevity.2019; 2019: 1.     CrossRef
  • Omega 3 rich diet modulates energy metabolism via GPR120-Nrf2 crosstalk in a novel antioxidant mouse model
    Deborah Amos, Carla Cook, Nalini Santanam
    Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.2019; 1864(4): 466.     CrossRef
  • Increased placental expressions of nuclear factor erythroid 2–related factor 2 and antioxidant enzymes in gestational diabetes: Protective mechanisms against the placental oxidative stress?
    Balachandiran Manoharan, Zachariah Bobby, Gowri Dorairajan, Sajini Elizabeth Jacob, Victorraj Gladwin, Vickneshwaran Vinayagam, Rajaa Muthu Packirisamy
    European Journal of Obstetrics & Gynecology and Reproductive Biology.2019; 238: 78.     CrossRef
  • Another look at phenolic compounds in cancer therapy the effect of polyphenols on ubiquitin-proteasome system
    Aleksandra Golonko, Tomasz Pienkowski, Renata Swislocka, Ryszard Lazny, Marek Roszko, Wlodzimierz Lewandowski
    European Journal of Medicinal Chemistry.2019; 167: 291.     CrossRef
  • Hydrogen sulfide-mediated regulation of cell death signaling ameliorates adverse cardiac remodeling and diabetic cardiomyopathy
    Sumit Kar, Tyler N. Kambis, Paras K. Mishra
    American Journal of Physiology-Heart and Circulatory Physiology.2019; 316(6): H1237.     CrossRef
  • Genomic and Genetic Approaches to Deciphering Acute Respiratory Distress Syndrome Risk and Mortality
    Heather Lynn, Xiaoguang Sun, Nancy Casanova, Manuel Gonzales-Garay, Christian Bime, Joe G.N. Garcia
    Antioxidants & Redox Signaling.2019; 31(14): 1027.     CrossRef
  • Enhanced Keap1-Nrf2 signaling protects the myocardium from isoproterenol-induced pathological remodeling in mice
    Gobinath Shanmugam, Anil Kumar Challa, Silvio H. Litovsky, Asokan Devarajan, Ding Wang, Dean P. Jones, Victor M. Darley-Usmar, Namakkal Soorappan Rajasekaran
    Redox Biology.2019; 27: 101212.     CrossRef
  • Effects of PP2A/Nrf2 on experimental diabetes mellitus-related cardiomyopathy by regulation of autophagy and apoptosis through ROS dependent pathway
    Yanhui Guan, Lichun Zhou, Yu Zhang, Huiqin Tian, Anqi Li, Xiuzhen Han
    Cellular Signalling.2019; 62: 109339.     CrossRef
  • An Aza resveratrol–chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress
    Shengban You, Jianchang Qian, Chuchu Sun, Hailing Zhang, Shiju Ye, Taiwei Chen, Zheng Xu, Jingying Wang, Weijian Huang, Guang Liang
    Journal of Cellular and Molecular Medicine.2018; 22(3): 1931.     CrossRef
  • Oxidative Stress in Mesenchymal Stem Cell Senescence: Regulation by Coding and Noncoding RNAs
    Rosa Vono, Eva Jover Garcia, Gaia Spinetti, Paolo Madeddu
    Antioxidants & Redox Signaling.2018; 29(9): 864.     CrossRef
  • An overview of the emerging interface between cardiac metabolism, redox biology and the circadian clock
    Rodrigo A. Peliciari-Garcia, Victor Darley-Usmar, Martin E. Young
    Free Radical Biology and Medicine.2018; 119: 75.     CrossRef
  • Klotho protects the heart from hyperglycemia-induced injury by inactivating ROS and NF-κB-mediated inflammation both in vitro and in vivo
    Yue Guo, Xiaodong Zhuang, Zena Huang, Jing Zou, Daya Yang, Xun Hu, Zhimin Du, Lichun Wang, Xinxue Liao
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2018; 1864(1): 238.     CrossRef
  • Paradoxical cardiotoxicity of intraperitoneally-injected epigallocatechin gallate preparation in diabetic mice
    Nora O. Abdel Rasheed, Lamiaa A. Ahmed, Dalaal M. Abdallah, Bahia M. El-Sayeh
    Scientific Reports.2018;[Epub]     CrossRef
  • Oxidative stress-induced miR-27a targets the redox gene nuclear factor erythroid 2-related factor 2 in diabetic embryopathy
    Yang Zhao, Daoyin Dong, E. Albert Reece, Ashley R. Wang, Peixin Yang
    American Journal of Obstetrics and Gynecology.2018; 218(1): 136.e1.     CrossRef
  • Regulation on SIRT1-PGC-1α/Nrf2 pathway together with selective inhibition of aldose reductase makes compound hr5F a potential agent for the treatment of diabetic complications
    Zhihua Wang, Sheng Yuan, Yanbing Li, Zhe Zhang, Wei Xiao, Dan Tang, Kaihe Ye, Zhijun Liu, Congcong Wang, Yixiong Zheng, Hong Nie, Heru Chen
    Biochemical Pharmacology.2018; 150: 54.     CrossRef
  • Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart
    Hong Yang, Anyun Feng, Sundong Lin, Lechu Yu, Xiufei Lin, Xiaoqing Yan, Xuemian Lu, Chi Zhang
    Cell Death & Disease.2018;[Epub]     CrossRef
  • Salusin-β contributes to oxidative stress and inflammation in diabetic cardiomyopathy
    Ming-Xia Zhao, Bing Zhou, Li Ling, Xiao-Qing Xiong, Feng Zhang, Qi Chen, Yue-Hua Li, Yu-Ming Kang, Guo-Qing Zhu
    Cell Death & Disease.2017; 8(3): e2690.     CrossRef
  • Role of Nrf2 Signaling in the Regulation of Vascular BK Channel β1 Subunit Expression and BK Channel Function in High-Fat Diet–Induced Diabetic Mice
    Tong Lu, Xiaojing Sun, Yong Li, Qiang Chai, Xiao-Li Wang, Hon-Chi Lee
    Diabetes.2017; 66(10): 2681.     CrossRef
  • Regulation of vascular large-conductance calcium-activated potassium channels by Nrf2 signalling
    Yong Li, Xiao-Li Wang, Xiaojing Sun, Qiang Chai, Jingchao Li, Benjamin Thompson, Win-Kuang Shen, Tong Lu, Hon-Chi Lee
    Diabetes and Vascular Disease Research.2017; 14(4): 353.     CrossRef
  • Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy
    Junlian Gu, Yanli Cheng, Hao Wu, Lili Kong, Shudong Wang, Zheng Xu, Zhiguo Zhang, Yi Tan, Bradley B. Keller, Honglan Zhou, Yuehui Wang, Zhonggao Xu, Lu Cai
    Diabetes.2017; 66(2): 529.     CrossRef
  • Kimchi methanol extracts attenuate hepatic steatosis induced by high cholesterol diet in low-density lipoprotein receptor knockout mice through inhibition of endoplasmic reticulum stress
    Minji Woo, Mijeong Kim, Jeong Sook Noh, Yeong Ok Song
    Journal of Functional Foods.2017; 32: 218.     CrossRef
  • Aspalathin Protects the Heart against Hyperglycemia-Induced Oxidative Damage by Up-Regulating Nrf2 Expression
    Phiwayinkosi Dludla, Christo Muller, Elizabeth Joubert, Johan Louw, M. Essop, Kwazi Gabuza, Samira Ghoor, Barbara Huisamen, Rabia Johnson
    Molecules.2017; 22(1): 129.     CrossRef
  • Intermittent hypoxia-induced cardiomyopathy and its prevention by Nrf2 and metallothionein
    Shanshan Zhou, Xia Yin, Jingpeng Jin, Yi Tan, Daniel J. Conklin, Ying Xin, Zhiguo Zhang, Weixia Sun, Taixing Cui, Jun Cai, Yang Zheng, Lu Cai
    Free Radical Biology and Medicine.2017; 112: 224.     CrossRef
  • Inhibitory effects of rosmarinic acid on pterygium epithelial cells through redox imbalance and induction of extrinsic and intrinsic apoptosis
    Ya-Yu Chen, Chia-Fang Tsai, Ming-Chu Tsai, Yu-Wen Hsu, Fung-Jou Lu
    Experimental Eye Research.2017; 160: 96.     CrossRef
  • Pathophysiological Fundamentals of Diabetic Cardiomyopathy
    Xinyue Hu, Tao Bai, Zheng Xu, Qiuju Liu, Yang Zheng, Lu Cai
    Comprehensive Physiology.2017; 7(2): 693.     CrossRef
  • Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus
    Anne Lejay, Fei Fang, Rohan John, Julie A.D. Van, Meredith Barr, Fabien Thaveau, Nabil Chakfe, Bernard Geny, James W. Scholey
    Journal of Molecular and Cellular Cardiology.2016; 91: 11.     CrossRef
  • The Role of the Nrf2/ARE Antioxidant System in Preventing Cardiovascular Diseases
    Robert Smith, Kevin Tran, Cynthia Smith, Miranda McDonald, Pushkar Shejwalkar, Kenji Hara
    Diseases.2016; 4(4): 34.     CrossRef
  • Prohibitin overexpression improves myocardial function in diabetic cardiomyopathy
    Wen-qian Dong, Min Chao, Qing-hua Lu, Wei-li Chai, Wei Zhang, Xue-ying Chen, Er-shun Liang, Ling-bo Wang, Hong-liang Tian, Yu-guo Chen, Ming-xiang Zhang
    Oncotarget.2016; 7(1): 66.     CrossRef
  • Restoration of Nrf2 Signaling Normalizes the Regenerative Niche
    Marc A. Soares, Oriana D. Cohen, Yee Cheng Low, Rita A. Sartor, Trevor Ellison, Utkarsh Anil, Lavinia Anzai, Jessica B. Chang, Pierre B. Saadeh, Piul S. Rabbani, Daniel J. Ceradini
    Diabetes.2016; 65(3): 633.     CrossRef
  • Myocardial transcription factors in diastolic dysfunction: clues for model systems and disease
    Alexander T. Mikhailov, Mario Torrado
    Heart Failure Reviews.2016; 21(6): 783.     CrossRef
  • Antioxidant Properties of Whole Body Periodic Acceleration (pGz)
    Arkady Uryash, Jorge Bassuk, Paul Kurlansky, Francisco Altamirano, Jose R. Lopez, Jose A. Adams, Guillermo López Lluch
    PLOS ONE.2015; 10(7): e0131392.     CrossRef
  • Mulberry leaves (Morus alba L.) ameliorate obesity-induced hepatic lipogenesis, fibrosis, and oxidative stress in high-fat diet-fed mice
    Ji-Young Ann, Hyeyoon Eo, Yunsook Lim
    Genes & Nutrition.2015;[Epub]     CrossRef
  • Oxidative Stress and Human Hypertension: Vascular Mechanisms, Biomarkers, and Novel Therapies
    Augusto C. Montezano, Maria Dulak-Lis, Sofia Tsiropoulou, Adam Harvey, Ana M. Briones, Rhian M. Touyz
    Canadian Journal of Cardiology.2015; 31(5): 631.     CrossRef
  • Haeme oxygenase signalling pathway: implications for cardiovascular disease
    Laura E. Fredenburgh, Allison A. Merz, Susan Cheng
    European Heart Journal.2015; 36(24): 1512.     CrossRef
  • Glucose Homeostasis and Cardiovascular Alterations in Diabetes
    Lusha Xiang, Peter N. Mittwede, John S. Clemmer
    Comprehensive Physiology.2015; 5(4): 1815.     CrossRef
The Role of Oxidative Stress in the Pathogenesis of Diabetic Vascular Complications
Shuji Sasaki, Toyoshi Inoguchi
Diabetes Metab J. 2012;36(4):255-261.   Published online August 20, 2012
DOI: https://doi.org/10.4093/dmj.2012.36.4.255
  • 7,578 View
  • 80 Download
  • 66 Crossref
AbstractAbstract PDFPubReader   ePub   

Oxidative stress has been paid increasing attention to as an important causative factor for diabetic vascular complications. Among possible various sources, accumulating evidence has indicated that NAD(P)H oxidase may be the most important source for reactive oxygen species production in diabetic vascular tissues. The mechanisms underlying activation and up-regulation of NAD(P)H oxidase has been supposed to be mediated by high glucose-induced protein kinase C (PKC) activation. In this review article, activation of local renin-angiotensin II system induced by chymase activation is also shown to amplify such a PKC-dependent activation of NAD(P)H oxidase. Additionally, human evidence showing the beneficial effect of antioxidants on diabetic vascular complications. Bilirubin has been recognized as a strong endogenous antioxidant. Here markedly lower prevalence of vascular complications is shown in diabetic patients with Gilbert syndrome, a congenital hyperbilirubinemia, as well as reduced markers of oxidative stress and inflammation. Lastly, statin, angiotensin II receptor blocker, chymase inhibitor, bilirubin and biliverdin, PKC β isoform inhibitor, and glucagon-like peptide-1 analog, are shown to serve as antioxidants and have some beneficial effect on diabetic vascular complications, via inhibiting PKC-NAD(P)H oxidase activation, supporting the notion that this mechanism may be an effective therapeutic target for preventing diabetic vascular complications.

Citations

Citations to this article as recorded by  
  • Effectiveness of vitamin E in the treatment of diabetic neuropathy: systematic review and meta-analysis
    Raghad Alhajaji, Ahmed A. Hassan, Manar Ahmad Al-Harahsheh, Reem Rabie Saber, Marina Amgad Soliman, Amr Mahmoud Alam Eldin, Engy Sherif Sabry, Mena Ayman Elgendy, Ganna Hatem Farouk, Walaa Mokhtar El-basiony, Heba Hendi Goda, Mohamed Saad Sayed
    Hormones.2026;[Epub]     CrossRef
  • Rhodanine-benzamides as potential hits for α-amylase enzyme inhibitors and radical (DPPH and ABTS) scavengers
    Samuel Attah Egu, Irfan Ali, Khalid Mohammed Khan, Sridevi Chigurupati, Urooj Qureshi, Uzma Salar, Zaheer Ul-Haq, Suliman A. Almahmoud, Shatha Ghazi Felemban, Mohsin Ali, Muhammad Taha
    Molecular Diversity.2025; 29(5): 3857.     CrossRef
  • Endoplasmic reticulum stress and unfolded protein response in renal lipid metabolism
    Xinyi Zhou, Ziyi Li, Fajian Ren, Hua Deng, Jiayu Wen, Qiwen Xiang, Zhihui Zhou, Xiyun Yang, Chaolong Rao
    Experimental Cell Research.2025; 446(1): 114463.     CrossRef
  • Cotton stalk derived lignin-based hydrogel and its therapeutic utility in diabetic retinopathy
    Pradip Nirbhavane, Sharad S. Kale, Sameer Kumar, Tejal Athare, Anuja G. Magar, Shailesh S. Chalikwar, Kailas K. Moravkar
    Biochemical and Biophysical Research Communications.2025; 775: 152123.     CrossRef
  • Functional and Therapeutic Roles of Plant-Derived Antioxidants in Type 2 Diabetes Mellitus: Mechanisms, Challenges, and Considerations for Special Populations
    Vicente Javier Clemente-Suárez, Alexandra Martín-Rodríguez, Ana Isabel Beltrán-Velasco, Alejandro Rubio-Zarapuz, Ismael Martínez-Guardado, Roberto Valcárcel-Martín, José Francisco Tornero-Aguilera
    Antioxidants.2025; 14(6): 725.     CrossRef
  • Targeting endothelial oxidative stress in hypertension
    Jinyan Liu
    Open Medicine.2025;[Epub]     CrossRef
  • The effects of whey protein on anthropometric parameters, resting energy expenditure, oxidative stress, and appetite in overweight/obese women with type 2 diabetes mellitus: A randomized placebo controlled clinical trial
    Maryam Nouri, Bahram Pourghassem Gargari, Zahra Ghasempour, Vahideh Sadra, Mohammad Asghari Jafarabadi, Arvin Babaei, Pedram Tajfar, Ali Tarighat-Esfanjani
    International Journal of Diabetes in Developing Countries.2024; 44(1): 155.     CrossRef
  • In Vitro Models of Diabetes: Focus on Diabetic Retinopathy
    Giulia Galgani, Giorgia Bray, Alma Martelli, Vincenzo Calderone, Valentina Citi
    Cells.2024; 13(22): 1864.     CrossRef
  • Research Progress of FGF-21 and CVAI in Type 2 Diabetic Kidney Disease
    央宗 才巴
    Advances in Clinical Medicine.2023; 13(07): 12056.     CrossRef
  • Is Subcutaneous Rifamycin Application Superior to Saline Application in Hip Hemiarthroplasty?
    Malik Çelik, Nezih Ziroğlu, Alkan Bayrak
    Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy.2023; 19(2): 186.     CrossRef
  • In pursuit of incorporation of markers of oxidative stress in traditional biochemical panels in clinical Chemistry: A risk assessment step in diagnosis and biotherapy
    John Ibhagbemien Anetor, Chukwuemelie Zedech Uche, Gloria Oiyahumen Anetor
    American Journal of Biopharmacy and Pharmaceutical Sciences.2022; 2: 1.     CrossRef
  • Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
    Chan-Young Jung, Tae-Hyun Yoo
    Diabetes & Metabolism Journal.2022; 46(2): 181.     CrossRef
  • p38 MAPK Inhibitor (SB203580) and Metformin Reduces Aortic Protein Carbonyl and Inflammation in Non-obese Type 2 Diabetic Rats
    Nuttikarn Nokkaew, Podsawee Mongkolpathumrat, Ruttanapong Junsiri, Supawit Jindaluang, Nichagron Tualamun, Niya Manphatthanakan, Nareumon Saleesee, Marisa Intasang, Jantira Sanit, Punyanuch Adulyaritthikul, Kantapich Kongpol, Sarawut Kumphune, Nitirut Ner
    Indian Journal of Clinical Biochemistry.2021; 36(2): 228.     CrossRef
  • Resveratrol-Elicited PKC Inhibition Counteracts NOX-Mediated Endothelial to Mesenchymal Transition in Human Retinal Endothelial Cells Exposed to High Glucose
    Roberta Giordo, Gheyath K. Nasrallah, Anna Maria Posadino, Francesco Galimi, Giampiero Capobianco, Ali Hussein Eid, Gianfranco Pintus
    Antioxidants.2021; 10(2): 224.     CrossRef
  • BIOLOGICAL ACTIVE COMPONENTS OF SILENE TOMENTELLA AND THEIR PHARMACOLOGICAL PROPERTIES
    Ugiloy Yusufovna Yusupova, Nurmurod Sheralievich Ramazonov, Khairulla Mamadievich Bobakulov, Feruza Rustamovna Egamova, Vladimir Nikolaevich Syrov, Durbek Abdikhoshimovich Usmanov
    chemistry of plant raw material.2021; (1): 197.     CrossRef
  • Chronically Elevated Exogenous Glucose Elicits Antipodal Effects on the Proteome Signature of Differentiating Human iPSC-Derived Pancreatic Progenitors
    Luiza Ghila, Thomas Aga Legøy, Andreas Frøslev Mathisen, Shadab Abadpour, Joao A. Paulo, Hanne Scholz, Helge Ræder, Simona Chera
    International Journal of Molecular Sciences.2021; 22(7): 3698.     CrossRef
  • Effect of Type-2 Diabetes Mellitus in Retinopathy Patients on MDA, SOD Activity and its Correlation with HbA1c
    Yali Hou, Mei Lin, Xuan Qiu, Mingjuan He, Yu Zhang, Feifei Guo
    Brazilian Archives of Biology and Technology.2021;[Epub]     CrossRef
  • Ameliorative effects of Hydrolea zeylanica in streptozotocin-induced oxidative stress and metabolic changes in diabetic rats
    Sandeep Kumar Swain, Umesh Chandra Dash, Satish Kanhar, Atish Kumar Sahoo
    Journal of Ethnopharmacology.2020; 247: 112257.     CrossRef
  • Imbalance in the antioxidant defence system and pro-genotoxic status induced by high glucose concentrations: In vitro testing in human liver cells
    Mattia Acito, Desirée Bartolini, Maria Rachele Ceccarini, Carla Russo, Samuele Vannini, Luca Dominici, Michela Codini, Milena Villarini, Francesco Galli, Tommaso Beccari, Massimo Moretti
    Toxicology in Vitro.2020; 69: 105001.     CrossRef
  • Synthesis of sulpha drug based hydroxytriazene derivatives: Anti-diabetic, antioxidant, anti-inflammatory activity and their molecular docking studies
    Poonam Sharma, Varsha Dayma, Aparna Dwivedi, Prabhat K. Baroliya, I.P. Tripathi, Murugesan Vanangamudi, R.S. Chauhan, A.K. Goswami
    Bioorganic Chemistry.2020; 96: 103642.     CrossRef
  • Analysis of long non-coding RNA expression profiles in high-glucose treated vascular endothelial cells
    Erqin Xu, Xiaolei Hu, Xiaoli Li, Guoxi Jin, Langen Zhuang, Qiong Wang, Xiaoyan Pei
    BMC Endocrine Disorders.2020;[Epub]     CrossRef
  • Potent α-amylase inhibitors and radical (DPPH and ABTS) scavengers based on benzofuran-2-yl(phenyl)methanone derivatives: Syntheses, in vitro, kinetics, and in silico studies
    Irfan Ali, Rafaila Rafique, Khalid Mohammed Khan, Sridevi Chigurupati, Xingyue Ji, Abdul Wadood, Ashfaq Ur Rehman, Uzma Salar, Muhammad Shahid Iqbal, Muhammad Taha, Shahnaz Perveen, Basharat Ali
    Bioorganic Chemistry.2020; 104: 104238.     CrossRef
  • A review of fibroblast growth factor 21 in diabetic cardiomyopathy
    Xiang Zhang, Luo Yang, Xiongfeng Xu, Fengjuan Tang, Peng Yi, Bo Qiu, Yarong Hao
    Heart Failure Reviews.2019; 24(6): 1005.     CrossRef
  • Recent advances in the pathogenesis of microvascular complications in diabetes
    Sungmi Park, Hyeon-Ji Kang, Jae-Han Jeon, Min-Ji Kim, In-Kyu Lee
    Archives of Pharmacal Research.2019; 42(3): 252.     CrossRef
  • Metabolic syndrome status over 2 years predicts incident chronic kidney disease in mid-life adults: a 10-year prospective cohort study
    So Jin Lee, Hun Ju Lee, Hyun jeong Oh, Taehwa Go, Dae Ryong Kang, Jang Young Kim, Ji Hye Huh
    Scientific Reports.2018;[Epub]     CrossRef
  • Role of peroxisome proliferator–activated receptor-gamma activation on visfatin, advanced glycation end products, and renal oxidative stress in obesity-induced type 2 diabetes mellitus
    A Tabassum, T Mahboob
    Human & Experimental Toxicology.2018; 37(11): 1187.     CrossRef
  • Coffee consumption and reduced risk of developing type 2 diabetes: a systematic review with meta-analysis
    Mattias Carlström, Susanna C Larsson
    Nutrition Reviews.2018; 76(6): 395.     CrossRef
  • Liraglutide ameliorates early renal injury by the activation of renal FoxO1 in a type 2 diabetic kidney disease rat model
    Pin Chen, Xiaozhi Shi, Xiangjin Xu, Yiyang Lin, Zhulin Shao, Rongdan Wu, Lihong Huang
    Diabetes Research and Clinical Practice.2018; 137: 173.     CrossRef
  • Antioxidant effects of vitamins in type 2 diabetes: a meta-analysis of randomized controlled trials
    Maria E. Balbi, Fernanda S. Tonin, Antonio M. Mendes, Helena H. Borba, Astrid Wiens, Fernando Fernandez-Llimos, Roberto Pontarolo
    Diabetology & Metabolic Syndrome.2018;[Epub]     CrossRef
  • Gilbert syndrome in patients with type 1 diabetes-Prevalence, glycemic control, and microalbuminuria
    Sigal Singer, Nurit Pilpel, Orit Pinhas-Hamiel
    Pediatric Diabetes.2017; 18(8): 803.     CrossRef
  • Low serum bilirubin level predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus
    Kang Hee Ahn, Sang Soo Kim, Won Jin Kim, Jong Ho Kim, Yun Jeong Nam, Su Bin Park, Yun Kyung Jeon, Bo Hyun Kim, In Joo Kim, Yong Ki Kim
    The Korean Journal of Internal Medicine.2017; 32(5): 875.     CrossRef
  • Tiron ameliorates high glucose‐induced cardiac myocyte apoptosis by PKCδ‐dependent inhibition of osteopontin
    Ping Jiang, Deling Zhang, Hong Qiu, Xianqi Yi, Yemin Zhang, Yingkang Cao, Bo Zhao, Zhongyuan Xia, Changhua Wang
    Clinical and Experimental Pharmacology and Physiology.2017; 44(7): 760.     CrossRef
  • Protective effects of 6-Gingerol on vascular endothelial cell injury induced by high glucose via activation of PI3K-AKT-eNOS pathway in human umbilical vein endothelial cells
    Dan Liu, Mengqing Wu, Yi Lu, Tao Xian, Yupeng Wang, Bowei Huang, Guohua Zeng, Qiren Huang
    Biomedicine & Pharmacotherapy.2017; 93: 788.     CrossRef
  • Adenosine signaling in diabetes mellitus and associated cardiovascular and renal complications
    Maria Peleli, Mattias Carlstrom
    Molecular Aspects of Medicine.2017; 55: 62.     CrossRef
  • Diabetes and increased lipid peroxidation are associated with systemic inflammation even in well-controlled patients
    Alliny de Souza Bastos, Dana T. Graves, Ana Paula de Melo Loureiro, Carlos Rossa Júnior, Sâmia Cruz Tfaile Corbi, Fausto Frizzera, Raquel Mantuaneli Scarel-Caminaga, Niels Olsen Câmara, Oelisoa M. Andriankaja, Meire I. Hiyane, Silvana Regina Perez Orrico
    Journal of Diabetes and its Complications.2016; 30(8): 1593.     CrossRef
  • Agkistrodon acutus-purified protein C activator protects human umbilical vein endothelial cells against H2O2-induced apoptosis
    Shu Li, Yun Hong, Xin Jin, Xianwei Li, Entao Sun, Genbao Zhang, Linming Lu, Liuwang Nie
    Pharmaceutical Biology.2016; 54(12): 3285.     CrossRef
  • The impact of mast cells on cardiovascular diseases
    Eva Kritikou, Johan Kuiper, Petri T. Kovanen, Ilze Bot
    European Journal of Pharmacology.2016; 778: 103.     CrossRef
  • Comparison of acarbose and metformin therapy in newly diagnosed type 2 diabetic patients with overweight and/or obesity
    Weiping Sun, Chunping Zeng, Lizhen Liao, Juan Chen, Ying Wang
    Current Medical Research and Opinion.2016; 32(8): 1389.     CrossRef
  • Mechanisms for the cardiovascular effects of glucagon-like peptide-1
    H. Poudyal
    Acta Physiologica.2016; 216(3): 277.     CrossRef
  • Integrated scientific data bases review on asulacrine and associated toxicity
    Attia Afzal, Muhammad Sarfraz, Zimei Wu, Guangji Wang, Jianguo Sun
    Critical Reviews in Oncology/Hematology.2016; 104: 78.     CrossRef
  • Impact of Diabetes and Defective Thyroid Ontogenesis on Audition
    Luciene da Cruz Fernandes
    Journal of Diabetes, Metabolic Disorders & Control.2016;[Epub]     CrossRef
  • Serum Total Bilirubin Levels Provide Additive Risk Information over the Framingham Risk Score for Identifying Asymptomatic Diabetic Patients at Higher Risk for Coronary Artery Stenosis
    Jaechan Leem, Eun Hee Koh, Jung Eun Jang, Chang-Yun Woo, Jin Sun Oh, Min Jung Lee, Joon-Won Kang, Tae-Hwan Lim, Chang Hee Jung, Woo Je Lee, Joong-Yeol Park, Ki-Up Lee
    Diabetes & Metabolism Journal.2015; 39(5): 414.     CrossRef
  • Clinical implications of carotid artery intima media thickness assessment on cardiovascular risk stratification in hyperlipidemic Korean adults with diabetes: the ALTO study
    Eun-Gyoung Hong, Jung Hun Ohn, Seong Jin Lee, Hyuk Sang Kwon, Sin Gon Kim, Dong Jun Kim, Dong Sun Kim
    BMC Cardiovascular Disorders.2015;[Epub]     CrossRef
  • Undiagnosed diabetes is prevalent in younger adults and associated with a higher risk cardiometabolic profile compared to diagnosed diabetes
    Yong-ho Lee, Ehrin J. Armstrong, Gyuri Kim, Jaewon Oh, Seok-Min Kang, Byung-Wan Lee, Chul Woo Ahn, Bong Soo Cha, Hyun Chul Lee, Christos S. Mantzoros, Eun Seok Kang
    American Heart Journal.2015; 170(4): 760.     CrossRef
  • Common Polymorphisms in Antioxidant Genes are Associated with Diabetic Nephropathy in Type 2 Diabetes Patients
    Jasna Klen, Katja Goričar, Andrej Janež, Vita Dolžan
    Personalized Medicine.2015; 12(3): 187.     CrossRef
  • Increased endogenous serotonin level in diabetic conditions may lead to cardiac valvulopathy via reactive oxygen species regulation
    Tahir Ali, Hina Waheed, Farhat Shaheen, Madiha Mahmud, Qamar Javed, Iram Murtaza
    Biologia.2015; 70(2): 273.     CrossRef
  • Antioxidant Effects of Statins in the Management of Cardiometabolic Disorders
    Soo Lim, Philip Barter
    Journal of Atherosclerosis and Thrombosis.2014; 21(10): 997.     CrossRef
  • Evidence-Based Practice Use of Incretin-Based Therapy in the Natural History of Diabetes
    Stanley Schwartz
    Postgraduate Medicine.2014; 126(3): 66.     CrossRef
  • Low serum bilirubin concentration is a novel risk factor for the development of albuminuria in patients with type 2 diabetes
    Hiroshi Okada, Michiaki Fukui, Muhei Tanaka, Shinobu Matsumoto, Kanae Kobayashi, Hiroya Iwase, Kiichiro Tomiyasu, Koji Nakano, Goji Hasegawa, Naoto Nakamura
    Metabolism.2014; 63(3): 409.     CrossRef
  • Serum total bilirubin levels and prevalence of diabetic retinopathy in a Chinese population (中国人群血清总胆红素水平与糖尿病视网膜病变相关性的研究)
    Syeda Sadia Najam, Jichao Sun, Jie Zhang, Min Xu, Jieli Lu, Kan Sun, Mian Li, Tiange Wang, Yufang Bi, Guang Ning
    Journal of Diabetes.2014; 6(3): 221.     CrossRef
  • Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk
    Morihiro Matsuda, Iichiro Shimomura
    Hormone Molecular Biology and Clinical Investigation.2014;[Epub]     CrossRef
  • Unilateral injection of Aβ25–35in the hippocampus reduces the number of dendritic spines in hyperglycemic rats
    Zayda Lazcano, Oscar Solis, María Elena Bringas, Daniel Limón, Alfonso Diaz, Blanca Espinosa, Isabel García‐Peláez, Gonzalo Flores, Jorge Guevara
    Synapse.2014; 68(12): 585.     CrossRef
  • Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications
    Vaibhav B. Patel, Nirmal Parajuli, Gavin Y. Oudit
    Clinical Science.2014; 126(7): 471.     CrossRef
  • Pathogenesis of Chronic Hyperglycemia: From Reductive Stress to Oxidative Stress
    Liang-Jun Yan
    Journal of Diabetes Research.2014; 2014: 1.     CrossRef
  • Daily intake of vitamin D‐ or calcium‐vitamin D‐fortified Persian yogurt drink (doogh) attenuates diabetes‐induced oxidative stress: evidence for antioxidative properties of vitamin D
    B. Nikooyeh, T. R. Neyestani, N. Tayebinejad, H. Alavi‐Majd, N. Shariatzadeh, A. Kalayi, M. Zahedirad, S. Heravifard, S. Salekzamani
    Journal of Human Nutrition and Dietetics.2014; 27(s2): 276.     CrossRef
  • Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases
    Morihiro Matsuda, Iichiro Shimomura
    Reviews in Endocrine and Metabolic Disorders.2014; 15(1): 1.     CrossRef
  • PKCδ-dependent Activation of the Ubiquitin Proteasome System is Responsible for High Glucose-induced Human Breast Cancer MCF-7 Cell Proliferation, Migration and Invasion
    Shan Zhu, Feng Yao, Wen-Huan Li, Jin-Nan Wan, Yi-Min Zhang, Zhao Tang, Shahzad Khan, Chang-Hua Wang, Sheng-Rong Sun
    Asian Pacific Journal of Cancer Prevention.2013; 14(10): 5687.     CrossRef
  • Increased oxidative stress in obesity: Implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer
    Morihiro Matsuda, Iichiro Shimomura
    Obesity Research & Clinical Practice.2013; 7(5): e330.     CrossRef
  • Hydrogen Sulfide Suppresses High Glucose–Induced Expression of Intercellular Adhesion Molecule-1 in Endothelial Cells
    Qingbo Guan, Xiaolei Wang, Ling Gao, Jicui Chen, Yuantao Liu, Chunxiao Yu, Nan Zhang, Xu Zhang, Jiajun Zhao
    Journal of Cardiovascular Pharmacology.2013; 62(3): 278.     CrossRef
  • Clinical Marker of Platelet Hyperreactivity in Diabetes Mellitus
    Jin Hwa Kim, Hak Yeon Bae, Sang Yong Kim
    Diabetes & Metabolism Journal.2013; 37(6): 423.     CrossRef
  • Glucose initially inhibits and later stimulates blood ROS generation
    Thomas Stief
    Journal of Diabetes Mellitus.2013; 03(01): 15.     CrossRef
  • Oxidative Stress in Cardiovascular Diseases and Obesity: Role of p66Shc and Protein Kinase C
    Elena De Marchi, Federica Baldassari, Angela Bononi, Mariusz R. Wieckowski, Paolo Pinton
    Oxidative Medicine and Cellular Longevity.2013; 2013: 1.     CrossRef
  • Toxicological and pharmacological concerns on oxidative stress and related diseases
    Soodabeh Saeidnia, Mohammad Abdollahi
    Toxicology and Applied Pharmacology.2013; 273(3): 442.     CrossRef
  • Comparison of antioxidant, α-glucosidase inhibition and anti-inflammatory activities of the leaf and root extracts ofSmilax chinaL.
    Kyoung Kon Kim, Yun Hwan Kang, Dae Jung Kim, Tae Woo Kim, Myeon Choe
    Journal of Nutrition and Health.2013; 46(4): 315.     CrossRef
  • Correlation between blood glucose fluctuations and activation of oxidative stress in type 1 diabetic children during the acute metabolic disturbance period
    Di WU, Chun-xiu GONG, Xi MENG, Qiu-lan YANG
    Chinese Medical Journal.2013; 126(21): 4019.     CrossRef
  • Oxidative stress and its complications in human health
    Guniz M. Koksal
    Advances in Bioscience and Biotechnology.2012; 03(08): 1113.     CrossRef
Original Articles
Decreased Expression and Induced Nucleocytoplasmic Translocation of Pancreatic and Duodenal Homeobox 1 in INS-1 Cells Exposed to High Glucose and Palmitate
Gyeong Ryul Ryu, Jun Mo Yoo, Esder Lee, Seung-Hyun Ko, Yu-Bae Ahn, Ki-Ho Song
Diabetes Metab J. 2011;35(1):65-71.   Published online February 28, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.1.65
  • 5,715 View
  • 47 Download
  • 5 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Type 2 diabetes mellitus (T2DM) is often accompanied by increased levels of circulating fatty acid. Elevations in fatty acids and glucose for prolonged periods of time have been suggested to cause progressive dysfunction or apoptosis of pancreatic beta cells in T2DM. However, the precise mechanism of this adverse effect is not well understood.

Methods

INS-1 rat-derived insulin-secreting cells were exposed to 30 mM glucose and 0.25 mM palmitate for 48 hours.

Results

The production of reactive oxygen species increased significantly. Pancreatic and duodenal homeobox 1 (Pdx1) expression was down-regulated, as assessed by reverse transcription-polymerase chain reaction and Western blot analyses. The promoter activities of insulin and Pdx1 were also diminished. Of note, there was nucleocytoplasmic translocation of Pdx1, which was partially prevented by treatment with an antioxidant, N-acetyl-L-cysteine.

Conclusion

Our data suggest that prolonged exposure of beta cells to elevated levels of glucose and palmitate negatively affects Pdx1 expression via oxidative stress.

Citations

Citations to this article as recorded by  
  • miRNA-642a-3p protects β cells from glucolipotoxicity
    Sandra Sofia Pinhanços, João Teixeira de Oliveira, C. Henrique Alves, Cláudia M. Deus, Twan J.J. de Winter, Sofia Viana, Flávio Reis, Jorge Santos, Mijke Buitinga, Françoise Carlotti, Lino Ferreira, Martin Gotthardt, John Jones, Hugo Fernandes
    Molecular Therapy Nucleic Acids.2025; 36(2): 102498.     CrossRef
  • Nrf2 Activation Protects Mouse Beta Cells from Glucolipotoxicity by Restoring Mitochondrial Function and Physiological Redox Balance
    Johanna Schultheis, Dirk Beckmann, Dennis Mulac, Lena Müller, Melanie Esselen, Martina Düfer
    Oxidative Medicine and Cellular Longevity.2019; 2019: 1.     CrossRef
  • Early overnutrition reduces Pdx1 expression and induces β cell failure in Swiss Webster mice
    Maria M. Glavas, Queenie Hui, Eva Tudurí, Suheda Erener, Naomi L. Kasteel, James D. Johnson, Timothy J. Kieffer
    Scientific Reports.2019;[Epub]     CrossRef
  • Anti-diabetic effect of mulberry leaf polysaccharide by inhibiting pancreatic islet cell apoptosis and ameliorating insulin secretory capacity in diabetic rats
    Yao Zhang, Chunjiu Ren, Guobing Lu, Zhimei Mu, Weizheng Cui, Huiju Gao, Yanwen Wang
    International Immunopharmacology.2014; 22(1): 248.     CrossRef
  • The Furan Fatty Acid Metabolite CMPF Is Elevated in Diabetes and Induces β Cell Dysfunction
    Kacey J. Prentice, Lemieux Luu, Emma M. Allister, Ying Liu, Lucy S. Jun, Kyle W. Sloop, Alexandre B. Hardy, Li Wei, Weiping Jia, I. George Fantus, Douglas H. Sweet, Gary Sweeney, Ravi Retnakaran, Feihan F. Dai, Michael B. Wheeler
    Cell Metabolism.2014; 19(4): 653.     CrossRef
The Association between Serum GGT Concentration and Diabetic Peripheral Polyneuropathy in Type 2 Diabetic Patients
Ho Chan Cho
Korean Diabetes J. 2010;34(2):111-118.   Published online April 30, 2010
DOI: https://doi.org/10.4093/kdj.2010.34.2.111
  • 9,289 View
  • 80 Download
  • 15 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Diabetic peripheral polyneuropathy (DPP) is one of the common complications of diabetes mellitus (DM) and can lead to foot ulcers or amputation. The pathophysiology of DPP includes several factors such as metabolic, vascular, autoimmune, oxidative stress and neurohormonal growth-factor deficiency and recent studies have suggested the use of serum gamma-glutamyl transferase (GGT) as an early marker of oxidative stress. Therefore, we investigated whether serum GGT may be useful in predicting DPP.

Methods

We assessed 90 patients with type 2 DM who were evaluated for the presence of DPP using clnical neurologic examinations including nerve conduction velocity studies. We evaluated the association between serum GGT and the presence of DPP.

Results

The prevalence of DPP was 40% (36 cases) according to clinical neurological examinations. The serum GGT concentration was significantly elevated in type 2 diabetic patients with DPP compared to patients without DPP (P < 0.01). There were other factors significantly associated with DPP including smoking (P = 0.019), retinopathy (P = 0.014), blood pressure (P < 0.05), aspartate aminotransferase (P = 0.022), C-reactive protein (P = 0.036) and urine microalbumin/creatinine ratio (P = 0.004). Serum GGT was independently related with DPP according to multiple logistic analysis (P < 0.01).

Conclusion

This study shows that increased levels of serum GGT may have important clinical implications in the presence of DPP in patients with type 2 diabetes.

Citations

Citations to this article as recorded by  
  • A Longitudinal Increase in Serum Gamma-Glutamyl Transferase Levels, but Not in Alanine Aminotransferase Levels, Improves the Prediction of Risk of Impaired Fasting Glucose in Male
    Jisoon Im, Susie Jung, Yuri Yang, Kyu-Nam Kim
    Journal of Korean Medical Science.2025;[Epub]     CrossRef
  • The association between smoking and diabetic neuropathy: a systematic review and meta-analysis
    Sana Bader, Sanah Hasan, Dianna J. Magliano, Rakibul M. Islam, Shanika Palawaththa, Lorena Romero, Md. Nazmul Karim
    Systematic Reviews.2025;[Epub]     CrossRef
  • Validation of the Framingham Diabetes Risk Model Using Community-Based KoGES Data
    Hye Ah Lee, Hyesook Park, Young Sun Hong
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
  • Liver enzymes and risk of ocular motor cranial nerve palsy: a nationwide population-based study
    Joonhyoung Kim, Kyungdo Han, Juhwan Yoo, Kyung-Ah Park, Sei Yeul Oh
    Neurological Sciences.2022; 43(5): 3395.     CrossRef
  • Validity of the diagnosis of diabetic microvascular complications in Korean national health insurance claim data
    Hyung Jun Kim, Moo-Seok Park, Jee-Eun Kim, Tae-Jin Song
    Annals of Clinical Neurophysiology.2022; 24(1): 7.     CrossRef
  • The association of liver enzymes with diabetes mellitus risk in different obesity subgroups: A population-based study
    Dinghao Zheng, Xiaoyun Zhang, Lili You, Feng Li, Diaozhu Lin, Kan Sun, Meng Ren, Li Yan, Wei Wang
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Early Biomarkers of Neurodegenerative and Neurovascular Disorders in Diabetes
    Aleksandra Gasecka, Dominika Siwik, Magdalena Gajewska, Miłosz J. Jaguszewski, Tomasz Mazurek, Krzysztof J. Filipiak, Marek Postuła, Ceren Eyileten
    Journal of Clinical Medicine.2020; 9(9): 2807.     CrossRef
  • Dissociable Contributions of Precuneus and Cerebellum to Subjective and Objective Neuropathy in HIV
    Natalie M. Zahr, Kilian M. Pohl, Adolf Pfefferbaum, Edith V. Sullivan
    Journal of Neuroimmune Pharmacology.2019; 14(3): 436.     CrossRef
  • Evaluation of Serum Gamma Glutamyl Transferase Levels in Diabetic Patients With and Without Retinopathy
    Neda Valizadeh, Rasoul Mohammadi, Alireza Mehdizadeh, Qader Motarjemizadeh, Hamid Reza Khalkhali
    Shiraz E-Medical Journal.2018;[Epub]     CrossRef
  • The Effect of Cigarette Smoking on Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis
    Carole Clair, Marya J. Cohen, Florian Eichler, Kevin J. Selby, Nancy A. Rigotti
    Journal of General Internal Medicine.2015; 30(8): 1193.     CrossRef
  • Evaluation of oxidative stress markers and vascular risk factors in patients with diabetic peripheral neuropathy
    Noha Ahmed El Boghdady, Gamal Ali Badr
    Cell Biochemistry and Function.2012; 30(4): 328.     CrossRef
  • Angiotensin-converting enzyme gene single polymorphism as a genetic biomarker of diabetic peripheral neuropathy: longitudinal prospective study
    J. Jurado, J. Ybarra, J.H. Romeo, M. Garcia, E. Zabaleta-del-Olmo
    Journal of Diabetes and its Complications.2012; 26(2): 77.     CrossRef
  • Routine enzymes in the monitoring of type 2 diabetes mellitus
    Osman Evliyaoğlu, Erkan Kibrisli, Yaşar Yildirim, Osman Gökalp, Leyla Çolpan
    Cell Biochemistry and Function.2011; 29(6): 506.     CrossRef
  • Antioxidant Effects of Fermented Red Ginseng Extracts in Streptozotocin-Induced Diabetic Rats
    Hyun-Jeong Kim, Sung-Gyu Lee, In-Gyeong Chae, Mi-Jin Kim, Nam-Kyung Im, Mi-Hee Yu, Eun-Ju Lee, In-Seon Lee
    Journal of Ginseng Research.2011; 35(2): 129.     CrossRef
  • Serum γ‐glutamyltransferase and associated damage among a She Chinese population
    Y. Lin, Y. Xu, G. Chen, B. Huang, J. Yao, Z. Chen, L. Yao, F. Lin, Y. Qiao, Z. Chen, S. Zhu, H. Huang, J. Wen
    Diabetic Medicine.2011; 28(8): 924.     CrossRef
High Glucose and/or Free Fatty Acid Damage Vascular Endothelial Cells via Stimulating of NAD(P)H Oxidase-induced Superoxide Production from Neutrophils.
Sang Soo Kim, Sun Young Kim, Soo Hyung Lee, Yang Ho Kang, In Ju Kim, Yong Ki Kim, Seok Man Son
Korean Diabetes J. 2009;33(2):94-104.   Published online April 1, 2009
DOI: https://doi.org/10.4093/kdj.2009.33.2.94
  • 3,134 View
  • 26 Download
AbstractAbstract PDF
BACKGROUND
Oxidative stress and inflammation are important factors in the pathogenesis of diabetes and contribute to the development of diabetic complications. To understand the mechanisms that cause vascular complications in diabetes, we examined the effects of high glucose and/or free fatty acids on the production of superoxide from neutrophils and their role in endothelial cell damage. METHODS: Human neutrophils were incubated in the media containing 5.5 mM D-glucose, 30 mM D-glucose, 3 nM oleic acid, or 30 microM oleic acid for 1 hour to evaluate superoxide production through NAD(P)H oxidase activation. Human aortic endothelial cells were co-cultured with neutrophils exposed to high glucose and oleic acid. We then measured neutrophil adhesion to endothelial cells, neutrophil activation and superoxide production, neutrophil-mediated endothelial cell cytotoxicity and subunits of neutrophil NAD(P)H oxidase. RESULTS: After 1 hour of incubation with various concentrations of glucose and oleic acid, neutrophil adherence to high glucose and oleic acid-treated endothelial cells was significantly increased compared with adhesion to low glucose and oleic acid-treated endothelial cells. Incubation of neutrophils with glucose and free fatty acids increased superoxide production in a dose-dependent manner. High glucose and oleic acid treatment significantly increased expression of the membrane components of NAD(P)H oxidase of neutrophil (gp91(phox)). Endothelial cells co-cultured with neutrophils exposed to high glucose and oleic acid showed increased cytolysis, which could be prevented by an antioxidant, N-acetylcysteine. CONCLUSION: These results suggest that high glucose and/orfree fatty acidsincrease injury of endothelial cells via stimulating NAD(P)H oxidase-induced superoxide production from neutrophils.
Review
Oxidative Stress and Cell Dysfunction in Diabetes: Role of ROS Produced by Mitochondria and NAD(P)H Oxidase.
Sang Soo Kim, Seok Man Son
Korean Diabetes J. 2008;32(5):389-398.   Published online October 1, 2008
DOI: https://doi.org/10.4093/kdj.2008.32.5.389
  • 3,594 View
  • 92 Download
  • 10 Crossref
AbstractAbstract PDF
Oxidative stress has been considered to be a major contributor to the pathogenesis of the diabetic macrovascular and microvascular complications. In the absence of an appropriate antioxidant defense mechanism, increased oxidative stress leads to the activation of stress-sensitive intracellular signaling pathways and the formation of gene products that cause damage and contribute to the late complications ofdiabetes. The source of reactive oxygen species (ROS) in the pancreatic beta cells and insulin sensitive cells has postulated to be the mitochondrial electron transport chain. NAD(P)H oxidase-dependent ROS production is also important as the source both in pancreatic beta cells and other cells. NAD(P)H oxidase mediated ROS can alter parameters of signal transduction, insulin secretion, insulin action, cell proliferation and cell death. Additionally, oxidative stress as the pathogenic mechanism linking insulin resistance with dysfunction of both pancreatic beta cells and endothelial cells, eventually leads to diabetes and its complications. Further investigation of the mechanisms and its therapeutic interventions based on focusing NAD(P)H oxidase associated ROS production in the islet cells and other islet cells are needed

Citations

Citations to this article as recorded by  
  • Cytoprotective Effect of Hot-Water Extracts of Protaetia brevitarsis seulensis Larvae in Cisplatin-Treated Macrophages
    Bo-Gyeong Yoo, Jun-Pyo Hong, Ha-Yeon Song, Eui-Hong Byun
    Journal of the Korean Society of Food Science and Nutrition.2022; 51(12): 1252.     CrossRef
  • The Effects of LR3 and SP6 Acupuncture on Renal Damage in Streptozotocin-induced Diabetic Mice
    Cho In Lee, Hyun Jong Lee, Yun Kyu Lee, Seong Chul Lim, Jae Soo Kim
    The Acupuncture.2015; 32(3): 41.     CrossRef
  • Effect of Chungkukjang supplementation on oxidative stress and antioxidant nutrients of diabetic rats induced by streptozotocin
    Heyun-Sook Park, Hyun-Joo Kong, Eon-Hee Lee, Eun-Mi Choi, Joung-Hyeon Jang, Myoung-Hee Lee, Ju-Yeon Hong, Su-Jung Hwang, Hyeon-A Jung, Kyung-Mi Yang
    Korean Journal of Food Preservation.2015; 22(2): 281.     CrossRef
  • The Effects of Several Halophytes on Insulin Resistance in Otsuka Long-evans Tokushima Fatty Rats
    Jeong-Yong Cho, Zhangjun Huang, Sun-Young Park, Kyung-Hee Park, Tong-Kun Pai, So-Young Kim, Haeng-Ran Kim, Kyung-Sik Ham
    Korean Journal of Food Science and Technology.2014; 46(1): 100.     CrossRef
  • Protective Effects of Radiation-induced Blackberry Mutant Extract on Carbon Tetrachloride (CCl4)-induced Liver Injury in Sprague-Dawley Rats
    Byoung Ok Cho, Chang-Wook Lee, Yangkang So, Chang-Hyun Jin, Hong-Sun Yook, Myung-Woo Byun, Yong-Wook Jeong, Jong Chun Park, Il-Yun Jeong
    Journal of the Korean Society of Food Science and Nutrition.2014; 43(6): 807.     CrossRef
  • Antioxidant Activities and α-Glucosidase Inhibitory Effect of Water Extracts from Medicinal Plants
    Hyun Sook Kim, Tae Woo Kim, Dae Jung Kim, Jae Sung Lee, Kyoung Kon Kim, Myeon Choe
    Korean Journal of Medicinal Crop Science.2013; 21(3): 197.     CrossRef
  • Antioxidant Effect of Hot water and Ethanol extracts from Cheonnyuncho (Opuntia humifusa) on Reactive Oxygen Species (ROS) Production in 3T3-L1 Adipocytes
    Bo-Ra Yoon, Young-Jun Lee, Sun-Gu Kim, Jung-Young Jang, Hyo-Ku Lee, Seong-Kap Rhee, Hee-Do Hong, Hyeon-Son Choi, Boo-Yong Lee, Ok-Hwan Lee
    Korean Journal of Food Preservation.2012; 19(3): 443.     CrossRef
  • Inhibitory Effects of Panax ginseng C. A. Mayer Treated with High Temperature and High Pressure on Oxidative Stress
    Bo-Ra Yoon, Young-Jun Lee, Hee-Do Hong, Young-Chul Lee, Young-Chan Kim, Young Kyoung Rhee, Kyung-Tack Kim, Ok-Hwan Lee
    The Korean Journal of Food And Nutrition.2012; 25(4): 800.     CrossRef
  • Effect of Dietary Supplementation of β-Carotene on Hepatic Antioxidant Enzyme Activities and Glutathione Concentration in Diabetic Rats
    Jung-Hyun Jang, Kyeung-Soon Lee, Jung-Sook Seo
    Journal of the Korean Society of Food Science and Nutrition.2011; 40(8): 1092.     CrossRef
  • An Association between 609 C →T Polymorphism in NAD(P)H: Quinone Oxidoreductase 1 (NQO1) Gene and Blood Glucose Levels in Korean Population
    Dohee Kim
    Korean Diabetes Journal.2009; 33(1): 24.     CrossRef
Original Articles
Migration of Vascular Smooth Muscle Cells by High Glucose is Reactive Oxygen Dependent.
Yong Seong An, Ji Hae Kwon, Yang Ho Kang, In Ju Kim, Yong Ki Kim, Seok Man Son
Korean Diabetes J. 2008;32(3):185-195.   Published online June 1, 2008
DOI: https://doi.org/10.4093/kdj.2008.32.3.185
  • 2,791 View
  • 23 Download
AbstractAbstract PDF
BACKGROUND
Oxidative stress contributes to vascular diseases in patients with diabetes. As the mechanism of development and progression of diabetic vascular complications is poorly understood, this study was aimed to assess the potential role of hyperglycemia-induced oxidative stress and to determine whether the oxidative stress is a major factor in hyperglycemia-induced migration of vascular smooth muscle cells (VSMCs). METHODS: We treated primary cultured rat aortic smooth muscle cells for 72 hours with medium containing 5.5 mM D-glucose (normal glucose), 30 mM D-glucose (high glucose) or 5.5 mM D-glucose plus 24.5 mM mannitol (osmotic control). We measured the migration of VSMCs and superoxide production. Immunoblotting of PKC isozymes using phoshospecific antibodies was performed, and PKC activity was also measured. RESULTS: Migration of VSMCs incubated under high glucose condition were markedly increased compared to normal glucose condition. Treatment with diphenyleneiodonium (DPI, 10 micromol/L) and superoxide dismutase (SOD, 500 U/mL) significantly suppressed high glucose-induced migration of VSMCs. Superoxide production was significantly increased in high glucose condition and was markedly decreased after treatment with DPI and SOD. High glucose also markedly increased activity of PKC-delta isozyme. When VSMCs were treated with rottlerin or transfected with PKC-delta siRNA, nitro blue tetrazolium (NBT) staining and NAD(P)H oxidase activity were significantly attenuated in the high glucose-treated VSMCs. Furthermore, inhibition of PKC-delta markedly decreased VSMC migration by high glucose. CONCLUSION: These results suggest that high glucose-induced VSMC migration is dependent upon activation of PKC-delta, which may responsible for elevated intracellular ROS production in VSMCs, and this is mediated by NAD(P)H oxidase.
The Protective Effect of EGCG on INS-1 Cell in the Oxidative Stress and Mechanism.
Mi Kyung Kim, Hye Sook Jung, Chang Shin Yoon, Min Jeong Kwon, Kyung Soo Koh, Byung Doo Rhee, Jeong Hyun Park
Korean Diabetes J. 2008;32(2):121-130.   Published online April 1, 2008
DOI: https://doi.org/10.4093/kdj.2008.32.2.121
  • 3,450 View
  • 39 Download
  • 3 Crossref
AbstractAbstract PDF
BACKGROUND
Oxidative stress is important in both diabetic complications and the development and the progression of type 2 diabetes via the effects on the pancreatic beta-cells. EGCG (epigallocatechin galleate), a major constituent of green tea, has been known to have beneficial effects on various diseases through the mechanisms of antioxidant and cell signaling modulation. But, very small numbers of studies were published about the direct effects of EGCG on the pancreatic beta cell lines. We performed this study to see the protective effect of EGCG on pancreatic beta cell line under H2O2 and the mechanisms of this phenomenon. METHODS: We used INS-1 cells and hydrogen peroxide as an oxidative stressor. Their viabilities were verified by MTT assay and FACS. The activity of glutathione peroxidase was assessed by total glutathione quantification kit. Western blot and semi-quantitative RT-PCR for the catalase, SOD (superoxide dismutase), PI3K and Akt were performed. Functional status of INS-1 cells was tested by GSIS (glucose stimulated insulin secretion). RESULTS: The biological effects of EGCG were different according to its concentrations. 10 micrometer EGCG effectively protected hydrogen peroxide induced damage in INS-1 cells. The expression and the activity of SOD, catalase and the glutathione peroxidase were significantly increased by EGCG. EGCG significantly increased PI3K and Akt activity and its effect was inhibited partially by wortmannin. GSIS was well preserved by EGCG. CONCLUSION: EGCG in low concentration effectively protected INS-1 cells from the oxidative stress through the activation of both antioxidant systems and anti-apoptosis signaling. Further studies will be necessary for the more detailed mechanisms and the clinical implications.

Citations

Citations to this article as recorded by  
  • Suppressive Effects of Epigallocatechin Gallate Pretreatment on the Expression of Inflammatory Cytokines in RAW264.7 Cells Activated by Lipopolysaccharide
    Eun Ji Seo, Jun Go, Ji Eun Kim, Eun Kyoung Koh, Sung Hwa Song, Ji Eun Sung, Chan Kyu Park, Hyun Ah Lee, Dong Seob Kim, Hong Joo Son, Cung Yeoul Lee, Hee Seob Lee, Dae Youn Hwang
    Journal of Life Science.2015; 25(9): 961.     CrossRef
  • The Protective Effects of Chrysanthemum cornarium L. var. spatiosum Extract on HIT-T15 Pancreatic β-Cells against Alloxan-induced Oxidative Stress
    In-Hye Kim, Kang-Jin Cho, Jeong-Sook Ko, Jae-Hyun Kim, Ae-Son Om
    The Korean Journal of Food And Nutrition.2012; 25(1): 123.     CrossRef
  • Protective Effects of Sasa Borealis Leaves Extract on High Glucose-Induced Oxidative Stress in Human Umbilical Vein Endothelial Cells
    Ji-Young Hwang, Ji-Sook Han
    Journal of the Korean Society of Food Science and Nutrition.2010; 39(12): 1753.     CrossRef
Cytoprotective Effect by Antioxidant Activity of Quercetin in INS-1 Cell Line.
Min Jeong Kwon, Hye Sook Jung, Mi Kyung Kim, Seong Hoon Kang, Gwang Wook Seo, Jae Kwang Song, Tae Yeon Yoon, Min Kyeong Jeon, Tae Hwan Ha, Chang Shin Yoon, Mi Kyung Kim, Woo Je Lee, Jeong Hyun Noh, Soo Kyung Kwon, Dong Joon Kim, Kyung Soo Koh, Byung Doo Rhee, Kyung Ho Lim, Soon Hee Lee, Jeong Hyun Park
Korean Diabetes J. 2007;31(5):383-390.   Published online September 1, 2007
DOI: https://doi.org/10.4093/jkda.2007.31.5.383
  • 3,956 View
  • 32 Download
  • 2 Crossref
AbstractAbstract PDF
BACKGROUND
Oxidative stress is induced under diabetic conditions and causes various forms of tissue damages in the patients with diabetes. Recently, pancreatic beta cells are regarded as a putative target of oxidative stress-induced tissue damage, and this seems to explain in part the progressive deterioration of beta cell function in type 2 diabetes. The aim of this study was to examine the potential of Quercetin (QE) to protect INS-1 cells from the H2O2-induced oxidative stress and the effects of QE on the glucose-stimulated insulin secretion in INS-1 cells. METHODS: To study the cell viability, cells were incubated with H2O2 and/or QE at the various concentrations. To confirm the protective effect by QE in response to H2O2, the levels of antioxidant enzymes were assessed by RT-PCR and Western blot, and glutathione peroxidase activities were quantified by spectrophotometrical method. Glucose-stimulated insulin secretion (GSIS) was measured by ELISA. RESULTS: Cell incubations were performed with 80 microM of H2O2 for 5 hours to induce 40 - 50% of cell death. QE gradually showed protective effect (IC50 = 50 microM) in dose-dependent manner. Superoxide dismutase (SOD) mRNA level in H2O2 + QE group was increased as compared to H2O2 group, but catalase did not changed. And the QE recruited glutathione peroxidase activity against H2O2-induced oxidative injuries in INS-1 cells. CONCLUSION: In conclusion, these findings suggest that QE might have protective effect on beta cells by ameliorating oxidative stress and preserving insulin secretory function.

Citations

Citations to this article as recorded by  
  • Anti-diabetic effects of Allium tuberosum rottler extracts and lactic acid bacteria fermented extracts in type 2 diabetic mice model
    Bae Jin Kim, Seung Kyeung Jo, Yoo Seok Jeong, Hee Kyoung Jung
    Korean Journal of Food Preservation.2015; 22(1): 134.     CrossRef
  • Protective Effects of Sasa Borealis Leaves Extract on High Glucose-Induced Oxidative Stress in Human Umbilical Vein Endothelial Cells
    Ji-Young Hwang, Ji-Sook Han
    Journal of the Korean Society of Food Science and Nutrition.2010; 39(12): 1753.     CrossRef
Activation of NF-kappaB and AP-1 in Peripheral Blood Mononuclear Cells Isolated from Patients with Diabetic Nephropathy.
Jisun Nam, Min Ho Cho, Jong Suk Park, Geun Taek Lee, Hai Jin Kim, Eun Seok Kang, Yu Mie Lee, Chul Woo Ahn, Bong Soo Cha, Eun Jig Lee, Sung Kil Lim, Kyung Rae Kim, Hun Joo Ha, Hyun Chul Lee
Korean Diabetes J. 2007;31(3):261-273.   Published online May 1, 2007
DOI: https://doi.org/10.4093/jkda.2007.31.3.261
  • 3,011 View
  • 21 Download
AbstractAbstract PDF
BACKGROUND
We evaluated the role of oxidative stress in diabetic nephropathy by measuring intracellular reactive oxygen species (ROS) and redox-sensitive transcription factors in isolated peripheral mononuclear cells (PBMC). METHODS: From 66 diabetic patients with or without diabetic nephropathy (Group III and II, respectively) and 49 normal control subjects (Group I), spontaneous and stimulated ROS levels, activities of nuclear factor-kappa B (NF-kappaB), activator protein-1 (AP-1), and specificity protein1 (Sp1) in PBMC, urinary and PBMC TGF-beta1 (transforming growth factor-beta1), and 24-hour urinary albumin excretion (UAE) were measured. RESULTS: Spontaneous ROS was significantly higher in group III and II than group I (60.7 +/- 3.3 vs. 60.0 +/- 3.0 vs. 41.1 +/- 2.4%, respectively), and stimulated ROS were significantly higher in Group III compared to Group II (Increment of H2O2-induced ROS production: 21.8 +/- 2.2 vs. 11.1 +/- 2.0%, respectively; increment of PMA-induced ROS production 23.5 +/- 4.5 vs. 21.6 +/- 2.2%, respectively). The activities of NF-kappaB and AP-1, but not of Sp1, were significantly higher in Group III than in Group II (2.53 vs. 2.0 vs. 1.43-fold, respectively). Both PBMC- and urinary TGF-beta1 levels were higher in Group III than Group II (3.23 +/- 0.39 vs. 1.99 +/- 0.68 ng/mg in PBMCs, 16.88 +/- 6.84 vs. 5.61 +/- 1.57 ng/mL in urine, both respectively), and they were significantly correlated with activities of NF-kappaB and AP-1 and 24-hour UAE. CONCLUSIONS: Increased intracellular ROS generation in PBMCs of diabetic patients is involved in the pathogenesis of diabetic nephropathy through activation of NF-kappaB and AP-1, but not Sp1, and increased expression of TGF-beta1.
Mechanism of 2-Deoxy-D-ribose-induced Damage in Pancreatic beta-cells.
Gwanpyo Koh, Jeong taek Woo, Dae Ho Lee, Seungjoon Oh, Sung Woon Kim, Jin Woo Kim, Young Seol Kim, Deok Bae Park
Korean Diabetes J. 2007;31(2):105-112.   Published online March 1, 2007
DOI: https://doi.org/10.4093/jkda.2007.31.2.105
  • 4,212 View
  • 29 Download
  • 2 Crossref
AbstractAbstract PDF
BACKGROUND
Mechanism for glucose toxicity is known to be an increased oxidative stress produced by multiple pathways. In our previous report, 2-deoxy-d-ribose (dRib) promoted apoptosis by increasing oxidative stress in a pancreatic beta-cell line. We performed this study to investigate the mechanism of dRib-induced damage of beta-cells. METHODS: HIT-T15 cells were cultured in RPMI-1640 medium with 40 mM dRib for 24 hours after pretreatment with various concentrations of a metal chelator (DTPA) and inhibitors of protein glycation (aminoguanidine and pyridoxamine). Cell viability was determined by MTT assay. Apoptosis was analyzed by flow cytometry with annexin V/PI double staining. RESULTS: DTPA, which inhibits the monosaccharide autoxidation, partially reversed dRib-induced cytotoxicity in a dose-dependent manner (P < 0.01). The cytotoxicity was also suppressed dose-dependently by aminoguanidine (AG) and pyridoxamine (PM) (P < 0.05 and P < 0.01, repectively). Flow cytometric analysis showed that pretreatment of DTPA and AG also reversed the dRib-triggered apoptosis in a dose-dependent manner. We assessed the additional protective effects of inhibitors of protein glycation from dRib-induced cytotoxiciy in the presence of a metal chelator. The additions of AG (P < 0.05) and PM (P < 0.01) significantly reduced the cytotoxicity compared with DTPA alone group. CONCLUSION: This results suggest that dRib produce cytotoxicity and apoptosis through the mechanisms of advanced glycation endproducts (AGEs) formation including the monsaccharide autoxidation and protein glycation in pancreatic beta-cell. Thus, dRib could be a surrogate for glucose in the study of glucose toxicity and chronic diabetic complications.

Citations

Citations to this article as recorded by  
  • Isolation of Citrus Peel Flavonoid Bioconversion Microorganism and Inhibitory Effect on the Oxidative Damage in Pancreatic Beta Cells
    Chi-Deok Park, Hee-Kyung Jung, Chang-Ho Park, Yoo-Seok Jung, Joo-Heon Hong, Hee-Sun Ko, Dong-Hee Kang, Hyun-Soo Kim
    KSBB Journal.2012; 27(1): 67.     CrossRef
  • Kaempferol protects HIT‐T15 pancreatic beta cells from 2‐deoxy‐D‐ribose‐induced oxidative damage
    Yun Jung Lee, Kwang Sik Suh, Moon Chan Choi, Suk Chon, Seungjoon Oh, Jeong‐Taek Woo, Sung‐Woon Kim, Jin‐Woo Kim, Young Seol Kim
    Phytotherapy Research.2010; 24(3): 419.     CrossRef
Oxidative Stress Causes Vascular Insulin Resistance in OLETF Rat Through Increased IRS-1 Degradation.
Jung Lae Park, Young Sil Lee, Bo Hyun Kim, Yang Ho Kang, In Ju Kim, Yong Ki Kim, Seok Man Son
Korean Diabetes J. 2007;31(1):22-32.   Published online January 1, 2007
DOI: https://doi.org/10.4093/jkda.2007.31.1.22
  • 3,415 View
  • 20 Download
  • 1 Crossref
AbstractAbstract PDF
BACKGROUND
Insulin resistance and oxidative stress have been reported to play essential pathophysiological roles in diabetic cardiovascular complication. The relationship between insulin resistance and oxidative stress in vasculature remains unclear. The study was conducted to assess whether oxidative stress induce vascular insulin resistance in OLETF rat, a model of type 2 diabetes METHODS: We used OLETF rats (20/30/40 weeks, n = 5/5/5), as models of type 2 DM, and LETO rats (20/30/40 weeks, n = 5/5/5) as controls. Aortas of each rats were extracted. Superoxide anion production was detected by NBT assay and lucigenin assay. 8-hydroxyguanosine (OHdG) and nitrotyrosine were detected as markers of oxidative stress in 20 and 40 weeks groups. The glucose uptake of aortas was measured by detecting 2-deoxyglucose uptake in both groups. The expression of IR, IRS-1, PI3-K and Akt/PKB were detected by immuno precipitation and immunoblotting in 20, 30 and 40 weeks groups RESULTS: Superoxide anion production and markers of oxidative stress (8-OHdG, nitrotyrosine) were significantly increased in aortas of OLETF rats compared with controls. Aortas of OLETF rats exhibited decreased IRS-1 content and increased phosphorylation of IRS-1 at Ser307 compared with LETO rats. There were no significant differences in expressions of IR, PI3-K and Akt/PKB between two groups CONCLUSION: These results suggest that oxidative stress induces insulin resistance in vasculature of OLETF rat specifically through increasing serine phosphorylation of IRS-1 and its degradation by a proteasome-dependent pathway, providing an alternative mechanism that may explain the association with insulin resistance and diabetic vascular complications.

Citations

Citations to this article as recorded by  
  • Anti-diabetic effects of benfotiamine on an animal model of type 2 diabetes mellitus
    Kang Min Chung, Wonyoung Kang, Dong Geon Kim, Hyun Ju Hong, Youngjae Lee, Chang-Hoon Han
    Korean Journal of Veterinary Research.2014; 54(1): 21.     CrossRef
Glucose Oxidation and Production of Reactive Oxygen Species (ROS) in INS-1 Cells and Rat Islet Cells Exposed to High Glucose.
Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
Korean Diabetes J. 2006;30(4):246-253.   Published online July 1, 2006
DOI: https://doi.org/10.4093/jkda.2006.30.4.246
  • 3,643 View
  • 43 Download
  • 2 Crossref
AbstractAbstract PDF
BACKGROUND
Chronic exposure of pancreatic islets to supraphysiologic concentrations of glucose causes beta cell dysfunction that is a process known as glucose toxicity. It has been reported that hyperglycemia increases the production of reactive oxygen species (ROS) in human islets and that ROS accumulation causes beta cell dysfunction associated with low capacity of intrinsic antioxidant enzymes. Also it has been postulated that this increase in ROS is prevented by an inhibitor of electron transport chain complex. The purpose of this study were to determine whether prolonged exposure of pancreatic islets to supraphysiologic glucose concentrations disrupts the intracellular balance between ROS thereby causing defective insulin secretion and to evaluate the site of hyperglycemia-induced ROS production. METHODS: INS-1 cells & rat islets were incubated in increasing concentrations of glucose and either an inhibitor of complex I & II (TTFA), an uncoupler of oxidative phosphorylation (CCCP), aCCA, etc and also incubated in increasing concentration of glyceraldehyde and N-acetylcystein. Then intracellular peroxide levels by flow cytometric analysis and glucose induced insulin secretion were detected. RESULTS: We observed that incubation with 30 mM glucose increased intracellular peroxide levels but decreased glucose-stimulated insulin secretion (GSIS) (P < 0.05). Exposure to TTFA, CCCP, aCCA did not reduce this increased intracellular peroxide levels, and did not increase GSIS (P < 0.05). 24-h incubation with glyceraldehyde at 5.6 mM glucose increased intracellular peroxide levels and decreased insulin content. CONCLUSION: These observations indicate that there might be other origins in which ROS species are produced besides electron transport chain in mitochondria and glyceraldehyde may be a key molecule to produce ROS, and induce beta cell dysfunction.

Citations

Citations to this article as recorded by  
  • Reactive oxygen species in biological systems: Pathways, associated diseases, and potential inhibitors—A review
    Abdur Rauf, Anees Ahmed Khalil, Samir Awadallah, Shahid Ali Khan, Tareq Abu‐Izneid, Muhammad Kamran, Hassan A. Hemeg, Mohammad S. Mubarak, Ahood Khalid, Polrat Wilairatana
    Food Science & Nutrition.2024; 12(2): 675.     CrossRef
  • The Protective Effects of Chrysanthemum cornarium L. var. spatiosum Extract on HIT-T15 Pancreatic β-Cells against Alloxan-induced Oxidative Stress
    In-Hye Kim, Kang-Jin Cho, Jeong-Sook Ko, Jae-Hyun Kim, Ae-Son Om
    The Korean Journal of Food And Nutrition.2012; 25(1): 123.     CrossRef
Protective Effect of PGC-1 on Lipid Overload-induced Apoptosis in Vascular Endothelial Cell.
Eun Hee Koh, Youn Mi Kim, Ha Jung Kim, Woo Je Lee, Jong Chul Won, Min Seon Kim, Ki Up Lee, Joong Yeol Park
Korean Diabetes J. 2006;30(3):151-160.   Published online May 1, 2006
DOI: https://doi.org/10.4093/jkda.2006.30.3.151
  • 2,958 View
  • 25 Download
AbstractAbstract PDF
BACKGROUND
Fatty acids contribute to endothelial cell dysfunction and apoptosis by inducing accumulation of long chain fatty acyl CoA (LCAC), which increases oxidative stress in vascular endothelial cells. Forced expression of PGC-1 was shown to induce mitochondrial biogenesis and to control expression of mitochondrial enzymes involved in fatty acid oxidation. This study was undertaken to test the hypothesis that PGC-1 overexpression could prevent endothelial cell apoptosis by enhancing fatty acid oxidation and relieving oxidative stress in vascular endothelium. METHODS: Adenoviruses containing human PGC-1 (Ad-PGC-1) and beta-galactosidase (Ad-beta-gal) were transfected to confluent human aortic endothelial cells (HAECs). To investigate the effect of adenoviral PGC-1 gene transfer on apoptosis, combined treatment of linoleic acid (LA), an unsaturated fatty acid, was performed. RESULTS: PGC-1 overexpression inhibited the increase in ROS production and apoptosis of HAECs induced by LA. Also, PGC-1 led to a significant increase in fatty acid oxidation and decrease in triglyceride content in HAECs. LA caused the decrease of adenine nucleotide translocase (ANT) activity and transient mitochondrial hyperpolarization, which was followed by depolarization. PGC-1 overexpression prevented these processes. CONCLUSION: In summary, PGC-1 overexpression inhibited mitochondrial dysfunction and apoptosis by facilitating fatty acid oxidation and protecting against the damage from oxidative stress in HAECs. The data collectively suggest that the regulation of intracellular PGC-1 expression might play a critical role in preventing atherosclerosis.
Oxidative Stress of INS-1 Cell, HIT-T15 Cell and Rat Islet Cell as a Mechanism of Glucose Toxicity.
Mi Jung Eun, Kyu Chang Won, Jun Sung Moon, Sun Jung Mun, Ji Eun Lee, Ji Sung Yoon, Kyung Ah Chun, Ihn Ho Cho, Hyoung Woo Lee
Korean Diabetes J. 2005;29(5):393-400.   Published online September 1, 2005
  • 1,893 View
  • 40 Download
AbstractAbstract PDF
BACKGOUND: Chronic hyperglycemia is the proximate cause of many complications of diabetes. The beta cells in type 2 diabetes are also adversely affected by chronic hyperglycemia, with this relentless deterioration in cell function, due to constant exposure to supraphysiologic concentrations of glucose, is termed glucose toxicity; however, the mechanism of glucose toxicity is uncertain. The purpose of this study was to determine whether prolonged exposure of pancreatic islets to supraphysiologic glucose concentration disrupts the intracellular balance between reactive oxygen species(ROS) and antioxidant enzyme; thereby, causing defective insulin secretion. METHODS: HIT-T15 cells were treated with H2O2(20, 50 and 100micrometer) directly added to the culture media, and then intracellular peroxide and insulin mRNA were then measured. The effects of H2O2 on the total peroxide level and insulin secretion were also examined. Isolated pancreatic islet cells from Wistar and 2 beta cell lines (INS-1, HIT-T15) were cultured in either a glucose or ribose (5.6, 11.1, 22.2, 30 and 50mM) containing culture media for 72hours. The intracellular peroxide was measured using flow cytometry and glucose stimulated insulin secretion(GSIS). RESULTS: The intracellular peroxide levels due to H2O2 in HIT-T15 cells were higher with a high concentration of H2O2, and the insulin mRNA in HIT-T15 cells decreased when the cells are treated with a high concentration H2O2. The insulin mRNA of the HIT-T15 cells cultured in a high concentration of ribose was lower than of those cultured in a low concentration of glucose. INS-1, HIT-T15 and rat islet cells, cultured for 72 hours, had progressively greater peroxide levels with higher concentrations of both glucose and ribose. The GSIS in the cells cultured in high concentrations of both glucose and ribose were decreased. CONCLUSION: These results suggest only one potential central mechanism for glucose toxicity in beta cells, this being the formation of excess ROS.
Role of Activation of NF- B and AP-1 by Oxidative Stress in Atherosclerosis in Diabetic Patients.
Chul Sik Kim, Geun Taek Lee, Jina Park, Min Ho Cho, Joo Young Nam, Jong Suk Park, Dol Mi Kim, Chul Woo Ahn, Bong Soo Cha, Sung Kil Lim, Kyung Rae Kim, Hyun Chul Lee
Korean Diabetes J. 2004;28(4):255-264.   Published online August 1, 2004
  • 1,537 View
  • 26 Download
AbstractAbstract PDF
BACKGROUND
The aim of this study was to evaluate the possible role of NF- B activation and AP-1 by oxidative stress in atherosclerosis in diabetic patients by measuring the carotid intima-media thickness, intracellular ROS generation and activation of transcription factors, including nuclear factor-kappa B (NF- B) and activator protein-1 (AP-1). METHODS: Sixty-six patients (28 males, 38 females; age 56.1 13.4 years; duration of diabetes 115.7 83.4 months) with type 2 diabetes mellitus (DM) were selected for this study. The DM patients included in this study were divided into those with a normal carotid intima-media thickness (Group II) and those with an increased intima-media thickness (Group III). 57 healthy controls matched for age and sex with the DM patients (Group I) were randomly selected. Dichlorodifluorescein (DCF)-sensitive intracellular ROS was measured by fluorescent spectrometry. The activities of NF- B and AP-1 in PBMCs were measured by an electrophoretic mobility shift assay. RESULTS: No differences were evident between the groups in terms of gender, age, BMI, blood pressure, total cholesterol, triglyceride, LDL-cholesterol and HDL-cholesterol. Spontaneous and H2O2 (or phorbol-12-myristate-13-acetate, PMA) stimulated ROS were significantly higher in the PBMCs from the DM patients with an increased intima-media thickness (Group III) than in those without (Group II), and were also higher in the control group (Group I). Moreover, the activities of NF- B and AP-1 were significantly higher in Group III than in Groups I or II. CONCLUSION: The present study demonstrates that intracellular ROS generation, and NF- B and AP-1 activation in PBMCs strongly correlates with the carotid artery IMT. These clinical results suggest that increased oxidative stress in PBMCs may play a role in the pathogenesis of atherosclerosis in DM patients .
The Effect of alpha-lipoic Acid on Endothelial Dysfunction Induced by Intralipid Infusion in Healthy Volunteers.
Dong Wook Lee, Mi Jung Kim, Hye Soon Kim, Tae Sung Yun, Ho Chan Cho, Sang Jun Lee, Seung Ho Hur, Kyo Cheol Mun, Yong Won Cho, Jae Hoon Bae, In Kyu Lee
Korean Diabetes J. 2002;26(5):336-346.   Published online October 1, 2002
  • 3,385 View
  • 27 Download
AbstractAbstract PDF
BACKGROUND
Endothelial dysfunciton has been proposed as an early manifestation of atherogenesis. Recently, emerging evidence suggests that hypertriglyceridemia and elevated free fatty acid are important risk factors in the development of atherosclerosis, probably through an increased oxidative stress. To clarify the hypothesis, we evaluated the effect of alpha-lipoic acid (ALA) on the endothelial dysfunction induced by intralipid infusion in healthy volunteers. METHODS: Hypertriglyceridemia and elevated free fatty acids was induced by infusion of intralipid. FMD (Flow-mediated dilation) of the brachial artery was investigated noninvasively by a high-resolution ultrasound technique in 13 young, healthy men without risk factors for coronary heart disease. RESULTS: Plasma triglyceride, free fatty acid and the superoxide anion were increased from 61.7+/-28.8 to 332.6+/-202.5 mg/dL, from 330.7+/-131.1 to 1267.0+/-486.2 microEq/L and from 6.6+/-2.2 to 8.7+/-1.5 X 10(-7)nmol/10(6)cells/30min (vs. basal p<0.001), respectively, following infusion of the intralipid. The FMD was decreased from 10.1+/-3.3 to 7.7+/-3.7% (vs. basal p<0.01) following infusion of the intralipid. After treatment with ALA, the increase in the FMD and the decrease in superoxide anion were significant. CONCLUSION: Acute hypertriglyceridemia, induced by intralipid infusion, is implicated in endothelial dysfunction. This endothelial dysfunction was reversed by treatment with ALA. These results suggest that chronic and repeated hypertriglyceridemia may play important roles in the development of atherosclerosis probably by increasing oxidative stress.
Effects of Hydrogen Peroxide on Insulin Secretion in Rat Pancreatic Islets.
Chul Hee Kim, Chan Hee Kim, Hyeong Kyu Park, Kyo Il Suh, Ki Up Lee
Korean Diabetes J. 2002;26(4):265-273.   Published online August 1, 2002
  • 2,734 View
  • 75 Download
AbstractAbstract PDF
BACKGROUND
It has been hypothesized that reactive oxygen species (ROS) are involved in the progression of beta cell dysfunction in both type 1 and type 2 diabetes mellitus. On the other hand, recent evidence suggests that ROS might be an integral component of intracellular signaling. This study was undertaken to examine effects of hydrogen peroxide (H2O2) on insulin secretion by various secretagogues in isolated rat pancreatic islets. METHODS: Pancreatic islets from normal Sprague-Dawley rats were isolated by intraductal injection of collagenase and Ficoll-gradient centrifugation. Isolated islets were treated with H2O2 directly added to the culture media or continuously generated by glucose-glucose oxidase system for 24 hours. Insulin secretion stimulated by glucose, arginine, and KCl was measured by radioimmunoassay. RESULTS: Basal insulin secretion was increased after treatment with H2O2. Treatment with low concentration of H2O2 stimulated insulin secretion in response to 27 mM glucose. In contrast, insulin secretion stimulated by 27 mM glucose was significantly decreased after treatment with high concentrations of H2O2. Arginine- stimulated insulin secretion was increased by both low- and high concentrations of H2O2. Insulin secretion stimulated by KCl was not affected by treatment with H2O2. CONCLUSION: These results suggest that the effect of H2O2 is diverse according to its concentration and different insulin secretagogues. In particular, H2O2 has a dual action on glucose-induced insulin secretion. At low concentration, H2O2 can stimulate insulin secretion probably by acting on signaling pathway of stimulus- secretion coupling. In contrast, high concentrations of H2O2 impairs glucose- induced insulin secretion, probably by acting as an oxidative stress.
The Effect of Alpha-lipoic Acid on Endothelial Dysfunction in Postmenopausal Uncomplicated Type 2 Diabetes.
Ho Chan Cho, Sang Jun Lee, Mi Jung Kim, Hye Sun Kim, Tae Sung Yun, Sung Jae Kim, Sang Hyon Kim, Seung Ho Hur, Kyo Chul Moon, Jae Hoon Bae, In Kyu Lee
Korean Diabetes J. 2002;26(4):242-252.   Published online August 1, 2002
  • 2,258 View
  • 29 Download
AbstractAbstract PDF
BACKGROUND
Recently, increased oxidative stress has been proposed as a major cause of vascular complications of patients with diabetes mellitus. Increased generation of oxygen free radicals in patients with diabetes mellitus could deplete cellular antioxidants and inactivate endothelial dependent vasodilating factor (EDRF), such as nitric oxide (NO). The purpose of this study was to evaluate whether the antioxidant alpha-lipoic acid (ALA) is effective in endothelial dysfunction of brachial artery, which induced by increased oxidative stress in postmenopausal diabetic women using high resolution ultrasound technique and initial reaction time (IRT) measurement. METHODS: We enrolled 11 menopausal women (mean age, 56.5+/-5.1 years) with uncomplicated type 2 diabetes. All patients were taking 1200 mg of ALA (Thioctacid(R), Bukwang, Korea). We measured of superoxide anion (O2-) in neutrophils as a marker of oxidative stress. Flow-mediated dilation (FMD) was measured using a high-resolution ultrasound. RESULTS: After treatment of ALA, fasting blood glucose was decreased significantly, the endothelium-dependent vasodilation of the brachial artery was increased, and O2- production was also decreased significantly. CONCLUSION: These results show that short term ALA treatment could improve the endothelial dysfunction in patients with type 2 diabetes mellitus. This improvement might be related with the antioxidants effect of ALA.
The Effect of alpha-Lipoic Acid on Vascular Smooth Muscle Cell Proliferation, Migration, Neointimal Formation and PAI-1 Expression.
Dong Woo Shin, Dong Wook Lee, Sang Jun Lee, Hye Soon Kim, Hyo Gyoung Kang, Jong Deok Ahn, In Kyu Lee
Korean Diabetes J. 2001;25(6):446-459.   Published online December 1, 2001
  • 1,813 View
  • 27 Download
AbstractAbstract PDF
BACKGROUND
Exposure to large amounts of glucose causes a characteristic dysfunction and morphologic changes of the endothelium by an increased production of reactive oxygen species (ROS) in diabetes. The plasminogen activator inhibitor-1 (PAI-1), which modulates fibrinolysis and cell migration, may influence proteolysis and neointimal formation in vascular smooth muscle cells (VSMC). Antioxidants have been proposed to inhibit multiple proatherogenic events. This study investigated the effect of (alpha)-Lipoic acid on PAI-1 expression and VSMC proliferation and migration both in vivo and in vitro. METHODS: In the in vitro study, cultured rat aortic smooth muscle cells (RASMC) were incubated in a medium containing high glucose (22 mM) and 100 nM angiotensin II for 4 hour. After (alpha)-Lipoic acidtreatment, a -migration and growth assay of the RASMC, and a gel mobility shift assay and reporter gene analysis for nuclear factor- B (NF-kappa B) and northern blot analysis for PAI-1 were performed. In the in vivo study, the effect of (alpha)-Lipoic acid on neointimal hyperplasia in a rat carotid balloon injury model was evaluated. RESULTS: RASMC migration was inhibited significantly by (alpha)-Lipoic acid (p<0.01), but their proliferation was not inhibited. The NF-kappa B DNA binding activity and NF-kappa B promoter activity was inhibited by (alpha)-Lipoic acid significantly (p<0.01). (alpha)-Lipoic acid inhibited PAI-1 mRNA expression by high glucose and angiotensin II in dose dependent manner (p<0.05). In the rat carotid artery balloon injury model, neointimal formation was reduced by (alpha)-Lipoic acid treatment in a dose dependent manner significantly (p<0.01). CONCLUSION: (alpha)-Lipoic acid suppresses migration, but not proliferation in RASMC. (alpha)-Lipoic acid also reduce neointima formation in a rat carotid balloon injured model. This effect might be related to the blocking of NF-kappa B which increase the expression of the genes associated with atherosclerosis including TNF-alpha, IL-1, IL-6, endothelin-1, MCP-1, VCAM-1, ICAM-1, E-selectin, tissue factor.
Oxidative Stress and Antioxidative Defense System in Offspring of Protein-Malnourished Rats.
Eun Young Cho, Hyeong Kyu Park, Hyeon Jeong Jeon, Suk Kyeong Kim, Kyong Soo Park, Chong Ho Lee, Seong Yeon Kim, Hong Kyu Lee
Korean Diabetes J. 2001;25(3):190-199.   Published online June 1, 2001
  • 1,736 View
  • 19 Download
AbstractAbstract PDF
BACKGROUND
Free radical-mediated oxidative damage has been implicated in a variety of pathological processes such as diabetes mellitus, aging and atherosclerosis. The susceptibility of a given organism to oxidative damage is influenced by the overall balance between the degree of oxidative stress and antioxidative capabilities. Nutrition plays an important role in determining the cellular antioxidative defense mechanism. Thus, the aim of this study is to investigate the effects of fetal protein malnutrition on oxidative stress and antioxidative capabilities. METHOD: Rats were fed a low-protein (8% casein) diet throughout pregnancy and lactation. Male offspring were weaned onto either a control (18% casein) diet (group 2) or a low-protein diet (group 3). Offspring from rats fed a control diet were weaned onto a control diet (group 1). The activities of superoxide dismutase (SOD), glutathione peroxidase (GPx) and the concentration of thiobarbituric acid- reactive substances (TBARS) were determined at 10 and 15 wk in liver and skeletal muscle from offspring. RESULTS: SOD activities of liver in group 3 were significantly lower than those in group 1 at 10 wk (4.14+/-0.65 U/mg protein, 9.09+/-0.85 U/mg protein) and 15 wk (4.18+/-0.58 U/mg protein, 7.63+/-0.74 U/mg protein), respectively. But SOD activities of skeletal muscle were not different between groups. Whilst GPx activities of liver were not different at 10 wk, GPx activities in group 2 (1.80+/-0.16 U/mg protein) were significant higher than those in group 1 (1.24+/-0.15 U/mg protein) at 15 wk. GPx activities of skeletal muscle were not different between groups. The TBARS concentrations in liver or skeletal muscle were not different between groups at 10 and 15 wk. There was a significant negative correlation between SOD activities and TBARS concentrations in liver (r=-0.359). CONCLUSION: In offspring of rats fed a low-protein diet throughout pregnancy and lactation, the antioxidant enzyme activities were significantly decreased, compared with offspring of rats fed a control diet. These alterations were not fully restored in low-protein offspring even when weaned onto a control diet. These results suggest that fetal protein malnutrition impair the antioxidative defense system.
The Oxidative Stress and the Antioxidant System in Type 2 Diabetics with Complications.
Ae Wha Ha, Hye Lim Noh, Yoon Sok Chung, Kawn Woo Lee, Hyeon Man Kim, Jung Soon Cho
Korean Diabetes J. 1998;22(3):253-261.   Published online January 1, 2001
  • 1,667 View
  • 30 Download
AbstractAbstract PDF
BACKGROUND
Diabetes mellitus represents a state of increased oxidative stress which is based on the evidence of increased peroxidation and glycosylation, and reduced antioxidant system. It has been suggested that increased oxidative stress may play an important role on the pathogenesis of diabetic complication in type 2 diabetes. However, limited informations regarding the oxidative stress and antioxidant system in diabetic complications are available. Therefore the purpose of this study is to determine the oxidative stress and antioxidant system in type 2 diabetes with diabetic complications. METHODS: The study population consisted of 94 type 2 diabetic patients and 44 normal subjects. The concentration of thiobarbituric acid reactive substance(TBA-RS) and the activities of antioxidants enzymes, catalase, superoxide dismutase(SOD), glutathione peroxidase(GSH-Px) in erythrocyte were detennined by using spectrophotometer. The plasma concantrations of b-carotene, lycopene, lutein, a-tocopherol and retinol were determined by using HPLC. RESULTS: The TBA-RS concentrations in type 2 diabetes(1.33+0.30nmol/mL) were significantly higher than those in normal subjects(1.10+0.17nmol/ mL). Also the TBA-RS concentrations between subjects with complications(1.37+0.27nmol/mL) and without complications(1.28+0.17nmol/mL) differed (p<0.05). The activities of SOD and GSH-Px in type 2 diabetes(2.99+0.80U/mgHb, 2.88+0.39U/ mgHb) were significantly lower than those in normal subjects(3.54+0.44U/mgHb, 3.14+0.39U/mgHb). GSH-Px between diabetics with(2.81+0.6U/mgHb) and without complications(3.17+0.4U/mgHb) differed significantly. The plasma concentrations of lycopene and b-carotene were significantly lower in type 2 diabetes(0.07+0.05umol/L, 0.54+0.27umol/L) than in control subjects(0.14+0.06umol/L, 0.67+0.32umol/L). Also, lycopene and b-carotene in subjects with complications(0.05+0.04umol/L, 0.45+0.23umol/L) were lower than in subjects without complications(0.08+0.05umol/L, 0.62+0.30umol/L). No significant differences in plasma a-tocopherol concentrations between subjects with and without complications(19.42+0.93umol/L vs 18.66+ 0.79umoll/L). CONCLUSION: This study showed that in diabetes with diabetic complications, the lipid peroxidation of erythrocytes are highly increased and the antioxidant reserves are significmtly depleted, compared with diabetes without diabetic complications, which suggests that diabetes with complications are under high oxidative stress and the supplementations of carotenoids could decrease the oxidative stress in diabetes with diabetic complications.
The Effect of Acute Hyperglycemia on Endothelial Function in Type 2 Diabetes.
Sang Jun Lee, Dong Wook Lee, In Kyu Lee
Korean Diabetes J. 2000;24(5):574-586.   Published online January 1, 2001
  • 1,675 View
  • 16 Download
AbstractAbstract
BACKGROUND
Multiple studies in patients with diabetes demonstrate impaired endothelial-dependent vasodilation. But the mechanisms of vascular dysfunction in type 2 diabetes are still controversial. Some risk factors, such as dyslipidemia, hypertension and obesity, are commonly associated with type 2 diabetes. These risk factor may cause endothelial dysfunction. And hyperglycemia may have a specific role in the increased risk of vascular complications in diabetes but it remains unclear. The purpose of this study was to examine whether endothelial dysfunction occurs when acute hyperglycemia is induced by oral glucose loading. METHOD: Using the high-resolution ultrasound, we measured flow-mediated vasodilation (endothelial dependent vasodilation: FMD) during oral glucose tolerance test in 11 men (mean age: 59+/-5 years) with type 2 diabetes without chronic diabetic complications. For statistical analysis, we used paired t-test, generalized linear method (GLM) to compare FMD before and after glucose loading. RESULT: Flow-mediated vasodilation was diminished after glucose loading (13.2+/- 6.4%, 7.3+/-3.3*%, 12.8+/-5.6%, in fasting, at 1- and 2-h, respectively; *p<0.001 vs fasting). Superoxide anion formation by neutrophils was increased after glucose loading (4.65+/-2.8, 6.17+/-2.2, in fasting, at 1-h respectively: p<0.05 vs fasting)( 10-7nmol/106cells/30min). Endothelial independent vasodilation was not significantly affected by glucose loading. The concentration of triglyceride were not changed after glucose loading. CONCLUSION: This study shows that acute hyperglycemia induced by 75 gm oral glucose intake results in endothelial dysfunction. These results suggest that prolonged and repeated hyperglycemia may play an important role in the developement and progression of vascular complication in diabetes.

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP